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Introduction
Heart failure is a clinical syndrome defined by the presence of typical symptoms 
(breathlessness, fatigue, ankle swelling), induced by an underlying functional cardiac 
abnormality, that results in an insufficient pump function or high intracardiac pressures 
at rest or during exertion1. Despite numerous advances in the prevention, diagnosis and 
treatment of cardiac disease that lead to dysfunction, heart failure still prevails in 1-2% 
of the adult population in high income countries, and up to 10% of people over 70 years 
of age, and accounts for high rates of mortality and hospitalization2-4.
However, recognizing the disease at this stage may be too late for possibly attempting 
a curative treatment that would restore the normal cardiac function. Before the clinical 
symptoms set on, patients do have unrecognized structural or functional abnormali-
ties that prelude heart failure5,6. Demonstrating such a structural (myocardial disease, 
valvular heart disease, etc.) or functional abnormality in the heart is thought to be 
essential to the early diagnosis and treatment. In the very early stages of the disease, 
such abnormality can be subtle or completely absent at rest, and present only during 
exertion, eliciting complicated investigations1.
1. SYSTOlIC AnD DIASTOlIC fUnCTIOn
It is very difficult to strictly define cardiac function1,7. More than a simple pump, the 
heart is a very active organ, adapting its shape and activity to the needs of the body, and 
even interacting with other organs and systems via endocrine secretions. For a long time 
researchers have tried to understand the inner workings of this fascinating organ that is 
essentially keeping us alive8.
Contraction and relaxation of the cardiac myocyte are active processes, meaning 
that coupling and uncoupling of the myofibril bridges needs adenosine triphosphate 
(ATP)9,10. Ischemia for example, thus the lack of ATP production, first impedes the active 
muscular relaxation and is manifested by acute diastolic dysfunction. Any prolonged 
ischemia would eventually also affect the systolic function11.
The first aspect that is evident is the forward pump function, in other words, how much 
blood could be sent forward into the body, and how good this flow can be adapted to the 
needs of the body. This is a raw description of what we presently understand by systolic 
function12.
10  
The other side of the heart function is being able to adequately accommodate the filling 
flow coming from the body or the lungs, without limiting or obstructing the continuity 
of this flow. This is the diastolic function of the heart9,10,12.
Much like the forward pump function, it is not only about the change in volume allowing 
a certain amount of blood to fill the cavities before the next ejection. It is also about 
the heart’s ability to do this at an adequate rate and with minimal pressure rise, since 
the extracardiac inflow system is a low-pressure system without unidirectional valves. 
This means that any excessive rise in pressure would reflect backwards and limit the 
filling9,10,12. Furthermore, the diastolic function varies in time, since it is conditioned by 
numerous active and passive factors.
2. CARDIAC CYClE
The dynamic relation between contraction and relaxation, filling and emptying of the 
heart, represents a continuum that has been studied extensively and is named the car-
diac cycle, arbitrarily divided in electrical, mechanical or volumetric aspects that do not 
perfectly superpose as there are interactions and overlapping between these aspects13. 
The temporal relationship of the events during this continuum is classically represented 
in the Wigger’s diagram (Figure 1):
It is important to note that the pressure and volume continuously vary during this cycle, 
with the exception of a few time intervals where at least one of these variables remains 
stable. For example, the only period when there is very little variation in pressure and 
volume is the end of diastasis, i.e., right before the atrial contraction. Also, during the 
isovolumetric periods very rapid build or decrease in pressure occurs without volume 
change, leading to rapid variation in parietal distension forces12-17.
To make this variability even more complex, the heart continuously interacts with the 
rest of the body through very complex regulation of the contractility (variation in heart 
rate and inotropic state), preload and load dependent increase in contractility (Frank 
Starling law), and afterload12,14-16.
3. HEART SOUnDS
Heart sounds have been among the first physical signs investigated by modern 
semiology.12,18-23Heart sounds are audible vibrations induced by the heart. The most 
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important components of these sounds are the valvular components, although other 
sounds may participate12,18,19 (turbulence of the blood flow, vibration of the heart walls, 
vibration of the aorta because of flow). In its turn, the valvular component is formed 
mainly by the closing of one heart valve, closely followed by the closing and opening 
of the other valves, in a sequence that is determined by the electrical activation and 
diff erence in pressures between the left  and the right heart12.
The first heart sound (S1) is mainly composed of the mitral valve closure, followed 
closely by tricuspid valve closure and successive opening of the pulmonary and aortic 
valves (M-T-P-A). Reciprocally, the second heart sound (S2) is formed by the closing of 
the aortic valve, followed by closure of the pulmonary and opening of the tricuspid and 
mitral valve (A-P-T-M)12,19. The respective closing sound is provoked by the reverberation 
of the blood as the column of blood suddenly decelerates and is blocked by the valve18,19.
figure 1. Classic Wigger’s diagram for the left  heart (Wiggers Diagram 2.svg. (2017, October 9). Wikimedia 
Commons, the free media repository. Retrieved 14:46, March 27, 2019 from https://commons.wikimedia.
org/w/index.php?title=File:Wiggers_Diagram_2.svg&oldid=262202428). The heart cycle and the relation 
between ECG, heart sounds, volume and pressure in the left  ventricle. Systole and diastole are defined 
according to the valve events. The diastole is further subdivided into isovolumetric relaxation, early filling, 
diastasis and atrial systole. The isovolumetric contraction is an early systolic event.
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The relation of the heart sounds with the flow and motion events in the left heart is 
depicted in Figure 2. Notice the presence of the two isovolumetric periods, between 
the closure of the mitral valve and opening of the aortic and respectively closure of the 
aorta and opening of the mitral valve. During these times pressure is changing rapidly, 
but volume remains virtually constant12,17. Also notice that the isovolumetric contrac-
tion is slightly shorter than the relaxation. Also, as already noted by several authors, 
the closing of the mitral valve happens a lot later in relation to the QRS complex R wave 
on the electrocardiogram (ECG) than theoretically considered in the classical Wigger 
diagram13,20-23.
Several studies looked at the delay between the actual valve snapping and the phono-
cardiography (PCG) tracing24,25. This delay is expected to be short because of the velocity 
of sound in the tissue (1540 m/s in soft tissue26), and was demonstrated to range under 3 
ms for modern echocardiographic systems24. In other words, any other event generated 
by the closing of the mitral or aortic valves should be seen as synchronous to the onset 
of the respective heart sounds. As will be seen in this thesis, the closing of the valves is 
a natural source of vibrations in the heart that can be analyzed and used to investigate 
the stiffness of the muscle.
4. QUAnTIfYInG THE HEART fUnCTIOn
The study of the evolution of intracavitary pressure during the cardiac cycle provides 
information about the dynamic relationship between preload (incoming pressure and 
volume), afterload (resistance to ejection) and chamber properties: contractility and 
compliance12,14,17. During diastole, the heart remains closed with regard to the great ar-
teries because the superior arterial diastolic pressure keeps the vetriculo-arterial valves 
closed12. Compliance is the ability of the heart to distend and increase its inner volume 
simultaneous to the increase of transmural pressure12,17. It is reciprocal to elastance, 
which would be the tendency of the heart to recoil to its initial volume after removing a 
distending force14,15,17.
These last two reciprocal elastic properties of the cardiac chambers are very interesting, 
because although they are still influenced by loading conditions, they represent the 
inner properties of the heart walls. Diseases that affect directly the elastic properties of 
the heart muscle lead to a pathological reaction to incoming flow. Diastolic dysfunction 
of the ventricles however is the result of a combination of one or more factors: impaired 
relaxation (active process), reduction in the elastic recoil (restoring forces) and increased 
wall stiffness (structural damage)12,16.
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The main parameter presently needed to classify heart failure patients is the left ven-
tricle ejection fraction (LVEF= the relative volumetric variation to the maximal diastolic 
volume). According to the latest guidelines1, it separates patients in three groups, from 
those with normal or preserved LVEF (LVEF≥50%), those with mid-range LVEF (LVEF 
figure 2. Relation between heart 
sounds and the events during the 
cardiac cycle in the left ventricle of a 
normal volunteer (Source: personal 
collection). Phonocardiography sig-
nal is amplified and unfiltered in or-
der to increase sensitivity at the cost 
of an excess noise. The heart sounds 
are clearly defined (S1 and S2). The 
valvular events are marked with 
vertical lines, corresponding to the 
valve opening or closing clicks on the 
Doppler tracings (MVO: mitral valve 
opening; MVC: mitral valve closing; 
AVO: aortic valve opening; AVC: aor-
tic valve closure. As has already been 
observed, mitral valve closure occurs 
much later than the peak of the QRS 
complex as presented in the Wigger 
diagram. Note also that isovolu-
metric contraction is shorter than 
the isovolumetric relaxation. In the 
upper panel the pulmonary venous 
inflow into the left atrium, with a 
forward systolic (S) and diastolic (D) 
phase and an atrial reversal (AR). Be-
low the mitral inflow, with rapid fill-
ing (E) and atrial contraction (A). On 
the next panel, the medial annulus 
velocity measured with pulsed wave 
Tissue Doppler. The negative diastol-
ic velocities e’ and a’, corresponding 
to the filling phases during diastole, 
as well as the positive velocity in 
systole s’ are visible. During the iso-
volumetric periods, velocity spikes 
correspond to the valvular events. 
Below is the color M-mode inflow of 
the left ventricle during diastole, and 
the aortic outflow in systole.
ECG: electrocardiogram; PCG: phonocar-
diogram.
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between 40-49%), and those with clearly reduced LVEF (LVEF<40%). In patients with 
preserved LVEF it is accepted that the diastolic dysfunction is the main cause for heart 
failure. There is however overlap between these groups, as patients with reduced LVEF 
also have diastolic dysfunction and patients with preserved LVEF have subtle abnor-
malities in the forward pump function that cannot be detected by measuring the LVEF1.
Initially the heart function was characterized by using invasive pressure/volume loops, 
which can have a limited application in patients undergoing other invasive procedures, 
but cannot be used systematically in other patients12,14,17. Invasive measurements 
remain the reference and gold standard for the evaluation of diastolic function16. Unfor-
tunately, even the pressure/volume loops have their own limitations and are subject to 
a large variability, especially with loading conditions, but also with heart rate, chamber 
volume or inotropic state17. Another disadvantage would be that the elastic properties 
of the heart wall are indirectly calculated from the diastolic slope of the pressure/vol-
ume curve. This induces another possible error, if the tangent line is not a perfect fit. 
Moreover, given the indirect nature of this determination, this type of investigation gives 
global estimation of the elastic properties of the heart chambers, while ignoring local 
variations in stiffness17.
Noninvasive imaging on the other hand allows to precisely define deformation (change 
in shape and volume) and flow between cardiac chambers or between the heart and the 
great arteries1,7,27.
Echocardiography is the first-line imaging investigation of the heart because of its low 
cost, repeatability, ease of access and lack of complications. It has been so in the last 50 
years, and we owe to this method the largest part of our present-day understanding of 
in-vivo heart mechanics, physiology and pathology28.
In real life volumes can be measured with acceptable precision in echocardiography. 
With present day 3D application, their change can be followed throughout systole and 
diastole7. However, measuring the systolic heart function with echocardiography is not 
simple. Simple volume changes cannot offer insight into the contractile forces needed 
to obtain it, nor the mechanical stress imposed to the left ventricular wall in the process. 
Extensive research has been directed recently to defining and establishing new param-
eters for the pump function that would perform better than the classical LVEF29-35. Even 
more so, LVEF precise measurements have moved more in the field of alternate imaging 
modalities such as magnetic resonance imaging (MRI) and computed tomography scan-
ning (CT)27,36.
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The diastolic function can also be estimated with echocardiography. As we cannot 
directly measure the intracavitary pressures, the measurements rely on indices of flow 
in order to derive the pressure gradient between two cardiac chambers and between 
the heart and the body via its natural connections. This type of surrogate measure tries 
to replace the pressure sensor used in the gold standard pressure/volumes loops12,17. 
As further detailed in the following chapter, tissue motion and deformation can also be 
estimated with echocardiography and integrated into the assessment of the diastolic 
function.
5.  PRESEnT DAY AlGORITHMS fOR DIASTOlIC fUnCTIOn 
EVAlUATIOn WITH ECHOCARDIOGRAPHY
Although CMR and nuclear imaging may be used to estimate the filling rate of the left 
ventricle, the best modality of investigating the diastole is echocardiography, which is 
highly feasible, harmless, low cost, and can be used repetitively for follow-up16. Several 
indices of flow, as well as 2D measurements and tissue deformation form the basis of the 
present-day algorithm for diastolic function evaluation (Table 1 and Figure 2).
Table 1. Echocardiographic parameters of diastolic function (Adapted from Nagueh et al 2016)
Variable Method Abnormal values
E wave peak velocity (cm/s) Pulsed wave Doppler mitral inflow
A wave peak velocity (cm/s) Pulsed wave Doppler mitral inflow
E/A ratio Pulsed wave Doppler mitral inflow
MV DT Pulsed wave Doppler mitral inflow < 160 ms or > 200ms
e’ peak velocity (cm/s) Pulsed wave TDI mitral annulus < 7 cm/s medial
< 10 cm/s lateral
E/e’ 14
LA index volume (mL/BSA) Simpson biplane or 3D volume > 34 mL/m2
S wave velocity Pulsed wave Doppler pulmonary veins
D wave velocity Pulsed wave Doppler pulmonary veins
S/D Pulsed wave Doppler pulmonary veins S<D
AR duration Pulsed wave Doppler pulmonary veins AR>A
Vp (cm/s) Color M-mode of mitral inflow > 45 cm/s
E/Vp Color M-mode of mitral inflow ≥ 2.5
TR velocity (m/s) Continuous wave Doppler TR >2.8 m/s
The approach to diastolic function assessment according to the latest guidelines com-
prises a few successive steps16: confirmation of the diastolic dysfunction, estimation of 
the LV filling pressures and of the degree of severity (degree of dysfunction).
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Diastolic dysfunction is present if more than half of the following parameters meet the 
cut-off values: annular e’ velocity septal < 7 cm/s and lateral < 10 cm/s; E/average e’ >14; 
LA volume index > 34 mL/m2; peak TR velocity > 2.8 m/s16. Diastolic function is normal if 
more than half the parameters do not meet the cut-off, but the result can also fall into 
the grey zone, where precisely half of the parameters meet the cutoff value37.
If diastolic dysfunction is present, grading is performed according to a complicated 
algorithm16 (Figure 3).
figure 3. The algorithm for grading the diastolic function of the left ventricle according to the latest guide-
lines16 (Amended from Nagueh et al 2016, p.1335). In spite of the multiple parameters available, precise 
non-invasive determination of the diastolic pressures is currently impossible, and in certain conditions the 
diastolic function cannot be determined (“grey area”). LA: left atrium; LAP: left atrial pressure; TR: tricuspid 
valve regurgitation maximal velocity.
Beside these algorithms, new methods have been used to estimate the diastolic func-
tion: diastolic strain rate during the isovolumetric relaxation or early diastole, untwisting 
rate, and LA systolic strain7,16,27. These modalities present several technical challenges 
making their reproducibility in real life insufficient for clinical use16. Diastolic strain rate 
displays a significant variability depending on the ultrasound system and the software 
used for analysis. LV untwisting depends on correct identification of the apical short 
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axis and is strongly influenced by loading conditions. LA strain remains challenging 
in patients with marked LA enlargement and important areas of echo dropout at the 
interatrial septum and pulmonary veins16.
Therefore, current echocardiographic evaluation of the diastolic function is based on the 
algorithm presented in Figure 3. This approach needs multiple parameters, and leaves 
room for undetermined situations. Recent multicenter studies have proven that the cor-
relations of the individual indices with the intracardiac pressure is overall rather poor 
when taken individually, and only “fairly reliable” when used as part of an algorithm38.
Invasive and non-invasive imaging estimate the diastolic function by looking at the 
consequences of the interaction between the elastic properties of the wall, pre-charge, 
post-charge and active relaxation, being also influenced by the relation between intra-
pericardial and intrathoracic pressure.
We currently have no clinical modality to directly investigate the myocardial tissue 
elastic properties, which are primarily modified in disease states.
6.  DEfORMATIOn, TISSUE ElASTIC PROPERTIES, STRESS AnD 
STRAIn
The elasticity of a tissue refers to its property to deform reversibly under stress. Defor-
mation of a tissue occurs under internal or external forces39-40. The deformation forces 
are different with respect to their direction (Figure 4).
figure 4. General deformation forces acting on a material (adapted after Wells RG 2013, p.885). Compres-
sion and tension are generated by opposite vectors acting in line with the longitudinal axis. Shear forces are 
induced by opposite vectors, but this time transversal to the longitudinal axis line.
These can be compression or tension forces (perpendicular on the surface) or shear 
forces (parallel to the surface). These forces induce a stress, defined as the force normal-
ized to the area over which the force is exerted, or
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Stress = σ = F
A
. (1)
Stress induces strain, which is the deformation per unit of length, or
Strain = ε = 
∆L
L
. (2)
Plotting the stress σ versus the strain ε, as the deforming force applied is increased, 
produces a stress-strain diagram for the respective material. Generally elastic materials 
follow a sigmoid deformation (strain) curve when subjected to stress (tension), starting 
with a linear portion where relatively little deformation occurs. The last part of the sig-
moid curve corresponds to the failure (rupture) of the material39. Materials behave elas-
tically if the strain disappears when the stress is removed (as do tissues), or plastically 
if the strain does not return to zero after removing the stress (permanent deformation).
Important properties of the material can be deduced from the stress/strain diagram, 
such as the elasticity modulus. If the deformation is relatively small, involving only the 
first linear portion of the curve, the relationship is described by Hooke’s law39:
σ = E ε. (3)
The coefficient E in this equation describes the relation between longitudinal defor-
mation and strain of a homogeneous isotropic material (material whose properties 
are similar in all direction of deformation) and is called Young’s modulus or elasticity 
modulus. Another important constant describing the properties of a given homoge-
neous material is the Poisson’s ratio (ν). It is a measure of the Poisson’s effect, in which a 
material that is stretched tends to get thinner in a direction transversal to the direction 
of deformation39, i.e.
ν = - 
transversal strain
axial strain
. (4)
If we consider simultaneous deformation in all spatial directions (volume change under 
pressure = compression), we have to introduce a new constant κ, known as bulk modu-
lus. It is a measure of how a volume change relates to the compression in a material:
κ = - 
∆P
∆V/V
 = 
E
3(1−2 ν)
. (5)
The reciprocal of the bulk modulus is called the compressibility of the material. An 
ideal uncompressible material would have an infinite bulk modulus (the denominator in 
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equation (5) becomes 0). In such a material the Poisson’s ratio resulting from equation 
(5) ν = 1
2
.
If the deformation forces act as opposite transversal vectors as depicted in Figure 4, the 
material is subjected to shearing stress (τ). The resulting deformation is a shearing strain 
(γ). Plotting τ versus γ will result in a shear stress-strain diagram for the respective mate-
rial. As for normal (linear) stress and strain, the initial portion of the shear stress-strain 
diagram is a straight line. For this type of deformation equation (3) can be written:
τ = G γ (6)
This is equivalent to Hooke’s law above, yet now for shearing stress and strain, and the 
constant G in this equation is called the shear modulus. Combining equations (1)-(6) will 
give us a relationship between the constants we introduced so far: E, ν and G:
G = 
E
2(1−ν)
 (7)
Materials whose properties depend upon the direction of the force are defined as aniso-
tropic. An important form of anisotropic materials are the fiber-reinforced composite 
materials. This type of materials represents the closest the myocardial tissue40.
Tissue is an elastic material that has much higher bulk compression modulus than shear 
modulus. Its Poisson’s ratio is very close to 0.5 (it is nearly uncompressible). Therefore, 
the relation between E and G resulting from equation (7) is approximatively E=3 G39. Soft 
tissues however are not perfectly elastic materials, as they display a viscoelastic behav-
ior40, that also varies nonlinearly with shear rate41. Adding this to their fiber-reinforced 
composite structure makes that live tissue needs very complex simulation models to 
study its behavior.
The result is that different soft tissues have different stiffness, and the same tissue can 
have a different stiffness under different stress conditions (hyperelasticity)41,43,44. Depo-
sition of excessive collagen (fibrosis) into a tissue is thought to induce an increase in 
stiffness (Figure 5)40,45,46.
The in vivo elastic properties of the heart chambers are influenced by several compo-
nents: an active component due to muscle contraction, a parietal tension derived from 
Laplace’s law (this conditions the hyperelastic behavior of the myocardium) and an inert 
elasticity of the fully relaxed wall. The instantaneous value of myocardial stiffness is the 
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result of the interaction between these dynamic and static components, at any given 
moment during the heart cycle47.
figure 5. Relationship between shearing stress and shearing strain in the cardiac relaxed muscle (Source: 
personal collection), as resulting from experimental studies44-46 1: normal conditions, the relation is more 
linear; 2: a stiffer muscle would have a more vertical slope; 3:in very stiff myocardium, the relationship fol-
lows a sigmoid curve, with an initial milder slope, followed by a very steep one. This sigmoid appearance is 
due to hyperleasticity (stiffness is not constant; it is a function of the applied stress41,43,44). In normal condi-
tions, the myocardium would never get to the point of material failure.
In the heart, diastolic deformation is induced by relatively low-pressure systems (the 
atria) and is restricted in the end by pressure equilibrium (the higher the equilibrium 
pressure the steeper the curve, see Figure 5), conditioned by the maximum distensibil-
ity of the heart walls. This in turn is dependent on cavity size, wall thickness, elastic/
hyperelastic properties of the myocardium, and the pericardium43-46.
The passive elastic behavior of the myocardium when subjected to a multidimensional 
stress (similar to the in vivo conditions) is dependent on the bulk modulus κ and shear 
modulus G. These material-specific constants influence for example the propagation 
velocity of mechanical waves in the myocardium39.
7. MECHAnICAl WAVES AnD ElASTOGRAPHY
Sound (and ultrasound) is a longitudinal wave, i.e. a succession of rarefactions and com-
pressions propagating in the same direction as the local particle vibration. Opposite to 
this, particle vibration induced by a shear wave has a direction that is perpendicular to 
the direction of propagation42,48 (Figure 6). The propagation velocity of bulk shear waves 
in a material is related to the square root of the shear modulus G42, whereas the speed of 
sound is proportional to the square root of the bulk modulus κ.
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figure 6. Longitudinal waves versus shear waves (source: personal collection). Longitudinal waves (upper 
panel) are formed by a succession of rarefactions and compressions propagating longitudinally, the local 
particle vibration being in line with the direction of propagation of the wave. Shear waves (lower panel) 
have a particle vibration that is perpendicular to their direction of propagation. This induces a local oscil-
lation that has an amplitude (or a specific velocity of transversal displacement) and a specific wavelength.
Elastography is a relatively new direction in medical diagnosis aiming to display the 
biomechanical property of elasticity of a tissue42,48. It relies in general on following a 
transient shear deformation that propagates in the tissue as shear waves. The generating 
force may be mechanical pressure or vibration, naturally occurring physiological mo-
tion or induced by a focused acoustic radiation force at a controlled depth. The internal 
shear deformation resulting from the applied external or internal force can be measured 
with an imaging method (ultrasound or MRI)42. If the external force varies slowly as in 
the case of probe palpation for parenchymatous organs it is considered quasi-static, and 
cannot provide direct quantification. By using dynamic forces, as vibrations or impulses, 
precise quantification becomes possible. Vibration is mostly used in MRI studies, where 
a continuous harmonic vibration is applied at the body surface42,48. The usual approach 
in ultrasound elastography is tracking the shear wave that is induced by acoustic radia-
tion force42.
The idea to use ultrasound for detecting the elastic properties of a tissue relies on the 
difference in propagation velocity between sound (ultrasound), which is between 1350-
1600 m/s in soft tissue, and shear deformation waves which have a velocity range of 1-10 
m/s42,48
22  
By following the deformation induced by shear waves along a certain distance, usually 
along an M-mode line, we can determine the velocity of the shear wave, and thus indi-
rectly the tissue stiffness (Figure 7).
figure 7. Shear wave induced by acoustic radiation force ( US pulse) into a tissue phantom (modified from 
Vos et al 2016)49 . The shear wave propagates away from the focus region. Adding an M-mode line (dotted 
horizontal line in the upper panels) allows to reconstruct a velocity map (lower panel left). This can be con-
verted to acceleration maps (lower panel right), where automatic tracking of the shear wave propagation is 
easier. The slope of this color pattern (dotted oblique lines in the lower panels) represents the propagation 
velocity of the shear wave.
Given the velocity range of the shear waves (1-10 m/s), in order to image their propaga-
tion we need a very fast image sampling rate, allowing to capture the wave as it travels 
in the tissue.
8. HIGH fRAME RATE In ECHOCARDIOGRAPHY
A classical echography image (frame) is formed by successively scanning and adding 
adjacent lines (line-by-line scanning)50. Frame rate represents the frequency at which 
each new full sector frame can be displayed. The main factor conditioning the frame rate 
in ultrasound imaging is the velocity of sound and the number of ultrasound transmis-
sions needed to make the frame. At a depth of 15 cm in the apical window a return-trip 
takes about 200 μs. So, at this depth, 5000 pulses could be emitted and analyzed every 
second. In order to reconstruct a 2D sector of 90° with one line per degree, we need 90 
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return-trips, thus 90*200 μs=18 ms. This means on average that around 50 frames can be 
created per second, giving a sufficient temporal resolution for the global major events 
visible in 2D, even more so as the human eye only can follow up to about 30 Hz frame 
rate. Of course, such a frame rate may prove largely insufficient when trying to image 
faster events, as already known in pulsed wave Doppler imaging where detection of high 
velocities may be hampered by aliasing.
The only way to increase the frame rate is by lowering the number of pulses required to 
construct a single frame. In a classical clinical ultrasound system, this can be achieved 
by decreasing the opening of the field-of-view, and thus preserving spatial resolution, or 
by reducing the line density at the cost of spatial resolution but potentially preserving 
the field-of-view51.
Another approach, already in use in currently-available systems is multiline acquisition 
(MLA). This means that several lines (their number constitutes the ’’MLA factor’’) are 
reconstructed from a single broader transmit beam, at the cost of a lower spatial resolu-
tion and lower signal-to-noise ratio51.
In tridimensional echocardiography, in addition to MLA techniques, retrospective gat-
ing is used. That means that the imaging volume is divided into subsectors, that are 
combined over several (usually 2 to 6) cardiac cycles in order to restore the full volume 
image at the best resolution achievable.
Research is presently directed to other ultrasound modalities allowing reconstructing 
images from sparse full-sector broad beams (plane or diverging unfocused beams). 
This allows for very high frame rates (maximum possible for the given depth), but with 
a lower spatial resolution and lower contrast than line-based scanning. In order to 
overcome this aspect, spatial compounding was proposed, by using a few number of 
transmit events from slightly different angles, thus limiting the frame rate but drasti-
cally improving resolution and contrast. However, as compared to focused beams, plane 
wave and diverging wave imaging make harmonic imaging very difficult, because the 
energy of the large beams generate lower amounts of harmonics51.
The possibility of reaching very high frame rates has until now remained in the field of 
echocardiography. High frame rate in MRI still refers to rates of around 50-60 frames/
second52. However, due to the technological limitations (the need for the very strong 
coherent magnetic field generation), MRI does not yet seem able to reach the portability, 
ease of use and bedside characteristics of echocardiography. In the field of computed 
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tomography, obtaining higher frame rates has not been a goal, but rather an optimal 
compromise between frame rate and radiation dose53.
9. TISSUE CHARACTERIzATIOn WITH ECHOCARDIOGRAPHY?
One of the important questions in heart imaging is precisely defining the type of tissue 
we are investigating. This means for example being able to differentiate a tumorous 
mass from the normal myocardium, a benign from a malignant tumor, normal from 
infarcted myocardium, or diagnose the presence of an infiltrative diffuse disease of the 
myocardium. This method is referred to as tissue characterization54. This is mainly done 
today with MRI27,36,54, though not exclusively, since computed tomography and nuclear 
imaging also provide information on tissue.
By using ultrasound reflection imaging alone, in the standard fashion used to make clini-
cal echocardiography images, precise tissue characterization cannot be achieved. Some 
differences can be found in the signal intensity, as denser tissues are usually stronger 
reflectors, giving a high intensity signal, by reflecting a higher amount of the ultrasound 
wave at the interface with the surrounding structures. Also fluid gives an absence of 
echoes and a lens effect. Differences have been evoked between the speckle patterns of 
the cardiac muscle that would be suggestive for certain disease states, like the ’’granular 
sparkling’’ in cardiac amyloidosis55. It is however not specific, and highly dependent 
on the echocardiography system and image settings. It is thus currently impossible for 
clinical cardiac ultrasound applications to determine with reasonable sensitivity and 
specificity the nature of two adjacent soft tissues with similar density.
Clinical tissue characterization by echocardiography is in great need of finding and 
exploiting other active phenomena, sufficiently different from the imaging forming one 
(as is the case for MRI), that could be detected and measured with ultrasound.
10. CHAllEnGES Of SHEAR WAVE ElASTOGRAPHY Of THE HEART
Clinical tissue characterization by ultrasound is presently possible in various parenchy-
matous organs by elastography. Elastography by using shear wave imaging is already in 
use for numerous clinical applications, like liver fibrosis and breast, thyroid, prostate, 
kidney and lymph node imaging42. Several research groups have used external sources 
to induce shear waves in the myocardium56-64, demonstrating that diastolic myocardial 
stiffness can be determined using ultrasonic shear wave imaging63,64. However it is not 
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clear if such investigation could be carried out reliably in everyday clinical patients, as 
the signal in these images can be quite noisy.
By using high frame rate experimental systems, it has been noted that during very short 
periods of the cardiac cycle, pulsatile waves would travel on the heart65-68, and these 
waves are caused by the impulse of the snapping valve on the mitral and aortic annuli 
which propagates within the cardiac wall (Figure 8).
figure 8. Theoretical model of the shear waves generated by the closure of the valves (source: personal 
collection). Upper panel: parasternal long axis view, with mitral valve open (MVO, left hand side image) and 
mitral valve closed (MVC, right hand side image). The closure of the mitral valve (lower panel, M-mode at 
the tips of the mitral valve as demonstrated in the central zoomed panel) induces a shear wave (red bands) 
appearing at the valvular annulus and coursing to the apex of the LV (yellow arrows).
26  
Later studies demonstrated this type of waves to be a variation of Lamb waves60-62, thus 
elastic waves that propagate in a medium with velocities that are theoretically depen-
dent on the elastic properties of that medium68-71. Such naturally-occurring shear waves 
could thus be tracked in order to investigate the stiffness of the cardiac tissue, as will be 
shown in this thesis.
These waves can even be seen as very brief events in classical color M-mode tracings 
(Figure 9). Color Tissue Doppler is a Duplex mode that has the advantage of coupling 
information on both local tissue velocity variation and effective tissue motion as vis-
ible on the underlying 2D/M-mode72-73. However, the preliminary observations using 
regular clinical systems and relatively low frame rates could not link these TDI events to 
naturally-occurring shear waves72.
figure 9. Clinical color TDI duplex mode in a normal volunteer (source: personal collection), with the TDI 
window focused on the left ventricle walls and the mitral valve (upper left and right panels). The M-mode 
line is traced through the mitral valve tips (upper panels). In the lower panel very short events can be visual-
ized at the level of the LV walls at the closing of the aortic valve (not depicted in this image, but happening 
just before the opening of the mitral valve in M-mode) and just after the closing of the mitral valve (mitral 
valve shear wave).
A translation from research to a clinical application of shear wave imaging in the heart 
presents numerous challenges, that are discussed further.
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- Theoretical and conceptual challenges
Although in other organs it has been possible to demonstrate that shear wave imaging 
can clearly discriminate pathology from normal tissue, allowing a noninvasive elastog-
raphy of various organs, this is not yet as clear for the heart. One could assume that 
shear wave velocity should increase with increasing tissue stiffness, either diffusely in 
the whole heart or locally in case of myocardial scar. But the question is whether this 
difference in velocity is large enough to be exploited for clinical purposes.
The amplitude of the deformation (Figure 6) induced by the shear wave (the amplitude 
of the wave) should be large enough to be detected by the ultrasound system (velocity 
amplitude for a TDI system). Also, the frequency of these waves should be sufficiently 
high allowing a relatively short wavelength that can be measured precisely65-69.
- Imaging challenges
The heart is situated deeply in the thorax, at a distance ranging from 5 cm in the para-
sternal view up to 10-20 cm in the apical position7. To overcome the inherent attenua-
tion of the ultrasound, lower-frequency probes are used to ensure penetration, yet also 
providing lower spatial resolution. Nonetheless, patient-specific attenuation can limit 
the imaging depth50.
Also, large linear probes cannot fit between the intercostal spaces, the classical technical 
solution being the use of phased-array probes (Figure 10). This type of probes can cover 
a larger sector than the footprint of the probe itself, at the cost of a worse resolution in 
the far field as the lines diverge50. Also, as explained earlier, the beam needs to cover a 
relative wide sector in order to achieve high frame rates, which also reduces penetration 
depth51.
figure 10. Difference between a linear probe and a phased-array probe (source: personal collection). Lin-
ear probes emit and receive along parallel lines. Near field and far field have the same width50. Phased-array 
probes emit along slightly diverging lines, making the far field much wider than the near field, and the total 
opening much larger than the probe footprint. This also means that the resolution in the far field is signifi-
cantly lower but can be improved by focusing.
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A compromise has to be found between probe size and field of view, frequency and 
penetration depth , frame rate and image resolution. Until now, no clinical ultrasound 
application exists for cardiac elastography.
MRI has also been experimentally used for shear wave elastography of the heart74,75, with 
promising results, but a clinical MRI cardiac elastography is not yet implemented.
- Physiological challenges
The heart is continuously moving with respect to the surrounding organs and the chest 
wall, displaying a complex tridimensional motion (rotation, translation, shortening and 
lengthening). Also, during the periods when the heart is relatively stationary or does not 
change volume, there is continuous variation in the intraparietal tension due to contrac-
tion/relaxation or flow exchange. Therefore the stiffness itself, hence the shear modulus, 
varies in time throughout the cardiac cycle76,77, thus also changing the instantaneous 
shear wave velocity.
The behavior of the shear waves in the heart wall, be them externally induced or 
naturally-occurring, is not yet completely understood77. The optimal position in which 
these waves would be visible is not clear, given the relation between their direction of 
propagation and the direction of local particle vibration, as presented above (Figure 6).
Also, mainly for the naturally-occurring shear waves, the closing of the heart valves 
happens during very short periods of the heart cycle in which other mechanical and 
electrical phenomena take place (see Chapter 2 and 3 of the Introduction) . A challenge 
lies in separating these events from the shear waves themselves, which high frame rate 
imaging should be capable of distinguishing based on the exact timing of phenomena.
- Technical challenges
High frame rate imaging generates large amounts of data. Treating this data in real-time 
and constructing an image for live feed-back is currently impossible on any clinical 
ultrasound system by lack of computation power and too slow data flow. Also, adapted 
storage space with very fast access should be available. On the other hand, as stated 
above, the human eye can only interpret frame rates up to 30 Hz, indicating that the high 
frame rate data needs to be converted in-line to useful information with a refresh rate 
of 30 Hz at most.
Offline post processing needs fast data transfer and ideally automated tracking software 
in order to decrease measurement errors. Such software does not yet exist for cardiac 
applications.
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- Clinical challenge
For clinicians the most important question is to show that there is actual benefit in quan-
tifying shear waves velocities, and that it provides better sensitivity and/or specificity 
or it facilitates early recognition of a cardiac condition. Actually showing this benefit 
needs a large study population and a longitudinal design, as there is no noninvasive 
gold standard.
11. THESIS OUTlInE
In an effort to overcome the numerous challenges cited above, this thesis aims to prove 
that high frame rate echocardiography and cardiac shear wave imaging is feasible and 
can be used in order to detect local stiffness of the heart walls which would be clini-
cally relevant. It is not the purpose of this thesis to propose a new engineering solution, 
since the scientific effort was more directed towards the clinical and pathophysiological 
perspective. Taking advantage of an unforeseen technical ability of a clinical ultrasound 
system, allowing us to readily reach a compromise between most of the aforementioned 
challenges, we aim to demonstrate the importance and the clinical message of shear 
wave imaging in the heart.
The thesis is divided into two main parts. The first part represents a series of clinical 
investigations covering the present day echocardiographic estimation of the diastolic 
function, aiming to demonstrate the unanswered questions or grey areas in the estima-
tion of the diastolic function of the left ventricle. The second part presents a new way of 
looking at the diastolic properties of the left ventricle, by using high frame rate imaging, 
trying to fill in the gaps of our present algorithms.
Part one: clinical studies defining the challenge in assessing the diastolic 
function with present-day non-invasive methods.
In Chapter 2 we discuss the present day algorithm for the grading of diastolic function, 
endorsed by the American Society of Echocardiography and European Association of 
Echocardiography (ASE/EAE) and compare it with a local modified algorithm.
One of the key parameters in diastology is the E/e’ ratio. It represented a revolution in 
our understanding of the diastolic function based on more than filling patterns and flow 
indices. In Chapter 3 we investigate the correlation between the septal, lateral and aver-
age E/e’ ratio and the value of the N-terminal pro-hormone of brain natriuretic peptide 
(NT-proBNP) in a group of two-hundred-fifty consecutive symptomatic patients with 
severe aortic stenosis.
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Elevated pulmonary artery pressure (PAP) is directly related to the diastolic function 
and is a strong predictor of adverse prognosis1,16. In Chapter 4 we assess the relation be-
tween PAP and clinical and echocardiographic parameters in the same group of elderly 
patients with severe aortic stenosis, and search for the determinants of the change in 
PAP after transcatheter aortic valve implantation(TAVI).
Left atrial size has been used as an important marker of diastolic function/dysfunction. 
Left atrial volume and function are considered more important than linear size. They are 
also important indices in our algorithms for diastolic function assessment. Left atrial 
dimensions and volume have been a matter of debate, leading to significant changes 
in the latest guidelines for chamber quantification7. This is investigated in Chapter 5.
Left atrial function can be studied not only by volume change, Doppler flow or TDI 
velocities, but also by annulus displacement, which may have an important role in the 
end-diastolic filling and generate sudden traction forces on the atrioventricular annulus 
and LV walls. Chapter 6 looks at this pulling force of the left atrium on the mitral annulus 
from the left atrial perspective.
In clinical practice imaging is only a part of a very complex array of elements allowing 
estimation of the prognosis in heart failure patients. In Chapter 7 we study the prognos-
tic value of the echocardiographic parameters of diastolic dysfunction in the detection 
of clinical events in stable heart failure patients.
Part two: translational research for a new way of looking at the diastolic 
function of the heart, by using high frame rate imaging.
In Chapter 8 we define and explain the method used, and validate it in vitro by using 
tissue phantoms.
Chapter 9 analyses the reproducibility and variability of the method. The results ob-
tained with the clinical scanner (our method) and with an experimental system capable 
of reaching significantly higher frame rates are compared.
Shear waves should be able to detect a difference in myocardial stiffness, differentiating 
between normal and pathologically stiff myocardium. This is investigated in Chapter 10, 
in patients having diffuse myocardial disease.
By using shear wave elastography it is possible to resolve different tissue elastic prop-
erties. A local variation in stiffness has not yet been studied in vivo. In Chapter 11 we 
investigated shear wave propagation in patients with myocardial scar.
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The mitral annulus displacement with atrial contraction induces a wave-like phenom-
enon into the LV walls that was also proposed as a measure of left ventricular stiffness. 
By using our high frame rate TDI method in Chapter 12 we investigate the wave-like pat-
tern which travels over the interventricular septum after atrial contraction in patients 
with hypertrophic cardiomyopathy compared with healthy volunteers.
As described in the previous chapters, the stiffness of the heart is dynamic, and var-
ies among others with the filling conditions. Intracardiac flow in diastole can also be 
followed by using high frame rate imaging. In Chapter 13 we describe a new tracking 
algorithm of fluid dynamics in the left ventricle during diastole, taking advantage of the 
abilities of high frame rate echocardiography, this time using an experimental system 
able to image in 2D at very high frame rates (above 1000Hz), with full sector opening, 
adding a new perspective to our understanding of the diastolic function.
The overall results of the work are discussed in Chapter 14, with an overview of the fu-
ture research and possible clinical applications, and a summary is provided afterwards.
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ABSTRACT
The American Society of Echocardiography and European Association of Echocardiog-
raphy (ASE/EAE) have published an algorithm for the grading of diastolic function. 
However, the ability to use this algorithm effectively in daily clinical practice has not 
been investigated. We hypothesized that in some patients it may be difficult to grade 
diastolic dysfunction with this scheme, since there may be discrepancies in the assessed 
parameters. The aim of the current study was to test the feasibility of the ASE/EAE al-
gorithm and to compare this with a new Thoraxcenter (TXC) algorithm. The ASE/EAE 
and TXC algorithms were applied to 200 patients. The ASE/EAE algorithm starts with 
assessment of diastolic myocardial wall velocities and left atrial (LA) volumes with sub-
sequent assessment of E/A ratio, E-wave deceleration time and pulmonary venous flow. 
The TXC algorithm reverses these steps, uses LA dimension instead of volume and does 
not include a Valsalva manoeuvre and pulmonary venous flow. Due to inconsistencies 
between diastolic myocardial wall velocities and LA volumes and a not covered E/A ratio 
in the range of 1.5–2 it was not possible to classify 48 % of patients with the ASE/EAE 
algorithm, as opposed to only 10 % by the TXC algorithm. LA volume was always needed 
in the ASE/EAE algorithm. In only 64 % of patients LA size was necessary by the TXC 
algorithm. When LA volume would have been used instead of LA dimension, grading of 
LV diastolic function would have been different in only 2 % of patients without apparent 
improvement. Assessment of LA dimension was considerably faster than LA volume. The 
TXC algorithm to grade LV diastolic dysfunction was compared to the ASE/EAE algorithm 
simpler, faster, better reproducible and yields a higher diagnostic outcome.
Chapter 2 43
A simple, fast and reproducible echocardiographic approach to grade left ventricular diastolic function
InTRODUCTIOn
Heart failure is a major public health problem in developed countries [1]. Left ventricular 
(LV) diastolic dysfunction is one of the important mechanisms responsible for symptoms 
in patients with heart failure, irrespective of the presence or severity of systolic LV 
dysfunction [2]. It has been well established that diastolic dysfunction and filling pres-
sures can be assessed by two-dimensional and Doppler echocardiography [3, 4]. The 
American Society of Echocardiography and European Association of Echocardiography 
(ASE/EAE) have published a guideline for the echocardiographic assessment of diastolic 
function in various clinical conditions [5]. This ASE/EAE guideline contains a practical 
algorithm for grading diastolic dysfunction (Fig. 1a). The ASE/EAE authors claimed that 
this algorithm was an important predictor of all-cause mortality in an earlier large cross-
sectional survey [6]. However, the ability to use this algorithm effectively in daily clinical 
practice has not been investigated. We hypothesized that in some patients it may be dif-
ficult to grade diastolic dysfunction with this scheme, since there may be discrepancies 
in the assessed parameters. Therefore, the aim of this study was to test the feasibility of 
the ASE/EAE algorithm and to compare this with a newly proposed Thoraxcenter (TXC) 
algorithm (Fig. 1b).
METHODS
Study participants
The study population consisted of 200 consecutive patients (mean age 52 ± 15 year, 49 % 
female) referred for echocardiography in both a tertiary referral center (n = 85, Erasmus 
University Medical Center, Rotterdam, The Netherlands) and a smaller non-academical 
general hospital (n = 115, Sint Franciscus Gasthuis, Rotterdam, The Netherlands). As-
sessment of LV diastolic function had to be part of the echocardiography protocol and 
patients had to be in sinus rhythm. Athletes (international or national level of participa-
tion for at least 2 years) were excluded, as well as patients with hypertrophic cardiomy-
opathy, more than mild valvular disease, and a history of cardiac surgery.
In order to obtain a cut-off value for the ratio of peak early filling velocity (E) over mitral 
annulus early diastolic wave velocity (Em), 100 healthy control subjects (mean age 46 
± 14 year, female 49 %) in sinus rhythm, without hypertension, diabetes, or regular use 
of medication for cardiovascular disease, and with normal left atrial dimensions, LV 
dimensions, and LV ejection fraction were studied. Control subjects were recruited from 
our department (personnel) or were family members or friends. The institutional review 
board approved the study.
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figure 1. A. Grading of left ventricular diastolic function according to the ASE/EAE algorithm; B. Grading of 
left ventricular diastolic function according to TXC algorithm. E peak early filling velocity, A peak late filling 
velocity, DT E-velocity deceleration time, Em velocity of the mitral annulus early diastolic wave, TDI tissue 
Doppler imaging, LA left atrium, LAD left atrial dimension, LAV left atrial volume, Av averaged (from septal 
and lateral measurements)
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Echocardiography
Two-dimensional grayscale harmonic images were obtained in the left lateral decubitus 
position using a commercially available ultrasound system (iE33, Philips, Best, The 
Netherlands), equipped with a broadband (1–5 MHz) S5-1 transducer (frequency trans-
mitted 1.7 MHz, received 3.4 MHz). All echocardiographic measurements were averaged 
from three heartbeats. Left atrial (LA) dimension was measured as the anterior-posterior 
diameter in an end-systolic parasternal image. LA volume was calculated using the bi-
plane area-length formula and indexed for body surface area [7]. From the mitral-inflow 
pattern, E and peak late (A) filling velocities, E/A ratio, and E-velocity deceleration time 
(DT) were measured. Tissue Doppler imaging was applied by placing the sample vol-
ume at the side of the medial (septal Em) and lateral annulus (lateral Em) in an apical 
4-chamber view [8]. For the ASE/EAE algorithm both septal and lateral Em were needed, 
whereas for the TXC algorithm only septal Em was mandatory. Gain and filter settings 
were adjusted as needed to eliminate background noises and to allow for a clear tissue 
signal. To acquire the highest tissue velocities, the angle between the Doppler beam and 
the longitudinal motion of the investigated structure was adjusted to a minimal level. 
Em was recorded end-expiratory at a sweep speed of 100 mm/s.
Grading LV diastolic dysfunction
Two algorithms were used to grade diastolic dysfunction. The ASE/EAE algorithm was 
based on the scheme published in 2009 [5]:
•	 When	 septal	 Em	was	 ≥8	 cm/s,	 lateral	 Em	 ≥10	 cm/s	 and/or	 LA	 volume	 <34	ml/m2 
diastolic function was graded as normal.
•	 Since	 athletes	 were	 excluded,	 septal	 Em	 ≥8	 cm/s,	 lateral	 Em	 ≥10	 cm/s	 and/or	 LA	
volume ≥34 ml/m2 suggested constriction, although other clinical variables should 
be considered as well in that case.
•	 When	 septal	 Em	was	 <8	 cm/s,	 lateral	 Em	 <10	 cm/s	 and/or	 LA	 volume	 ≥34	ml/m2 
diastolic function was graded abnormal.
When it was not possible to grade diastolic dysfunction due to discrepancies in the as-
sessed parameters, the exact reason was registered.
The newly proposed TXC algorithm was primarily based on the same study by Redfield 
et al. [6] that was used as the basis of the ASE/EAE algorithm. However, it starts with as-
sessment of the E/A ratio and DT. Further subdivision was based on the E/Em ratio (using 
Em septal) and when necessary on LA dimension (rather than volume). E/Em ratio in the 
100 healthy control subjects was 7.2 ± 1.9, leading to a cut-off value of 11 (mean ± 2SD).
•	 When	the	mitral	E/A	ratio	was	≤0.8	and	DT	≥220	ms	diastolic	function	was	graded	as	
relaxation abnormality.
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•	 When	E/A	ratio	was	≤0.8	but	DT	was	relatively	short	(<220	ms)	for	relaxation	abnor-
mality, E/Em and LA dimension were used to differentiate between normal diastolic 
function	(E/Em	<11	and	LA	≤40	mm),	and	relaxation	abnormality	(E/Em	≥11	or	E/Em	
<11 but LA >40 mm).
•	 When	E/A	ratio	was	>0.8	and	DT	≥160	ms,	again	E/Em	and	LA	dimension	were	used	
to	differentiate	between	normal	diastolic	function	(E/Em	<11	and	LA	≤40	mm),	and	
pseudonormal diastole (E/Em 11–15 and LA >40 mm or E/Em >15).
•	 A	short	DT	 (<160	ms)	suggested	restrictive	 filling.	However,	 in	healthy	adolescents	
and young adults, there may be a marked contribution of active LV relaxation to LV 
filling, resulting in a short DT that resembles a restrictive LV filling pattern. Yet, in 
these	subjects	E/Em	was	supposed	to	be	<11	and	LA	dimension	≤40	mm.
In 50 randomly selected subjects the time needed to (offline) measure LA dimension and 
volume were assessed.
Statistical analysis
Continuous variables are presented as mean ± SD and compared using Student’s t test. 
In the 50 randomly selected subjects in whom the time needed to measure LA dimension 
and volume were assessed, reproducibility of measurements were tested. Measurement 
variability was calculated as the mean per cent error, defined as the absolute difference 
between the two sets of measurements, divided by the mean of the measurements.
RESUlTS
Characteristics of the study population
In Table 1, the clinical and echocardiographic characteristics of the study population 
are shown. In 96 (48 %) patients it was possible to grade LV diastolic function by both 
algorithms. In only 2 out of these 96 patients there was a discrepant classification of LV 
diastolic function. According to clinical parameters such as age and final diagnosis, the 
newly proposed algorithm seemed to be correct in one patient (patient number 1, Table 
2), while this is less obvious in the other patient, although both may be disputed. In the 
remaining 94 patients there was agreement with respect to classification of LV diastolic 
function by both algorithms. Normal diastole, relaxation abnormality, pseudonormal 
diastole and restrictive diastole in these latter 94 patients were found in 60, 19, 16, and 
5 %, respectively.
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Table 1. Clinical and echocardiographic characteristics of the study population
 Patients (n = 200) Controls (n = 100)
Age (year) 52 ± 15 46 ± 14
Male, n (%) 101 (51) 51 (51)
Body surface area (m2) 1.9 ± 0.2 1.9 ± 0.2
Heart rate, beats/min 74 ± 11 72 ± 15
Systolic blood pressure (mmHg) 126 ± 18 122 ± 15
Diastolic blood pressure (mmHg) 77 ± 9 71 ± 10
Indication echocardiography, n (%)
 First echocardiogram 68 (34)  
  Chest pain 11 (6)  
  Dyspnea 24 (12)  
  Paroxysmal atrial fibrillation 8 (4)  
  Cardiac murmur 8 (4)  
  Post myocardial infarction 13 (7)  
  Syncope/sudden cardiac death 4 (2)  
 Follow-up 132 (66)  
  Post myocardial infarction 31 (15)  
  Heart failure 39 (19)  
  Valve disease 27 (14)  
  Miscellaneous 35 (17)  
Diastolic echocardiographic characteristics
 Left atrial dimension (mm) 41 ± 6 30 ± 5
 Normalized left atrial volume (ml/m2) 31.3 ± 10.4 23.1 ± 5.4
 E-wave velocity (cm/s) 79 ± 20 66 ± 16
 A-wave velocity (cm/s) 72 ± 18 52 ± 16
 E/A ratio 1.1 ± 0.5 1.2 ± 0.5
 E-velocity deceleration time, ms 203 ± 50 180 ± 36
 Em septal (cm/s) 8.1 ± 2.7 9.6 ± 2.6
 E/Em ratio 9.8 ± 4.6 7.2 ± 1.9
Values represent mean ± standard deviation. E-wave velocity = peak early phase filling velocity, A-wave velocity = peak late 
filling velocity, Em peak early diastolic wave velocity
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Table 2. Patients with discrepant classification of left ventricular diastolic function by both algorithms
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ASE/EAE TXC
1 Normal Pseudonormal 73 Female Follow-up mild
aortic regurgitation
HFPEF 1.9 181 9.4 11.3 42 33
2 Relaxation
abnormality
Normal 69 Male Chest pain 4 year post MI,
good systolic LVF
0.7 199 5.8 6.9 36 35
E/A ratio ratio of peak early over peak late filling, velocity, Em peak early diastolic wave velocity, HFPEF heart failure with 
preserved ejection fraction, MI myocardial infarction, LVFleft ventricular function, ASE/EAE American Society of Echocar-
diography and European Association of Echocardiography algorithm, TXC thoraxcenter algorithm
feasibility of both algorithms to grade diastolic dysfunction
It was not possible to grade LV diastolic function in 48 % of patients by the ASE/EAE al-
gorithm. In contrast, only 10 % of the patients were not classified by the newly proposed 
TXC algorithm (P < 0.001). The reasons for failure to qualify LV diastolic function are 
shown in Table 3. When there was failure to grade LV diastolic function by the ASE/EAE 
algorithm, moderate to severe LV diastolic function (according to the TXC algorithm) was 
relatively abundant: normal diastole, relaxation abnormality, pseudonormal diastole 
and restrictive diastole were seen in 32, 26, 32, and 10 % of patients, respectively.
Table 3. Reasons for failure to classify left ventricular diastolic function
ASE/EAE algorithm, n (%)
Normal Em but increased left atrial volume* 16 (8)
Decreased Em but normal left atrial volume 47 (24)
Decreased Em and increased left atrial volume but E/A ratio 1.5–2.0 7 (4)
Decreased Em and increased left atrial volume but discrepant E/A ratio and DT 27 (14)
Total 97 (48)
TXC algorithm, n (%)
Normal E/A, DT and E/Em but increased left atrial dimension (Unclear Box 1**) 12 (6)
Normal E/A, DT and left atrial dimension but E/Em in “gray zone” (Unclear Box 2**) 5 (3)
Normal E/A and E/Em but short DT and increased left atrial dimension (Unclear Box 3**) 2 (1)
Total 19 (10)
E/A ratio ratio of peak early over peak late filling velocity, DT E-velocity deceleration time, Em peak early diastolic wave 
velocity, DT E-velocity deceleration time. ASE/EAE American and European Associations of Echocardiography, TXC thorax-
center
* No constriction, ** According to Fig. 1b
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Feasibility of both algorithms was also tested for the control group. It was not possible to 
grade LV diastolic function in 18 % of the controls by the ASE/EAE algorithm, mainly due 
to discrepancy between Em and LA volume (normal Em but increased LA volume in 4 % 
and decreased Em but normal LA volume in 10 %). Classification by the TXC algorithm 
was not possible in 4 % of the controls (2 in “Unclear Box 1”, 1 in “Unclear Box 2”, 1 in 
“Unclear Box 3”).
Use of lA dimension versus lA volume
In the total group of patients there was discrepancy in 11 patients (6 %) with respect to 
the cut-off values of LA dimension (40 mm) and volume (34 ml/m2) used in the different 
algorithms. In 3 patients LA volume was ≥34 ml/m2 whereas LA dimension was <40 mm. 
On the other hand, in 8 patients LA dimension was ≥40 mm whereas LA volume was <34 
ml/m2.
LA volume was per protocol always needed to qualify LV diastolic function in the ASE/
EAE algorithm. In 128 patients (64 %) LA size was necessary to classify LV diastolic func-
tion by the TXC algorithm. When LA volume (cut-off value 34 ml/m2) would have been 
used instead of LA dimension (cut-off value 40 mm), grading of LV diastolic function by 
the TXC algorithm would have been different in only 3 patients (2 %) (Table 4). In two 
patients (patient number 1 and 3, Table 4), classification of LV diastolic function changed 
from unclear to normal, which in both patients may be correct. In the other patient (pa-
tient number 2, Table 4), use of LA dimension led to the seemingly correct diagnosis of 
pseudonormal LV diastolic function.
Table 4. Patients with different classification of left ventricular diastolic function when left atrial volume 
(≥34 ml/m2) was used instead of left atrial dimension (≥40 mm)
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lA dimension lA volume
1 Unclear (box 1*) Normal 26 Male Chest pain Normal 1.0 169 9.7 7.6 45 28
2 Pseudonormal Unclear (box 2*) 57 Male Follow-up heart failure DCM 0.9 170 4.5 11.6 47 32
3 Unclear (box 1*) Normal 69 Male Chest pain Normal 0.9 216 7.7 9.3 43 29
E/A ratio ratio of peak early over peak late filling velocity, Em peak early diastolic wave velocity, DCM dilated cardiomyopa-
thy. * According to Fig. 1b
Finally, assessment of LA dimension (6 ± 4 s) was considerably faster as compared to assessment of LA volume (40 ± 12 s, 
P < 0.001).
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Reproducibility
There was agreement between both observers in all subjects with respect to grading of 
LV diastolic function, irrespective of the algorithm used. The intra- and inter-observer 
variability of E/A ratio, DT, Em and E/Em were 4.8 ± 4.2 and 5.0 ± 4.4 %, 7.8 ± 5.2 and 8.4 ± 
4.5 %, 5.0 ± 5.1 and 5.1 ± 4.4 %, and 5.9 ± 5.3 and 6.1 ± 4.9 %, respectively. Reproduciblity 
of LA dimension was better as compared to LA volume: intra- and inter-observer vari-
ability 4.8. ± 4.0 and 5.8 ± 4.2 % versus 8.8 ± 6.3 and 9.1 ± 5.9 %, respectively.
DISCUSSIOn
The most important conclusion of the current study is that in daily practice it is not pos-
sible to feasibly use the algorithm endorsed by ASE/EAE for grading LV diastolic function. 
On the other hand, the proposed TXC algorithm did allow assessment of LV diastolic 
function in 90 % of consecutive patients in sinus rhythm in an efficient manner.
A gold standard of LV diastolic function is lacking in the current study. However, the 
ASE/EAE algorithm also had never been validated against an invasive evaluation of 
LV diastolic function, although it is based on numerous studies that did use invasive 
standards. Nevertheless, both algorithms are based on these same landmark studies. 
Importantly, it should be noted that in the 48 % of patients with possible grading of dia-
stolic function with both algorithms, no essential differences were found. Therefore, it 
seems unlikely that the newly proposed TXC algorithm would have different prognostic 
power compared to the ASE/EAE algorithm.
Background of the ASE/EAE algorithm
The ASE end EAE have put commendable efforts in the publication in 2009 of a guideline 
for the echocardiographic assessment of diastolic function. It is an impressive docu-
ment providing direction in this difficult aspect of echocardiography. Although it should 
be noted that the algorithm for qualification of diastolic function published in this 
guideline is supposed to be used in harmony with other potentially relevant parameters, 
the algorithm on itself does include several problems and inefficiencies.
Discrepancy between parameters (e.g. Em and LA volume or E/A ratio and DT) was the 
most important reason for failure to classify LV diastolic function. Also, an E/A ratio in 
the range of 1.5–2.0 is not covered in the algorithm, leading to unfeasibility to qualify 
some patients. In more recent studies, E/A ratio >1.5 was used as an indicator of stage III 
diastolic dysfunction [9, 10].
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Septal and lateral Em and LA volume direct the primary differentiation between normal 
and abnormal LV diastolic function in the ASE/EAE algorithm to qualify LV diastolic func-
tion. The scientific background of the decision to create the algorithm in this manner 
was not fully elucidated in the paper in which the ASE/EAE algorithm was presented 
[5]. In the paper it was stated that the algorithm was based on findings of a large cross-
sectional survey by Redfield et al. [6]. In this survey a combination of data from mitral 
inflow (E/A ratio and DT), tissue Doppler imaging (E/Em ratio) and pulmonary venous 
flow was used to qualify LV diastolic function. LV diastolic function was categorized as: 
normal; mild dysfunction, defined as impaired relaxation without evidence of increased 
filling pressures; moderate dysfunction, defined as impaired relaxation associated with 
moderate elevation of filling pressures or pseudonormal filling; and severe dysfunction, 
defined as advanced reduction in compliance or (reversible or fixed) restrictive filling. 
Redfield et al. based this classification on earlier publications by Nishimura [11] and 
Ommen et al. [12]. The study by Nishimura was a review from 1997, focusing on mitral 
inflow velocity curve patterns. Ommen et al. found the septal E/Em ratio to be the single 
best parameter for predicting mean LV diastolic pressure. However, from these stud-
ies, there seems to be no solid evidence in favour of using septal and lateral Em and in 
particular LA volume for the primary differentiation between normal and abnormal LV 
diastolic function. In fact, in 63 out of 200 patients in our study (see Table 3) there was 
a discrepancy between Em and LA volume, making it impossible to qualify LV diastolic 
function with this algorithm.
In the ASE/EAE algorithm, a cut-off value of 34 ml/m2 was chosen to differentiate be-
tween normal and abnormal LV diastolic function. The decision to choose this cut-off 
value was supported in the ASE/EAE paper by a reference to a review by Abhayaratna 
et al. [13]. However, the only studies identified by Abhayaratna et al. that found a LA 
volume of 34 ml/m2to be the discriminatory threshold, were one case control study of 
atrial fibrillation in hypertrophic cardiomyopathy patients [14] and one study of subjects 
without a history of congenital heart disease, treatment with pacemaker implantation, 
valvular surgery, or cardiac transplantation, undergoing general medical consultation 
[15]. In the other 12 studies identified in this review cut-off values for LA volume ranging 
from 27 to 68 ml/m2 were found, depending on the study population and the chosen 
endpoints. Furthermore, in the recommendation paper by Lang et al. [7], a LA volume 
>29 ml/m2 was already considered abnormal, although this cut-off value has recently 
been adjusted to >34 ml/m2 [16].
Background of the newly proposed TXC algorithm
For optimal application in daily clinical practice, any algorithm for qualification of LV 
diastolic function should be simple, fast and reproducible. The ASE/EAE scheme in-
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cludes diastolic parameters that are more difficult to measure (less feasible) such as 
pulmonary venous flow. There is currently no evidence that assessment of these pa-
rameters is clinically relevant in a sense that they have independent incremental value 
over the more robust parameters for the assessment of LV filling pressures or overt heart 
failure. Therefore, in order to be as simple, fast and reproducible as possible, the newly 
proposed TXC algorithm did not include these LV diastolic function parameters.
Even more in-line with the aforementioned study by Redfield et al. [6], our algorithm 
starts with assessment of E/A ratio and DT. Since DT is normally between 160 and 220 
ms [17] we used 220 ms as a cut-off value, instead of the 200 ms used in the ASE/EAE 
algorithm.
The E/Em ratio is known to correlate well with LV filling pressures [8]. Although either 
side of the mitral annulus can be used, septal E/Em has been shown to provide better 
diagnostic utility [18, 19], most likely because it is easier to align the tissue Doppler 
beam with the septal wall. For reasons of efficiency we decided therefore to use only the 
septal E/Em ratio. In two landmark papers in the field of E/Em ratio assessment [8, 12], 
different cut-off values for abnormal E/Em ratio have been reported. Ommen et al. [12] 
concluded that a septal E/Em ratio <8 suggests normal LV filling pressure, whereas >15 
was highly specific for elevated LA pressure. Even though Nagueh et al. [8] found lateral 
Em to be slightly higher than septal Em, a lateral E/Em ratio >10 was already associated 
with increased LA pressure. Therefore, we have decided to define a normal value for E/
Em ratio for our own department. Since E/Em was 7.2 ± 1.9 in healthy control subjects, a 
cut-off value of 11 (mean ± 2SD) was chosen.
Increased LA size is associated with adverse cardiovascular outcomes [20] since it is 
a marker of increased LA pressure over time [21]. A large volume of prior clinical and 
research work used the two-dimensional derived antero-posterior linear LA dimension 
obtained from the parasternal long-axis view, making this the standard for linear LA 
measurement [7]. Evaluation of the LA in the antero-posterior dimension assumes that 
a consistent relationship is maintained between the antero-posterior dimension and all 
other LA dimensions as the atrium enlarges, which is sometimes not the case [7, 22]. Ex-
pansion of the LA in the antero-posterior dimension may for example be constrained by 
the thoracic cavity between the sternum and the spine. Therefore, it has been advocated 
to use 2D (or even 3D) volumes rather than the antero-posterior dimension although 
data that show the superiority of LA volumes are rather sparse [23, 24, 25, 26, 27, 28, 
29, 30]. Nevertheless, in the present study we found that use of LA volume instead of LA 
dimension in the newly proposed TXC algorithm, would lead to a different classification 
of LV diastolic function in only 2 % of patients, without any evidence that it improves 
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the correct classification of diastolic function. Since measurement of LA dimension was 
considerably faster and better reproducible as compared to LA volume measurement, 
we have chosen to still use LA dimension in the routine application of grading of dia-
stolic function. A Framingham Heart Study cohort of 1099 subjects between the ages 
of 20 and 45 years old who were not obese, were of average height and were without 
cardiovascular disease, identified an anteroposterior LA dimension of 27–40 mm as the 
normal range [31]. Therefore, we have chosen to use an anteroposterior LA dimension 
of 40 mm as a cut-off value.
limitations
Validation of the new TXC algorithm against clinical outcome would be ideal. Yet, this 
was beyond the scope of the current paper but may be investigated in future studies. 
In order to represent daily clinical practice and to optimize feasibility of the new TXC 
scheme, further subdivision of abnormal diastolic function was only based on E/A ratio, 
DT, E/Em and LA dimension. In other words, although potentially helpful when there 
is discrepancy between different parameters, the relatively less used parameters “time 
difference between the pulmonary venous flow atrial reversal velocity waveform and 
mitral A-wave duration (Ar–A)” and “change of the E/A ratio with Valsalva maneuver 
(Val ΔE/A)” were not used. In future studies the incremental values of these variables 
should be shown before routine application may be advised. Also, when evaluating LV 
diastolic function, one may want to consider other echocardiographic variables such as 
the extent of LV hypertrophy, ejection fraction, ischemic wall motion abnormalities, and 
pulmonary pressure estimates. However, again, to optimize feasibility these parameters 
were not incorporated in the TXC algorithm, but of course each clinician should be free 
to use such variables as well when deemed necessary.
COnClUSIOn
Assessment of LV diastolic function is an essential part of most echocardiograms, in 
particular when heart failure is suspected. The newly proposed TXC algorithm to grade 
LV diastolic dysfunction is compared to the ASE/EAE algorithm simpler, faster, better 
reproducible and yields a higher diagnostic outcome. Simpler because use of LA size 
was less needed (64 vs. 100 %) and when needed a dimension rather than a volume was 
measured, only the septal mitral annular velocity was measured and less useful param-
eters such as pulmonary venous flow and use of a Valsalva maneuver were not included 
in the algorithm. It is faster because of the aforementioned arguments and for example 
the diagnosis of LV relaxation abnormality requires only 2 measures (E/A ratio and DT) 
rather than 5 measures (E/A ratio, DT, septal Em, lateral Em and LA volume) in the ASE/
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EAE algorithm. It is better reproducible because the intra- and inter-observer variability 
of the LA dimensions was lower compared to the LA volume and less parameters are 
involved. Finally, it yields better feasibility because a straight forward diastolic grade 
was defined in 90 % rather than 52 % of patients.
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ABSTRACT
Background: Symptoms in the elderly patients with severe aortic stenosis (AS) and co-
morbidities seem to lack in specificity. Therefore, objective parameters for increased 
left ventricular(LV) filling pressures are needed. The aim of this study was to investigate 
the correlation between the septal, lateral and average E/e’ ratio and the value of the 
N-terminal pro-hormone of brain natriuretic peptide (NT-proBNP).
Methods: Two-hundred-fifty consecutive symptomatic patients (mean age 80 ± 8 years, 
52% men) with severe AS underwent transthoracic echocardiography and NT-proBNP 
measurement.
Results: in the overall population the septal E/e’ (r=0,459, r2=0,21, P <0,0001), lateral 
E/e’ (r=0,322, r2=0,10, P <0,0001), and the average E/e’ (r=0,432, r2=0,18, P <0,0001) were 
all significantly correlated to NT-proBNP. After the exclusion of patients with confound-
ers (more than mild aortic or mitral regurgitation, severe renal dysfunction, obesity or 
severe COPD) the septal E/e’ (r=0,584, r2=0,34, P <0,0001), lateral E/e’ (r=0,377, r2=0,14, P 
<0,0001), and the average E/e’ (r=0,487, r2=0,24, P <0,0001) were all significantly better 
correlated to NT-proBNP. In obese patients no significant correlations were seen. Previ-
ous bypass surgery did not alter the correlations.
Conclusions: In elderly patients with severe symptomatic AS there is a significant cor-
relation between the E/e’ ratio and NT-proBNP, in particular after exclusion of confound-
ers. The correlation was best for the septal E/e’ ratio and was preserved in patients with 
a history of bypass surgery.
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InTRODUCTIOn
Aortic stenosis (AS) is the most common valvular heart disease in the Western world 
and its prevalence is expected to increase due to the aging of the population1. Current 
recommendations warrant the presence of symptoms in order to indicate aortic valve 
replacement2. However, in elderly patients symptoms related to increased left ventricu-
lar (LV) filling pressures are less specific, because of the normal aging process and the 
multiple comorbidities3. One objective parameter of increased LV filling pressures is the 
echocardiographic ratio of the transmitral E-wave velocity and early diastolic velocity 
of the myocardium, the so called E/e’ ratio4ˉ7. Although the value of this ratio may be 
less reliable in elderly AS patients with important annular calcifications⁷, the E/e’ was 
proven to be a strong predictor of mortality in non-operated elderly patients with AS, 
especially in conjunction with the N-terminal pro-hormone of brain natriuretic peptide 
(NT-proBNP)8. This hormone reflects the total burden of the disease on the LV, and has 
been demonstrated to have a good prognostic value in the setting of severe AS 9ˉ¹6.
This study sought to assess the relation between the E/e’ ratio and NT-proBNP. More 
specifically, the values of the septal versus lateral myocardial wall derived E/e’ ratio 
were investigated in detail.
METHODS
Patient population
After exclusion of patients with an aortic or mitral valvular prosthesis, mitral stenosis or 
significant areas of focal LV akinesia (defined as an akinetic region extending to at least 
3 segments, involving the basal septum and/or the basal lateral wall) the study included 
250 consecutive subjects (mean age 80 ± 8 years, 52% men) with symptomatic severe AS, 
defined as an aortic valve area less than 1 cm2 and/or less than 0.6 cm2/m2 and available 
NT-proBNP level who were treated by transcatheter aortic valve replacement (TAVI).
Transthoracic echocardiography
Two-dimensional echocardiography was performed using a Philips iE33 system (Philips, 
Best, The Netherlands) with the patient in the left lateral decubitus position. Echocar-
diographic studies were performed by an independent experienced echocardiographer, 
blinded to the patient’s clinical and biochemical status. All echocardiograms were saved 
as video loops or still frames in a digital database and were reanalyzed by an experienced 
cardiologist (MS). The LV ejection fraction cut-off value of 50% was calculated using the 
biplane modified Simpson rule. The mitral inflow velocity profile (E/A wave ratio, E wave 
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deceleration time) was assessed with pulse-wave Doppler. The early diastolic velocities 
at the septal and lateral annulus level were assessed with pulse-wave Tissue Doppler 
from a standard apical 4-chamber view.
Blood sampling
Venous blood samples were drawn from patients with AS within 30 minutes of the Dop-
pler echocardiography study from an antecubital vein into EDTA acid Vacutainer test 
tubes (Mediost BV, Doesburg, The Netherlands) after 30 minutes of supine rest. Samples 
were placed immediately on ice, and plasma separation was performed at 4°C. For NT-
proBNP determination, an electrochemiluminescence immunoassay (ProBNP Elecsys, 
Roche Diagnostics GmbH, Mannheim, Germany) was used.For the evaluation of renal 
function, serum creatinine levels were determined and glomerular filtration rate (GFR) 
was calculated using the 2009 CKD-EPI creatinine equation17.
Definitions of possible confounders
Impaired ejection fraction was defined as <50%. Obesity was defined as a BMI (body 
mass index) above 30 kg/m2 18. Severe COPD was considered in GOLD class III or IV19.
Severe impairment of the renal function was defined as GFR less than 30ml/min/1,73m2, 
present for more than 3 months, as estimated by 2009 CKD-EPI creatinine equation17. 
Aortic and mitral regurgitation were assessed semi quantitatively according to current 
guidelines for the evaluation of native valves20.
Significant coronary artery disease was defined as >50% stenosis in at least one coro-
nary artery.
Pulmonary hypertension was considered when the estimated pulmonary pressure 
derived from Doppler tracings of the tricuspid insufficiency was above 40mmHg.
Statistical analysis
Continuous variables are presented as means (± SD) if normally distributed, or other-
wise by geometric means for natriuretic peptide levels. Because of the very large range 
of values of the natriuretic peptide and the abnormal distribution of this variable, the 
log10 of the NT proBNP was used in the analysis. Categorical variables are presented 
as frequencies and percentages. Differences between similar continuous variables were 
assessed by the paired-samples t test. Multivariable linear regression was performed in 
order to identify the possible confounders. Correlations were computed using Pearson’s 
method, and graphically represented with linear regression lines whenever appropriate. 
For nonlinear parameters, a best-fit regression line was traced, using multiple nonlinear 
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regression equations and choosing the most statistically significant model that fitted the 
data. A two-sided p value less than 0.05 was used for declaring statistical significance. All 
statistical analyses were performed with SPSS 21.0 software (SPSS Inc, Chicago, IL, USA).
RESUlTS
The baseline characteristics of the population are shown in Table 1.
Table 1. Baseline characteristics of the study patients
Variable Study population
n=250
Age 80(±8)
Male gender 129(52%)
BMI > 30kg/m2 52(21%)
Diabetes 69(28%)
Severe renal dysfunction 27(11%)
Atrial fibrillation 47(19%)
Coronary artery disease 138(55%)
Previous CABG 53(21%)
PCI 90(36%)
COPD GOLD 3-4 17(7%)
NYHA class I 17(7%)
NYHA class II 76(30%)
NYHA class III-IV 149(60%)
Angor 66(26%)
Syncope 18(7%)
Pulmonary hypertension 85(34%)
Ejection fraction less than 50% 60(24%)
More than mild mitral regurgitation 39(16%)
More than mild aortic regurgitation 29(12%)
Data are presented as mean ±SD or number (percentage %)
BMI= body mass index; CABG= coronary artery by-pass graft surgery; COPD= chronic obstructive pulmonary disease; GOLD 
= Global Initiative for Chronic Obstructive Lung Disease classification of COPD; NYHA class= New York Heart Association 
classification of heart failure symptoms; PCI= percutaneous coronary intervention.
All patients were symptomatic. 66 patients(26%) had angina and only 18(7%) syncope. 
149(60%) were in class NYHA III and IV, 76 (30%) in class II and 17(7%) in NYHA class I. 
In 8 patients NYHA class could not be determined. Impaired LV function was present 
in 60 patients (24%). Other potential confounders were present in 139 patients (56%):, 
severe COPD in 17 (7%), obesity in 52 (21%), severe renal dysfunction in 27 (11%) and 
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significant associated mitral or aortic regurgitation or a combination of the two in 61 
(24%). In Table 2 the mean values for the echocardiographic parameters and NT-proBNP 
data are shown.
Table 2. Echocardiographic and biological data
Maximal pressure gradient (mmHg) 73±23
Mean pressure gradient (mmHg) 44±15
Pulmonary artery pressure (mmHg) 39±13
Ejection fraction (%) 55±12
E/A ratio 1,0 ± 0,6
e’ septal (cm/s) 4,6 ± 1,7
e’ lateral (cm/s) 6,3 ± 2,4
e’ average (cm/s) 5,5 ± 1,9
E/e’ septal 20,2 ± 9,1
E/e’ lateral 15,7 ± 7,2
E/e’ average 17,4 ± 6,9
E-wave deceleration time (ms) 240 ± 86
N terminal pro Brain Natriuretic Peptide (pmol/l) 217, 95% CI (161,226)
Log10 N-terminal pro Brain Natriuretic Peptide 2,3(±0,6)
Data are presented as mean ±SD or number (percentage %)for normally distributed values and as geometric mean and 
95% CI for NT-proBNP
The E/A ratio was 1.0 ± 0.6, E-wave deceleration time was 240 ± 86 ms, septal E/e’ was 
20.2 ± 9.1, lateral E/e’ was 15.7 ± 7.2, and average E/e’ was 17.4 ± 6.9. NT-proBNP was 271 
pmol/L (95% confidence interval 161,226), Log10 NT-proBNP was 2.3 ± 0.6.
Correlations between the diastolic parameters and nT-proBnP
As seen in Figure 1, in the overall population the septal E/e’ (r=0,459, r2=0,21, P <0,0001), 
lateral E/e’ (r=0,322, r2=0,10, P <0,0001), and the average E/e’ (r=0,432, r2=0,18, P <0,0001) 
were all significantly correlated to NT-proBNP. Also, the E/A ratio (r=0,230, r2,= 0,05, P 
<0,001), and E-wave decelaration time (r=-0,263, r2=0,07, P <0,0001) were significantly 
correlated to NT-proBNP.
Influence of ejection fraction on the correlations between the E/e’ ratio and 
nT-proBnP
In the 60 patients with impaired EF <50% the correlation for the septal E/e’ (r=0,361, 
r2=0,13, P=0,005) and average E/e’ (r=0,377, r2=0,14, P=0,01) was weaker. For the lateral 
E/e’ the correlation was even not significant (r=0,234, r2=0,05, P=0,13). In the 190 patients 
with EF ≥50% the septal E/e’ (r=0,426, r2=0,18, P <0,0001), lateral E/e’ (r=0,277, r2=0,07, P 
<0,01), and the average E/e’ (r=0,353, r2=0,12, P <0,0001) were all significantly correlated 
to NT-proBNP.
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Influence of other potential confounders on the correlations between the 
diastolic parameters and nT-proBnP
A multivariable linear regression model was constructed to assess the potential influ-
ence of the clinical, echocardiographic and biological factors on the correlation between 
E/e’ ratio and NT-proBNP. On this model, the potential confounders that were identified 
were: severe COPD (standardized ß=-0,088, p=0,05), obesity (standardized ß=-0,092; 
p=0,05), significant aortic regurgitation (standardized ß=0,096; p=0,04), significant mitral 
regurgitation (standardized ß=0,148; p=0,002), altered ejection fraction (standardized 
ß=0,314; p=0,0001) and renal dysfunction (standardized ß=0,343; p=0,0001). Diabetes 
(p=0,46), coronary artery disease (p=0,56), pulmonary hypertension (p=0,14), previous 
CABG (p=0,09) did not significantly alter the correlation between E/e’ and NT-proBNP.
After the exclusion of the 139 patients (56%) with more than mild aortic or mitral regur-
gitation, severe renal dysfunction, obesity or severe COPD there remained 111 patients 
(mean age 82 ± 8 years, 51% men), representing 44% of the initial group. As seen in 
Figure 2, the septal E/e’ (r=0,584, r2=0,34, P <0,0001), lateral E/e’ (r=0,377, r2=0,14, P 
<0,0001), and the average E/e’ (r=0,487, r2=0,24, P <0,0001) were now all significantly 
better correlated to NT-proBNP.
figure 1. Correlations between E/e’ ratio and Log10 NT-proBNP in the overall study population. A: septal 
point; B: lateral point; C: mean septal-lateral E/e’
figure 2. Correlations between E/e’ ratio and Log10 NT-proBNP in the patient population without major 
confounders. A: septal point; B: lateral point; C: mean septal-lateral E/e’
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In contrast, the level of linear correlation with the mitral E/A ratio did not change 
(r=0,255, r²=0,07, P=0,01) and the E-wave deceleration time was not at all correlated to 
NT-proBNP (r=-0,065, r²=0,04, P=0,5). As seen in Figure 3, the best-fit correlation lines 
were described by quadratic equations, with r²=0,12, P=0,002 for the E/A ratio and non-
significant results on all models for the E-wave deceleration time.
The influence of the ejection fraction on the correlation between the E/e’ 
ratio and nT-proBnP in the confounder-free group
In the confounder-free group, the relations between E/e’ and NT-proBNP were sig-
nificant (r=0,574, r2=0,33, P <0,0001 at the septal wall, r=0,392, r2=0,15, P=0,002 for the 
lateral wall, and r=0,484, r2=0,23, P <0,0001 for the average value) in the 93 patients with 
preserved EF. In the 18 patients with impaired EF all correlations were non-significant: 
r=0,258, r2=0,07, P=0,3 for the septal wall, r=-0,02, r2=0,00, P=0,95 for the lateral wall, and 
r=0,058, r2=0,00, P=0,8 for the average value.
Correlations between the diastolic parameters and nT-proBnP in the obese 
patients
In the specific subgroup of 52 obese patients the septal E/e’ (r=0,260, r2=0,07, P=0,07), 
lateral E/e’ (r=0,150, r2=0,02, P=0,37), and the average E/e’ (r=0,237, r2=0,06, P=0,15) were 
all not significantly correlated to NT-proBNP. After exclusion of 10 patients with other con-
founders, the septal E/e’ (r=0,260, r2=0,07, P=0,07), lateral E/e’ (r=0,256, r2=0,07, P=0,17), 
and the average E/e’ (r=0,293, r2=0,09, P=0,11) remained not significantly correlated to 
NT-proBNP in the obese sugroup. The value of the NT proBNP in obese patients was 
figure 3. Correlation between E/A ratio and Log10 NT-proBNP. A: linear correlation; B: best-fit correlation 
line(quadratic equation). The regression lines are displayed with blue lines, and the 95% confidence inter-
vals with black lines.
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lower, with a geometrical mean of 94 pmol/l, 95% CI (81,142), compared to 217 pmol/L 
in the non-obese patients (P =0.027). In the other subgroups (COPD, renal dysfunction) a 
specific analysis was not possible because of the limited number of patients.
Influence of previous coronary bypass surgery on septal versus lateral E/e’ 
assessment
In the 53 patients (68% men) with a history of coronary artery bypass graft (CABG) sur-
gery the septal E/e’ (r=0,583, r2=0,34, P <0,0001), lateral E/e’ (r=0,441, r2=0,20, P <0,01), 
and the average E/e’ (r=0,571, r2=0,33, P <0,0001) were also all significantly correlated to 
NT-proBNP. After exclusion of 24 patients with the previously mentioned confounders 
these numbers were for septal E/e’ (r=0,577, r2=0,33, P <0,01), for lateral E/e’ (r=0,507, 
r2=0,26, P <0,05), and for the average E/e’ (r=0,565, r2=0,32, P <0,01).
Difference between the correlation levels of the E/e’ ratio at the medial, 
lateral and average septal points
The level of correlation was significantly better for the septal point when compared to 
the lateral (p<0,0001). There was also a difference favoring the septal point against the 
average e’, but this difference did not reach a significant p value (p=0,051)
DISCUSSIOn
In this study in elderly patients with severe symptomatic AS the main findings were: 1) 
there is a significant correlation between the E/e’ ratio and NT-proBNP, in particular in 
patients without obesity, severe renal dysfunction, severe COPD, or significant left-sided 
valvular regurgitation, 2) the correlation was best for the septal E/e’ ratio, and 3) this 
latter correlation was preserved in patients with a history of CABG.
In elderly patients with severe AS, clinical symptoms are difficult to ascertain and less 
specific because of the normal aging process and the multiple comorbidities usually 
present in the AS patients referred for TAVI. In order to help the decision for aortic valve 
intervention, an objective parameter of increased LV filling pressure seems important in 
their evaluation. The E/é ratio is the main stay of echocardiography to indirectly assess 
LV filling pressure21-22. The current guidelines recommend the use of the average E/é 
ratio derived from the septal and lateral wall22-23. However, evidence for the use of the 
average E/e’ ratio is lacking and the specific accuracy of the septal or lateral E/e’ is still 
debated. Each of the two E/e’ ratios has its specific benefits. Translational movement of 
the heart may less affect septal wall velocity and certainly Doppler beam angle errors are 
less likely to occur when septal wall velocities are measured. Also, it was shown that the 
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septal E/e’ ratio best correlated to LV filling pressures in subjects with preserved systolic 
LV function24 and in particular in the elderly25. On the other hand, Nagueh et al. claimed 
that ‘’the lateral E/e’ ratio was easier to quantify’’26-27. Obviously, a septal or lateral local-
ized myocardial wall infarction will negatively influence the respective measurements. 
Therefore, patients with such abnormalities were excluded from our study.
Our study population has some important unique features. The patients were elderly 
with extensive aortic and mitral annular calcifications and a significant number of these 
patients had coronary artery disease and a history of previous CABG. Despite these char-
acteristics a good correlation between the E/e’ ratio and NT-proBNP was found. The best 
results were seen for the septal E/é ratio with a correlation coefficient of 0.459. Exclusion 
for confounders (obesity, severe renal dysfunction, severe COPD, or significant left-sided 
valvular regurgitation) resulted in even better correlations. The best improvement was 
seen for the septal E/é ratio with a correlation coefficient of 0.584.
The septal E/é ratio could be superior due to the aforementioned reasons but also be-
cause of the extensive posterior mitral annular calcification that may have resulted in 
more problems in assessing the lateral annulus, which is a part of the posterior annular 
ring28.
We had expected that a previous CABG with its influence on septal function29-30 would 
affect the accuracy of the septal E/é ratio. Surprisingly, a history of CABG did not affect 
the correlation of the septal E/é ratio with NT-proBNP.
Comparison to other studies and clinical implications
The level of correlation found between E/E’  and NT-proBNP in our study in elderly 
patients with AS is quite similar to correlations published in the literature in general 
cardiac patients.31-33 In AS little data are available 16,34. There is only a very small study 
on 29 middle-aged (65 ± 12 years) severe AS patients16. In that paper weak correlations 
were described between E/e’ and NT-proBNP with only significant results seen for the 
septal E/e’. Because of the evidence in the literature16,25, as well as the results of the pres-
ent study and the specific practical benefits, the use of septal E/e’ ratio rather than the 
lateral or average E/e’ should be encouraged, until other sound data are available from 
prospective large-scale trials such as the EURO-FILLING study35.
In the global population included here, the correlation between the surrogate markers 
of LV filling pressures remains moderate. Only about 44% of the symptomatic elderly 
patients with severe aortic stenosis displayed strong correlations. From a practical clini-
cal standpoint, care should be taken in interpreting the results of the usual diastolic 
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function parameters in the presence of the confounders defined in this study: more than 
mild aortic/mitral regurgitation, severe renal impairement, severe COPD, obesity and 
left ventricular dysfunction.
Apart from the negative impact of impaired EF on the correlation between E/e’ and 
NT-proBNP, the influence of obesity was striking. Even for the septal E/e’ ratio no sig-
nificant correlation was seen, probably because of the well-known paradoxically lower 
NT-proBNP levels than in normal weight patients for the same filling pressures36. In such 
patients we can only speculate that the E/e’ ration better reflects LV filling pressures.
These findings could have an impact on the costs of medical care, since adding a NT 
proBNP assay to the routine evaluation is relatively expensive37 and not covered by 
medical insurances, while E/e’ ratio can be measured repetitively during each echocar-
diographic examination, without any supplemental risk or cost for the patient.
Study limitations
As mentioned above, the population included in this study was carefully selected by 
a ‘’heart team’’ according to present guidelines on the management of valvular heart 
disease38. That means first of all that they had to have clinical symptoms in associa-
tion with a severe aortic stenosis in order to be considered for TAVI. An asymptomatic 
control group with severe aortic stenosis could have better demonstrated the role of 
echocardiographic data in the decision making. Such a group is difficult to constitute in 
an elderly population with several comorbidities.
The cross-sectional nature of the study could be a limitation in itself. However, data col-
lection in this population was very rigorous, according to a very strict and prospectively 
designed protocol.
Although it demonstrates a correlation between echocardiographic and biological 
markers of elevated left ventricular filling pressures, it is possible that the cutoff value 
of 15 for the septal E/e’ is too sensitive (practically all the patients having an E/E’ ratio 
above this value, with a mean of 20±9), or that all the selected patients had chronically 
elevated LVEDP, as reflected by the mean value of NT proBNP=217pmol/l. Unfortunately, 
a better cutoff point could not be determined from our data, because the LVEDP was 
measured in all patients during the initial phase of the intervention, before TAVI, but 
already on general anesthesia, which invariably leads to dramatic changes in pressures.
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COnClUSIOn
In elderly patients with severe symptomatic AS there is a significant correlation between 
the E/e’ ratio and NT-proBNP, in particular after exclusion of confounders. The correla-
tion was best for the septal E/e’ ratio and was preserved in patients with a history of 
CABG.
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1 | InTRODUCTIOn
Assessment of the left atrium (LA) is gaining increased attention as it reflects the severity 
and chronicity of many different conditions and is associated with significant morbidity 
and mortality.1
In the absence of valvular disease, LA volume reflects the presence of elevated left ven-
tricular (LV) diastolic pressure and dysfunction.2 LA maximum volume is the most often de-
scribed pa-rameter, but LA phasic function could be a more sensitive measure in patients 
with heart failure, valvular disease, and atrial fibrilla-tion. LA function can be assessed by 
volumetric measurements and includes reservoir, conduit, and pump function which can 
be expressed as absolute volumes or fractions. Recently speckle tracking echocardiography 
(STE) has been validated for LA mea-surements3; LA strain and strain rate can be measured 
which re-flect LA myocardial function without the need for geometrical assumptions.
The clinical value of LA volumetric and myocardial function has not been translated into recom-
mendations to be used in clinical practice. This is in part because solid reference ranges have 
not been established, neither for volumetric measurements4–6 nor for strain measurements.7–12
Therefore this study aims to provide reference ranges for LA myocardial and volumetric 
function in healthy adults and investi-gates the impact of age, sex, and BSA.
2 | METHODS
2.1 | Study design and population
Healthy volunteers were enrolled in 2014–2015 for this prospective cross--sectional study 
and stratified into 5 age groups: 20–29, 30–39, 40–49, 50–59, 60–72 years (n ≥ 28 for each 
group, each 50% female). Details have been published earlier.13 Briefly, subjects were re-
cruited via advertisement and underwent a questionnaire regarding medi-cal history and 
current health status, physical examination, venous blood sampling, 12--lead ECG, and an 
echocardiogram. Subjects were excluded if one or more of the following criteria were pres-
ent: (prior) cardiovascular disease, systemic disease, the finding of cardiac abnor-malities 
during the examination (including any valvular abnormalities) or risk factors including 
hypertension (cutoff values: 140/80 mm Hg), diabetes mellitus, impaired renal function 
or hypercholesterolemia. In case of elevated blood pressures, follow--up measurements 
were per-formed by the general practitioner to confirm this. If follow--up revealed normal 
blood pressures, the subject was included. Reasons for exclu-sion due to abnormalities on 
ECG were conduction disorders: Atrial fibrillation, right or left bundle branch block, pro-
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longed PR interval, and prolonged QRS. Professional athletes, people who were morbidly 
obese (BMI > 40 kg/m2), having breast implants or pregnant were ex-cluded. This study was 
carried out according to the principles of the Declaration of Helsinki and approved by the 
local ethics committee. Written informed consent was obtained from every participant.
2.2 | Echocardiographic image acquisition
Echocardiographic studies were performed by one of two experi-enced sonographers. Two-
-dimensional grayscale harmonic images were obtained in the left lateral decubitus position 
using a iE33 or EPIQ7 ultrasound system (Philips Medical Systems, Best, The Netherlands) 
equipped with a transthoracic broadband X5--1 matrix transducer (composed of 3040 
elements with 1–5 MHz). The LA was acquired in dedicated apical four--and two--chamber 
views with frame rates ≥ 50 frames/s.14 At least 2 consecutive heartbeats were recorded.
2.3 | Volumetric analysis
In order to assess LA maximum volume, the revised recommenda-tions for cardiac 
chamber quantification were used.1 LA minimum volume (measured at mitral valve 
closure) and pre--a--wave volume (one frame before atrial contraction starts) were 
measured using the biplane method--of--disk summation technique (Figure 1) and the 
area--length method. All measurements were performed with Xcelera (Philips Medical 
Systems). Using the above volumes, LA function can be assessed as follows:
Left atrial reservoir function:
•	 Left	atrial	total	emptying	volume	(TEV)	=	LA	maximum	volume–LA	minimum	volume.
•	 Left	atrial	total	emptying	fraction	=	TEV/LA	maximum	volume.
•	 Left	atrial	expansion	index	=	TEV/LA	minimum	volume.
Left atrial conduit function:
•	 Left	 atrial	 passive	 emptying	 volume	 (PEV)	 =	 LA	maximum	vol-ume–LA	pre-a-wave	
volume.
•	 Left	atrial	passive	emptying	fraction	=	PEV/LA	maximum	volume.
Left atrial pump function:
•	 Left	 atrial	 active	 emptying	 volume	 (AEV)	 =	 LA	 pre-a-wave	 vol-ume–LA	 minimum	
volume.
•	 Left	atrial	active	emptying	fraction	=	AEV/LA	pre-a-wave	volume.
All reported volumes are indexed for BSA. Since the Dutch popula-tion is the tallest in 
the world,15 we indexed for an allometric function of height2.7.16 LV diastolic function was 
assessed according to the EAE-- ASE recommendations for diastolic function.17
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2.4 | Speckle tracking analysis
Offline analysis was performed using QLAB10 (Philips Medical Systems). LA myocardial 
function was assessed according to an earlier published guideline and a recent validation 
study,18,19 using the api-cal four--and two--chamber views and the R--wave as reference 
point. LA reservoir function can be expressed as peak strain (LA--strain) and LA conduit 
and pump function with LA strain rate. The negative peak in early diastole represents LA 
conduit function (LA--SRe) and the negative peak in late diastole represents LA pump 
function (LA--SRa) (Figure 2).
figure 2. Example of left atrial (LA)--strain measurement in a apical four--chamber view. LA--strain(A) is 
measured as the maximum strain value during atrial diastole. Conduit (B) and pump (C) function are mea-
sured using strain rate
 
 
 
 
 
 
 
  
 
 
 
 
  
 
figure 1. Example of the volumetric mea-
surements using the method--of--disk 
summation technique in dedicated apical 
four--and two--chamber views. From top to 
bottom: the left atrial minimum, maximum, 
and pre--a--wave volume
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2.5 | Statistical analysis
Normal distribution was checked using histograms and Shapiro--Wilk tests. Depending 
on data distribution, continuous data are presented as mean ± standard deviation (SD) 
or median with first--third quar-tile. Categorical data are presented as frequencies and 
percentages. Student’s t--test, the Mann–Whitney U test, chi--square test or Fisher’s exact 
test was used when appropriate. Correlations between LA meas-urements and baseline 
characteristics were assessed using the Pearson correlation test. When a variable was 
statistically significant and did not show collinearity with another variable, they were 
included in a multi-variable linear regression model. In case of collinearity, the one with 
the strongest correlation was selected. Statistical analysis was done with the Statistical 
Package for Social Sciences version 21 (IBM DPDD Statistics for Windows, Armonk, NY, 
USA). A P--value	of	≤0.05	(two--	sided)	was	considered	statistically	significant.
Interobserver (RG, MS) agreement was assessed for LA volumet-ric and strain param-
eters using Bland–Altman plots in a sample of 30 random subjects.20 Measurements 
were done while being blinded for the other measurement approximately 1 month later. 
Agreement between two measurements was determined as the mean of the difference 
± 1.96 SD.
3 | RESUlTS
Out of the 155 eligible subjects, 147 subjects were included (me-dian age 43.8 [32.7–56.2], 
50% female) into 5 age groups (n ≥ 28 per group). In total, 8 subjects were excluded: 
2 due to having breast implants, 2 subjects had valvular pathology, 1 had a surgically 
closed ductus, 1 had hypertension, 1 with morbid obesity, and 1 with a right bundle 
branch block. Table 1 shows the baseline characteristics of the study population.
3.1 | lA volumetric function
Feasibility for volumetric measurements was good, ranging from 92.5% to 95.9% (Table 
2). LA volumes were indexed for BSA (Table 2), and an additional analysis was performed 
with height indexed pa-rameters (Table 3). Changes in volumes can be seen between 
the age groups regardless of the indexation method. LA minimum and pre--a--wave vol-
umes increased with each age decade. With regard to function, LA reservoir and conduit 
function decreased while pump function increased with age (Table 4).
3.2 | lA myocardial function
Left atrial--strain analysis results are shown in Table 4, including the feasibility, which 
ranged from 78.2% to 80.3%. LA--strain was low-est in the oldest age groups as was LA--
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Sre, but LA--Sra increased with age (Figure 3). LA--Sra was significantly more negative in 
men than women, no sex--dependent differences were found in LA--strain and LA--Sre 
(Figure 4). The limits of normal (mean ± 2 SD) were also calculated (Table 5).
3.3 | Correlations
Besides age, LA reservoir function did not correlate with baseline characteristics (Table 
6). Conduit function decreased slightly with increasing weight, BMI, and blood pressure, 
while pump function in-creased with BMI, heart rate, and blood pressure. Conduit and 
pump function correlated well with LV diastolic parameters. LA--strain, LA-- Sre, and LA-
-Sra correlated well with their volumetric counterparts, LA expansion index and passive 
and active emptying fraction(r: 0.471 P: <0.001, r: −0.613 P: <0.001, r: −0.541 P: <0.001).
3.4 | Reproducibility
Interobserver agreement was assessed for volumetric and strain measurements: Mean 
difference for LA maximum volume was −5.2 ± 12.1 mL. For pre--a--wave and minimum 
volume, this was −0.9 ± 10.2 and −1.0 ± 8.4 mL, respectively. Regarding strain measure-
ments, mean difference for LA peak strain, early and late strain rate were 1.83 ± 7.91%, 
−0.04 ± 0.63, and 0.03 ± 0.67 s−1, respectively.
Table 1. Baseline table
Total n = 147 Male n = 73 female n = 74 P-value
Age (years) 44.6 ± 13.8 44.0 ± 13.7 45.3 ± 13.8 ns
Height (cm) 175 ± 9 181 ± 7 169 ± 6 <0.001
Weight (kg) 74.6 ± 12.8 82.4 ± 11.2 66.9 ± 9.0 <0.001
Body mass index (kg/m²) 24.4 ± 3.3 25.2 ± 3.3 23.6 ± 3.0 0.002
Body surface area (m²) 1.89 ± 0.19 2.03 ± 0.15 1.76 ± 0.12 <0.001
Systolic blood pressure (mm Hg) 127 ± 15 131 ± 16 123 ± 12 0.001
Diastolic blood pressure (mm Hg) 80 ± 9 82 ± 9 77 ± 9 <0.001
Creatinine (μmol/L) 78 ± 12 85 ± 10 71 ± 10 <0.001
Bold means statistically significant difference between both groups.
4 | DISCUSSIOn
This prospective study shows that LA function assessed with volu-metric and myocar-
dial methods is feasible in a healthy population and that age and LV diastolic function 
are important determinants of LA function. This study presents values per age decade 
for LA volumetric and myocardial function in a healthy population.
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The largest body of evidence with regard to LA assessment is on LA maximum volume; 
this reflects remodeling due to increased LV filling pressures. The upper limit of normal 
is set at 34 mL/m2, regardless of age, though recent studies showed that LA maximum 
volume increases with age.3–5,21 This is especially true in the elderly; no correlation was 
found in our cohort which included individuals up to 72 years old. We speculated that 
by using STE, LA dysfunction could be detected earlier, which suggests that LV diastolic 
dysfunc-tion can be detected before apparent LA dilatation, providing clini-cians a pos-
sibility to intervene earlier. Our results show that LA peak strain did increase with age, 
which may implicate that strain is a more sensitive marker for LA remodeling in an earlier 
stage. A recent study also demonstrated that LA myocardial function was diminished in 
patients with LV diastolic dysfunction while there was no apparent LA dilatation.19
4.1 | lA volumetric vs myocardial function
This study demonstrates that LA volumetric and myocardial assess-ment is highly 
feasible. We recognize that the BSA--indexed maxi-mum volume in our study was large 
according to current guidelines. However, with parameters such as LA expansion index, 
passive and active emptying fraction this is no longer relevant, since these measurements 
are relative.22 Therefore, the reference values of LA volumetric and myocardial function 
can be extrapolated to other populations. However, there are certain disadvantages to 
volumetric assessment, like the assumption of geometrical shapes and relatively low 
reproducibility of especially smaller volumes. STE can overcome these shortcomings 
because strain analysis does not rely on geo-metrical assumptions.
Table 2 Left atrial echocardiographic volumes indexed for BSA per age decade
Entire study 20–29 y 30–39 y 40–49 y 50–59 y 60–72y
n = 32 n = 28 n = 28 n = 31 n = 28 r
feasibility (%) n = 147
Method--of--disk summation technique 
8LAmaximumvolume(mL/m²)
n=136(92.5%)28. ± 7.2
827. ± 5.7 128. ± 6.6 029. ± 9.2 429. ± 5.5 030. ± 9.1 ns
1LAminimumvolume(mL/m²)
n=141(95.9%)10. ± 3.7
78. ± 2.5 49. ± 2.8 810. ± 4.0 410. ± 3.2 911. ± 5.2 2520.4370.
1LApre--a--wavevolume(mL/m²)
n=141(95.9%)18. ± 5.5
514. ± 3.8 416. ± 3.9 818.± 5.9 419. ± 4.0 921. ± 6.9
Area-length method 
0LAmaximumvolume(mL/m²)
n=136(92.5%)31. ± 7.5
929. ± 6.0 230. ± 6.7 131. ± 9.4 731. ± 6.1 332. ± 9.6 ns
9LAminimumvolume(mL/m²)
n=141(95.9%)10. ± 3.9
49. ± 2.8 010. ± 3.1 511. ± 4.2 311. ± 3.3 013. ± 5.4 2730.4630.
4LApre--a--wavevolume(mL/m²)
n=141(95.9%)19. ± 5.7
815.± 3.9 517. ± 3.9 919. ± 6.1 021. ± 4.2 723. ± 7.1
Correlation with age and corresponding --value are reported.PBoldmeansstatisticallysignificantcorrelationwithageasac-
ontinuous variable.
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4.2 | factors influencing lA function
There are a lot of factors that could influence LA volume and con-sequently function. 
We have assessed the LA through volumetric function with total emptying fraction, a 
sort of ejection fraction of the LA. It is well known that this is divided into a passive and 
active phase and that a portion will flow back into the pulmonary veins. Therefore, we 
also provided LA expansion index, which better de-scribes reservoir function. Instances 
that influence LA volumes are age, sex, height, and weight. To address these, LA volumes 
are often indexed using BSA. In our study, we no longer found differences between men 
and women after correcting for BSA but we did find relatively high values; a quarter of 
these volunteers had a LA max volume above the upper limit of normal.1 This might be 
explained by the fact that height and weight are not both as important for LA volume. 
The Dutch are the tallest people in the world15 which is why an additional analysis was 
done correcting for height as done previ-ously by Eshoo et al.16 We found no differences 
when comparing these results with the BSA corrected volumes. The only exception was 
that LA maximum volume became significantly but weakly cor-related with age (r: 0.202, 
P: 0.018).
Table 3. Left atrial echocardiographic volumes indexed for an allometric function of height2.7
Entire study 20–29 y 30–39 y 40–49 y 50–59 y 60–72 y
n = 147 n = 32 n = 28 n = 28 n = 31 n = 28 r P-value
LA maximum volume (mL/m2.7) 12.2 ± 3.4 11.2 ± 2.5 11.7 ± 2.7 12.2 ± 4.4 12.6 ± 2.7 13.1 ± 4.4 0.202 0.018
LA minimum volume (mL/m2.7) 4.3 ± 1.7 3.5 ± 1.0 4.0 ± 1.1 4.5 ± 1.9 4.4 ± 1.3 5.2 ± 2.5 0.307 <0.001
LA pre--a--wave volume (mL/m2.7) 7.7 ± 2.6 5.9 ± 1.6 6.9 ± 1.5 7.9 ± 2.7 8.3 ± 1.9 9.5 ± 3.4 0.474 <0.001
Values are presented per age group and the correlation with age and corresponding P--value are reported.
Bold means statistically significant correlation with age as a continuous variable.
4.3 | Effects of age and lV diastolic function on lA function
Several studies have looked at possible age--related effects on LA size and function, with 
mixed results.3–6,23 The idea that age influ-ences LA function is not new; Benjamin et al24 
stated that E--wave velocity decreases while A--wave velocity increases with advanc-ing 
age. Our study demonstrates that age influences LA myocardial function. LA--strain and 
LA--Sre are lowest in older subjects while LA--Sra is higher, which is as expected. This is 
partly in line with the study of Morris et al,19 who implicated as much for LA--strain meas-
urements. In our study, LA--Sre and LA--Sra also changed with age, though the values 
that we found for LA--strain were slightly lower than reported earlier.19 This may be due 
to age differences between studies or intervendor differences, as a recent study showed 
that QLAB10 reports slightly lower values for GLS than other software packages.25 The 
study of Miglioranza et al,26 which looked at influ-ences due to age, showed similar ef-
fects, though the actual results cannot be compared as the P--wave was used as onset.
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Currently, there is no consensus on how to assess LA phasic func-tion with STE. In this 
study, we used R--wave as onset because that would allow extrapolation of our data 
to patients with atrial fibrillation. There are other recent studies that used either the 
R--wave or the P-- wave as onset showing that both these techniques are possible.19,26,27 
We choose for strain rate to assess LA booster pump function instead of peak strain, as 
this was found to be superior.27,28 Pathan et al29 per-formed a meta--analysis to formulate 
normal values for LA function. Reservoir function was 39.4% which corresponds very 
well with our findings, unfortunately for conduit and pump function, strain instead of 
strain rate was used, which makes it impossible to compare our findings.
Left ventricular diastolic dysfunction is closely related with LA function, and our results 
reflect that as well. E--and A--wave velocity correlated well with LA conduit and pump 
function, regardless of the method used. An increase in LV stiffness leads to a reduction 
in LA conduit function, which is compensated by an increase in pump function. This 
can be witnessed by the E/A--ratio, which inverses with age. This was seen for the LA 
myocardial function parameters.
4.4 | limitations
This was a single--center study including Dutch Caucasian subjects. Extrapolation to 
other ethnicities should be done with caution. We used QLAB for the strain analysis, 
though a recent study found no dif-ferences between vendors for LA measurements,29 
comparison with other vendors should be done with caution. Also, subjects had no re-
strictions regarding food intake prior to the echocardiographic examina-tion. This could 
influence tissue--and pulsed--Doppler measurements.30
4.5 | Clinical implications
The results from this study may add to the foundation to formulate reference values 
regarding LA functional analysis, in preparation for studies to determine potential diag-
nostic and prognostic value which may eventually be used to assess patients in a clinical 
set-ting. In our experience, LA functional analysis, especially myocardial deformation, 
is easy and quick to perform. As expected, age plays an important role, which is why 
we propose age--dependent refer-ence ranges. The fact that LA maximum volume did 
not correlate with age but LA--strain did indicates that functional assessment is a more 
sensitive marker.
Future studies should investigate the potential prognostic value of LA function and 
which technique, myocardial deformation or vol-umetric assessment, is most valuable.
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5 | COnClUSIOn
Left atrial volumetric and myocardial function measurement is a viable option, and 
age--dependent reference ranges for LA phasic function are presented. LA myocardial 
and volumetric function pa-rameters have proven to be age--but not sex--dependent. 
Considering the high feasibility and clinical relevance of LA myocardial function mea-
surements, these results can help integrate LA STE analysis into clinical practice.
 
figure 3. Correlations between left atrial (LA)--strain, LA--Sre and LA--Sra and age. Each dot represents one 
individual’s measurement. The fitted lines and r2 values are given. All three variables were significantly 
correlated with age
figure 4. Three graphs showing left atrial myocardial function per sex for each age group
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Table 6. Table describing correlations between LA function (volumetric and myocardial) and baseline char-
acteristics
lA--strain lA--Sre lA--Sra
r r r
Age −0.227* 0.715** −0.348**
Height −0.045 0.011 −0.012
Weight −0.068 0.246* −0.153
Body mass index −0.043 0.307* −0.197*
Body surface area −0.067 0.185* −0.119
Heart rate −0.052 0.076 −0.254*
Systolic blood pressure −0.081 0.186* −0.275*
Diastolic blood pressure −0.1 0.333* −0.295*
E--wave 0.331** −0.566** 0.182*
A-wave −0.004 0.422** −0.367**
E′ 0.331** −0.697** 0.268*
E/e′ −0.111 0.298* −0.128
Left atrial expansion index 0.468** −0.381** −0.257*
Left atrial passive emptying fraction 0.354** −0.590** 0.249*
Left atrial active emptying fraction 0.198* 0.115 −0.545**
LA--Sra −0.478** – –
Bold mean statistically significant, *P--value < 0.05, **P--value < 0.001
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ABSTRACT
Background: The methods used to characterize the volume change and the deforma-
tion of the left atrium(LA) are highly dependent on technical factors and difficult to use 
in a clinical environment. The aim of this study was to demonstrate that mitral annulus 
displacement(MAD) by speckle tracking can be an alternative method to studying the 
longitudinal LA function.
Methods: 90 subjects(54% males), with a mean age of 53(±15), underwent a complete 
echocardiographic examination, comprising 2D, 3D and TDI. They were divided into 
normal individuals(35) and patients having an abnormal echocardiography(55).
Results: There was a very strong correlation between 3D volumetric function and MAD, 
both for the reservoir(r=0,78; p<0,0001) and contractile(r=0,76; p<0,0001) functions. The 
correlation with the longitudinal strain displayed an r=0,87, p>0,0001 for the reservoir 
and r=0,81, p<0,0001 for the contractile function. The systolic speed in pulsed TDI and 
the systolic displacement had an r=0,83, p<0,0001. MAD was a very good discriminator 
for normal vs abnormal subjects(AUC for reservoir=0,872 and for contractile=0,843; 
p<0,0001), performing less well than 3D(AUC reservoir=0,892 and contractile=0,915; 
p<0,0001) or deformation(AUC=0,921 and 0,903 respectively; p<0,0001), but better than 
pulsed TDI(AUC=0,807; p<0,0001). The percentage error was ±15% for inter and ±12% for 
intra-observer variability. The time taken for displacement analysis was 9±3 sec for an 
experienced cardiologist and 12±4 sec for a beginner.
Conclusion: MAD by speckle tracking is a reliable and fast method to evaluate LA func-
tion. Given the strength of the correlations with strain parameters, it could be used as a 
surrogate measure of the deformation of LA.
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InTRODUCTIOn
Left atrium global and longitudinal function have been subjects of study for a long 
time1-6. The particular shape of the left atrium makes the volumetric methods employed 
for the left vetricle difficult to use7-8. Numerous articles describe the role of the 2D and 
3D imaging9-12, and deformation techniques, using tissue Doppler13-18 or 2D speckle 
tracking19 . The results are globally encouraging, and there is a growing body of evidence 
concerning the prognostic value of the left atrium function, in particular the deforma-
tion parameters related to atrial reservoir, conduit or contractile function20-24. However, 
these methods are not easy to use in everyday clinical practice. They are time consum-
ing and they rely (especially for the 2D methods), on algorithms designed initially for the 
evaluation of the left ventricle25.
The purpose of this methodological study was to demonstrate that the displacement of 
the mitral annulus, computed by speckle tracking, can be an easy and fast alternative 
method to studying the longitudinal function of the left atrium, having the advantages 
of the 2D speckle tracking and TDI techniques.
METHODS
Subjects referred for cardiac ultrasound examination were divided into two groups. The 
normal subjects were disease-free individuals above the age of 18, undergoing a rou-
tine screening evaluation. The main inclusion criteria for this group were the absence 
of significant medical history and a strictly normal echocardiographic examination, 
defined as the absence of any abnormal findings and echocardiographic parameters 
situated in the defined normal range26. The abnormal subjects group was chosen among 
general cardiology patients, with significant history of cardiovascular disease, having 
an enlarged left atrium, with or without other abnormal echocardiographic findings. 
Patients having prosthetic valves, important annular calcification (more than 2/3 of 
the posterior annulus27), significant areas of myocardial scar (more than 3 myocardial 
segments, involving the basal segments), atrial fibrillation/flutter at the time of image 
acquisition, or more than mild mitral regurgitation were excluded from the study.
The study was approved by the Medical Ethical Committee. The subjects gave their 
informed consent for the inclusion in this research.
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Echocardiography
Two-dimensional and three-dimensional echocardiography was performed at inclu-
sion, using a Philips iE33 system (Philips, Best, The Netherlands), with the patient in 
the left lateral decubitus position. The examinations were performed by two different 
experienced cardiologists (MS and MM) and then interpreted separately offline by MS 
and CA (resident doctor in Cardiology), who were blinded to the status of the subject, 
using the QLab9 Software (Philips). The results of their evaluations were compared in 
order to assess the inter and intra observer agreement. 2D images were acquired in 
standard apical 2, 3 and 4 chambers. Full volume of at least 4 beats, optimized for the 
visualization of the left atrium (LA), were also obtained in the apical window26.
The indexation for the body surface area was considered unnecessary, since this value 
was stable for the same patient.
a) 3D full volume semi automated border detection method
The LA maximum volume was considered the largest volume of the LA measured at the 
end of the left ventricular systole, in the frame just before mitral valve opening. The LA 
minimum volume is defined as the smallest LA volume, just after the P wave on ECG, 
at mitral valve closure. The LA pre-systolic volume is measured in the frame before the 
onset of the P wave on the ECG.
The emptying fraction (EptF) was defined as EptF= (LA maximum volume-LA minimum 
volume)/ LA maximum volume. The ejection fraction (EF) was defined as EF= (LA pre-
systolic volume-LA minimum volume)/ LA pre-systolic volume26.
The 3D EptF and EF were used as reference for the other methods.
b) Tissue Doppler
Tissue Doppler pulsed-wave acquisitions were obtained in the apical 2 and 4 chambers 
views, at the level of the 4 mitral annulus points: medial(septal), lateral, anterior and 
inferior, using a narrow tissue Doppler sector and a parallel alignment for an optimal 
image.
The value used to characterize left atrium contractile function was the maximum veloc-
ity of the a’ wave on the tissue Doppler tracing (the late diastolic negative deflection 
following the P wave on the ECG).
Chapter 6 117
The mitral annular displacement by two-dimensional speckle tracking – a new tool in evaluating the left atrial function
c) 2D speckle tracking
The left atrial strain and strain rate were estimated using the 2d speckle tracking meth-
od, also initially designed for the evaluation of the left ventricle, in 2,3 and 4 chambers 
apical views. The baseline point was set at the onset of QRS. We retained the global 
longitudinal strain (GLS= mean maximal atrial strain during atrial diastole) as a marker 
of the reservoir function of the left atrium and the atrial systolic strain rate28 (SSR= the 
maximal negative deflection of the mean strain rate curve, after the P wave on the ECG) 
as a marker of the contractile function (Figure 1).
figure 1. The longitudinal deformation of the left atrial wall by speckle tracking. A: maximal strain (GLS); 
B: atrial systolic strain rate (SSR).
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d)  Mitral annular displacement
Mitral annulus displacement by speckle tracking was calculated offline using the QLAB 
9 software 29(Philips Healthcare). In order to minimize the errors, the “apical“fixed point 
was chosen at the bottom of the left atrium, together with the classical four mitral 
annular points (Figure 2). Using the time-displacement curves the maximum negative 
and positive displacement points were noted, as well as the position during diastasis. 
Because the program was developed for the assessment of left ventricular function, the 
baseline is considered at the onset of QRS. The annular displacement is calculated as 
the arithmetic sum of the displacement values. The global displacement (D) can be ob-
tained by averaging the four annular points, between the maximal negative and positive 
positions (Figure 3A). The systolic displacement (S) is defined as the average of the four 
points movement between diastasis and maximal positive position (Figure 3B).
figure 2. Mitral annular displacement by speckle tracking in apical 4 chambers view. The ‘’apical’’ fixed 
point is situated at the bottom of the left atrium.
Statistical analysis
Continuous variables are presented as means (± SD). Categorical variables are presented 
as frequencies and percentages. Differences between proportions were estimated by 
the chi-square test, between mean values by the unpaired t test, and between similar 
parameters by the paired t-test. Correlations were computed using Pearson’s method, 
and graphically represented with linear regression lines. ROC curve analysis was used to 
estimate the discriminative power of the different methods. A two-sided p value of less 
than 0.05 was used for declaring statistical significance.
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figure 3. Displacement values calculated from the time-displacement curves, for the medial point. A: 
D(total displacement value) from maximal negative to the maximal positive position; B: systolic displace-
ment S, between diastasis and maximal positive position.
The inter and intra observer variability were assessed using Bland-Altman plots, and re-
ported as bias, limits of agreement and percentage error. This variability was compared 
to the variability between subjects as reference for the limits of agreement30.
All statistical analyses were performed with SPSS 21.0 software (SPSS Inc, Chicago, IL, USA).
RESUlTS
90 patients (54% males), with a mean age of 53 ±15, were included in the study. 35 (39%) 
of them had a normal echocardiographic examination. 55 patients with abnormal echo 
examination were also selected. The baseline clinical features are depicted in Table 1.
Table 1. Baseline clinical features of study participants (normal vs abnormal )
Parameter normal
n=35
Abnormal
n=55
p
Age 48±17 56±11 0,008
Male gender 16 (46%) 34(62%) 0,13
Obesity 8(23%) 18(33%) 0,31
Smoking 11(31%) 17(31%) 0,95
Dyslipidemia 16(46%) 36(66%) 0,06
Diabetes 0 11(20%)
Hypertension 0 28(51%)
Renal failure 0 4(7%)
Atrial fibrillation (converted to sinus rhythm) 0 36(66%)
Coronary artery disease 0 3(6%)
COPD 0 2(4%)
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Table 2. Echocardiographic variables
Variable Normal individuals
n=35
Abnormal echo
n=55
p
LA 3D
maximal volume (ml)
47(±8) 68(±19) <0,0001
LA EptF (%) 67(±8) 49(±16) <0,0001
LA EF (%) 39(±12) 21(±16) <0,0001
TDI mean a’ 10(±2) 7(±3) <0,0001
LA GLS (%) 39(±8) 24(±12) <0,0001
LVEF (%) 65(±4) 59(±10) 0,001
Systolic strain rate (%) 2,8(±0,5) 1,7(±1,1) <0,0001
Total mean annulus displacement (mm) 14(±1,7) 10(±3,3) <0,0001
Atrial systolic annulus displacement (mm) 7(±1,7) 4,5(±2,5) <0,0001
Data are presented as mean ±SD or number (percentage %)
EF= ejection fraction of the LA; EptF= emptying fraction of the LA; GLS=global longitudinal strain of the left atrium; LA=left 
atrium; LVEF=left ventricle ejection fraction; TDI=tissue Doppler Imaging
The main echocardiographic variables analyzed in this population are shown in Table 2. 
Significant differences existed for all variables between normal and abnormal echocar-
diography groups.
Intra and inter observer agreement for the mitral annulus displacement by 
speckle tracking
24 consecutive patients were analyzed by MS at the time of acquisition of data, on the 
QLAB 9 postprocessing software available on the echo machine, and reviewed lately in 
a blinded random manner, together with all the other patients. The same group was 
evaluated by AC (resident doctor in Cardiology), to estimate for inter observer variabil-
ity. The results concerning the intra and inter observer variability are shown in Table 
3 and the Bland-Altman plots in Figure 4. The limits of agreement were tighter for the 
intra compared to inter observer variability (a percentage error of -11% to 13% vs -15% 
to 15%), and the variability between subjects largely greater than inter or intra observer 
variabilities.
Table 3. Intra and inter observer variability for the measure of global displacement D in millimeters
Mean D initial Mean D second Bias Lower limit/
percentage error
Upper limit/
percentage error
Intra observer 11,8(±2,9) 11,9(±3,2) 0,12 -1,29 (-11%) 1,53 (13%)
Inter observer 11,8(±2,9) 11,8(±3,3) -0,03 -1,77 (-15%) 1,74 (15%)
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figure 4. Bland-Altman plots showing the limits of agreement for intra observer (A) and inter observer (B) 
agreement.
Time requirements
The time taken to obtain the mitral annulus displacement was estimated for an experi-
enced user (MS) and for a beginner (CA). The time taken to obtain a tracking in only api-
cal 4 chambers view was 9±3 sec for MS and 12±4 sec for CA. The time taken to measure 
the displacement values in this single apical window was 72±14 sec for MS and 106±19 
sec for CA. The total time necessary to obtain all the displacement values used in this 
study was 164±36 sec for MS and 233±49 sec for CA.
Correlations between variables in the overall group
The GLS was strongly correlated to the EptF, r=0,80, R2=0,65, p<0,0001. The total annular 
displacement D correlated strongly with the EptF, r=0,78, R2=0,61, p<0,0001. The global 
longitudinal strain strongly related to D, r=0,87, R2=0,75, p<0,0001 (Figure 5).
The mean value of annular velocity in TDI correlated well with the EF, r=0,66, R2=0,44, 
p=0,0001. The atrial systolic strain rate (SSR) displayed a strong correlation with the EF, 
r=0,76, R2=0,57, p<0,0001. The relation of the systolic annular displacement S with the 
EF was strong with r=0,76, R2=0,58, p<0,0001. The correlation of the SSR and S was very 
good, r=0,81, R2=0,65, p<0,0001 (Figure 5). The mean TDI speed of the annular teledia-
stolic motion correlated very strongly with S, r=0,83, R2=0,69, p<0,0001.
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Correlations of variables in the normal echo group
In the patients’ group having a normal echocardiography (n=35, 43% males), the level of 
correlation of the empty fraction EptF to the GLS was moderate, r=0,47, R2=0,22, p=0,004.. 
The mean annular displacement D, when compared with EptF, had an r=0,641, R2=0,41, 
p<0,0001. The relation between GLS and D was good, r=0,624, R2=0,39, p<0,0001.
The mean annular systolic speed measured in TDI was not related to the EF, r=0,311, 
p=0,07.The SSR correlated moderately to the EF, r=0,402, R2=0,16, p=0,02. The systolic 
displacement of the annulus (S) correlated strongly with the ejection fraction, r=0,67, 
R2=0,45, p<0,0001, and with the mean value of TDI annular speed r=0,608, R2=0,37, 
p<0,0001. The systolic strain rate was also moderately associated with the systolic dis-
placement, r=0,411, R2=0,17, p=0,01.
Correlations of variables in the abnormal echo group
In the patients with an abnormal echocardiography (n=55, 62% males), the global lon-
gitudinal strain was strongly correlated to the EptF, r=0,77, R2=0,59, p<0,0001. The total 
mean annular displacement D was also strongly correlated with EptF, r=0,73, R2=0,53, 
p<0,0001. The GLS was very strongly correlated with displacement r=0,89, R2=0,79, 
p<0,0001.
The mean value of tissue Doppler annular speed correlated well with the EF, r=0,68, 
R2=0,46, p<0,0001. The SSR relation with EF had an r=0,78, R2=0,60, p<0,0001. The sys-
tolic displacement of the mitral annulus correlated strongly with the EF, r=0,75, R2=0,56, 
p<0,0001. The correlation between SSR and S was very strong, r=0,84, R2=0,70, p<0,0001. 
The same level of correlation of S could be found with the mean value of the annular 
displacement speed in TDI, r=0,85, R2=0,73, p<0,0001.
Comparison of the parameters of global function, the deformation indices 
and the local annular displacement
ROC curves were plotted to compare the global longitudinal strain (GLS) and the empty-
ing fraction (EptF), as measurements of the global function of the left atrium with the 
global and local total displacement of each annular point (medial, lateral, inferior and 
anterior). The ejection fraction (EF), the A velocity in TDI and the atrial systolic strain rate 
(SSR) were compared with the systolic displacement globally and point by point.
The results are presented in Table 4 and graphically represented in Figure 6. We have 
found that the best discriminators of abnormal vs normal patients were the global 
longitudinal strain, with an area under the curve (AUC)=0,921, the ejection fraction of 
the left atrium (AUC=0,915), and the SSR (AUC=0,903). They were followed by the empty-
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ing fraction of the LA (AUC=0,892), the total displacement D(AUC=0,872), the systolic 
displacement S (AUC=0,843) and the mean value of A in TDI (AUC=0,807). On the point-
by-point analysis, the medial point was a better predictor than the other annular points 
when considering the total (AUC=0,872) or systolic displacement (AUC=0,846).
figure 5. Correlations in the overall group. A: correlation between the global displacement (D) and the 
emptying fraction (EptF); B: Relation between systolic displacement (S) and the ejection fraction of the left 
atrium (EF); C: Correlation between the global longitudinal strain (GLS) and D; C: Correlation of the systolic 
strain rate (SSR) and S.
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Table 4. Comparison between volumetric, TDI and deformation parameters and the mitral annulus dis-
placement
functional parameter ROC area under the curve
95% Confidence interval
Area under the curve (AUC) Lower bound Upper bound p
GLS (%) 0,921 0,868 0,974 <0,0001
EptF (%) 0,892 0,825 0,958 <0,0001
Lateral D (mm) 0,812 0,723 0,901 <0,0001
Medial D (mm) 0,872 0,797 0,946 <0,0001
Anterior D (mm) 0,838 0,754 0,922 <0,0001
Inferior D (mm) 0,858 0,775 0,941 <0,0001
D (mm) 0,872 0,797 0,947 <0,0001
EF (%) 0,915 0,857 0,972 <0,0001
SSR (s-1) 0,903 0,836 0,971 <0,0001
TDI mean A (cm/s) 0,807 0,714 0,908 <0,0001
Lateral S (mm) 0,749 0,645 0,852 <0,0001
Medial S (mm) 0,846 0,764 0,928 <0,0001
Anterior S (mm) 0,826 0,736 0,916 <0,0001
Inferior S (mm) 0,798 0,705 0,892 <0,0001
S (mm) 0,843 0,761 0,926 <0,0001
figure 6. ROC plots for the global and point-by point displacement of the mitral annulus and the classical 
functional parameters. A: global function parameters: EptF, GLS and D; B: atrial systolic parameters: EF, TDI 
A velocity, SSR and S. D and S are represented with black lines.
DISCUSSIOn
The main findings of this study were: 1) mitral annular displacement by speckle track-
ing is a reliable and simple method to evaluate the left atrium function; 2) there is a 
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very strong correlation between the volumetric parameters of left atrial function and 
deformation indices on one side and the mitral annulus displacement on the other; and 
3) the annulus displacement is a very good discriminator between normal and abnormal 
subjects. It performs less than well the deformation indices (GLS and SSR) or the volu-
metric fractions ( EptF and EF), but better than TDI velocities.
The present guidelines for chamber quantification recommend the use of the biplane 
Simpson method in the assessment of maximal left atrial volume26, as a powerful index 
of the overall burden of disease on the left heart, in several pathological states. The 
prognostic signification of this volume has also been stressed by numerous studies31-36. 
The global change in atrial volume during the cardiac cycle is simpler than the one of 
the left ventricle, having mainly a longitudinal component, mostly due to the motion 
of the mitral annulus (which in turn is mostly due to LV contraction). But in order to 
characterize the left atrial function using a volumetric approach, the Simpson method 
becomes very difficult to use in real clinical practice, because three volumes are needed 
(the maximal atrial volume, the minimal volume and the pre-A volume), correspond-
ing to the reservoir, conduit and contractile atrial function26,28, 37. The same difficulty is 
present for area/length methods. The most practical method, proven to be accurate and 
fast, allowing the extraction of virtually all atrial volumes in a very rapid way, is the use 
of tridimensional imaging. For 3D techniques, however, it is important to have sufficient 
image quality in order to have reliable and reproducible results.
During recent years, a great deal of attention has been directed towards the deformation 
of the left atrium as an index of left atrial function, and to its prognostic importance. 
These methods are still highly dependent on image quality. For example, an ideal LA 
strain analysis should have a frame rate of 50-70Hz and a clear visualization of the 
left atrial wall so as to obtain a good tracking28. This quality is sometimes difficult to 
obtain at the level of the left atrium, situated in the far field of view, and with thin walls, 
interrupted by the pulmonary veins and the left atrial appendage. As for TDI, its angle-
dependency is well known38, but it has the advantage of being useful even when 2D 
images are not so good. The problem for deformation studies derived from TDI would be 
the excess of noise and the signal/noise ratio. The pulsed tissue Doppler of the mitral an-
nulus is very feasible, even for low-quality images, with a good intra and inter-observer 
agreement, mainly because it follows the movement of a strong acoustic reflector (the 
mitral annular points), but it remains angle-dependent, and cannot give direct informa-
tion about wall deformation6.
The mitral annular displacement using speckle tracking was studied as a method of 
evaluation of the left ventricular function, and correlated well with the ejection fraction, 
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especially when the quality of the image did not allow a good tracing of the endocardial 
borders, but still a good visualization of the hyperechoic annulus39-41. The mitral annular 
displacement by speckle tracking can also reflect the left atrial function. Preliminary 
results of this method were promising42.
This method has no angle dependency, as any speckle tracking technique, and theoreti-
cally does not need a high quality image, because it is following the same strong reflec-
tors as the pulsed TDI. It is also much simpler than the 2D tracking of the whole atrial 
wall, because it neglects completely the pulmonary veins or the left atrial appendage. 
The thickness of the wall also poses no problem.
In this study there was a very strong correlation between the function of the left atrium, 
estimated by using a tridimensional volumetric method, and the mitral annulus dis-
placement by speckle tracking. This is very significant for the reservoir (r=0,78, p<0,0001) 
and contractile (r=0,76, p<0,0001) functions. The deformation parameters derived from 
2D speckle tracking of the atrial wall display an excellent level of correlation with the 
displacement of the annulus, both for the reservoir (r=0,87, p<0,0001) and contractile 
function (r=0,81, p<0,0001). There was also an excellent correlation between the mean 
telediastolic (atrial systolic) speed of the annulus in pulsed TDI and the systolic annular 
displacement (r=0,83, p<0,0001). The level of correlation with 3D volumetric function 
was similar between the mitral annular displacement and the usual deformation param-
eters derived from 2D speckle tracking. The abnormal echo group displayed a clearly 
lower atrial function, and the difference with the normal group was highly significant. 
They had stronger correlations with the functional parameters derived from 3D volumes. 
The relationship with the deformation indices and the pulsed TDI was also stronger in 
abnormal subjects. We hypothesize that in pathologically enlarged atria, the tracing of 
the endocardial border by the 3D algorithm and the detection of the left atrial wall by 
speckle tracking is easier than in normal sized atria. The constant underestimation of 
left atrial volumes by 3D algorithms is already known, and the degree of error is prob-
ably more important for the smaller atrial volumes.
The age difference between groups was statistically significant but biologically ir-
relevant (mean value 48 vs 56, thus practically belonging to the same age group). It is 
explained by the difficulty of including elderly disease-free individuals with a normal 
echocardiography.
The mitral annular displacement was a very good discriminator for normal vs abnormal 
subjects, performing less well than volumetric or deformation indices, but better than 
TDI. When analyzing separately the displacement of the classical annular points, the 
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medial (septal) point in apical 4 chambers view performed best, with an AUC equal to 
the one of the mean displacement. This could be due to the axial position of the medial 
point, thus in the best resolution region, and with a strictly longitudinal excursion. Ac-
cording to these results, we could even discuss the use of only the displacement of the 
medial (septal) point in order to characterize the global longitudinal function of the left 
atrium.
The intra and inter observer variability were acceptable, the larger inter observer vari-
ability probably being explained by the second evaluation being done by an inexperi-
enced user. The time taken for the analysis was relatively short, even for a beginner. 
The time taken to have an estimation of the displacement (for example only the medial 
point) was less than 2 minutes.
Comparison with results in the literature
Very recently, a normal values’ estimation for the deformation parameters of the left 
atrium was published28. In our normal population, the GLS of the LA was 39%(±8) and 
the atrial SSR =2,8(±0,5)s-1. These values are very close to the mean proposed by Morris 
et al. That was also the case for the GLS of the abnormal echo group, with a GLS mean 
of 24±12 and a SSR of 1,7±1,1. These comparisons have been made bearing in mind that 
the study by Morris et al was performed using General Electric machines and software, 
and addressing different pathologies than in our study population.
To our knowledge, this is the first study to look at the use of mitral annular displacement 
by speckle tracking in the estimation of the left atrial function. However, this tracking 
is practically the same as the one used for the left ventricular function43. A very good 
correlation was already noted between the left ventricular global longitudinal strain44 
and the mitral annular systolic displacement derived from TDI45-46.
Study limitations
The number of patients in this study was limited, but the statistical significance of the 
results was very high. The patients were selected so as to have a good quality image, in 
order to allow the use of deformation imaging and 3D. In the absence of an independent 
reference method, we can only speculate on the feasibility of the mitral annular dis-
placement in low quality echo, by extension of the results already published regarding 
the left ventricular function. The use of a 3D method for volume estimation has specific 
limitations that were mentioned above.
The choice of patients’ population makes the results only apply to pathologies with a 
homogenous left ventricle, without important annular calcification or valvular prosthe-
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sis. Most likely the results cannot be extrapolated to patients with mitral valve lesions or 
pericardial disease.
Another issue is the need for vendor-specific software that is not widely available. How-
ever, our study proves that the displacement of one single annular point remains a very 
good discriminator between pathological or normal subjects. Linear displacement by 
speckle tracking is available on all ultrasound systems.
COnClUSIOn
Mitral annulus displacement by speckle tracking proves to be a reliable and simple 
method to evaluate the left atrial function. Given the strength of the associations found 
with the deformation parameters derived from 2D strain, it could be used as a surrogate 
measure of the deformation of the left atrial wall.
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ABSTRACT
Background: We aimed to compare the prognostic value of a single ‘baseline’ echocar-
diogram with repeated echocardiography in stable chronic heart failure (CHF) patients. 
We hypothesized that repeated echocardiograms would contain incremental prognostic 
information.
Methods: In the prospective Bio-SHiFT study, we performed 332 echocardiograms 
in 106 patients during a median follow-up of 2.3 years. The endpoint comprised HF 
hospitalization, left-ventricular assist device implantation, heart transplantation, and 
cardiovascular death. We compared hazard ratios (HRs; adjusted for NT-proBNP) from 
Cox models for the first available measurement with HRs from joint models, which 
model individual trajectories based on the repeated measurements and link these to 
the time-to-event data.
Results: Mean age was 58.1 years, 78.3% were male, 12.6% had NYHA-class >II, all had 
reduced ejection fraction (rEF) and most common HF etiologies were cardiomyopathies 
(51%) and ischemia (40%). The endpoint occurred in 25 patients. Both the single mea-
surements and the temporal trajectories were significantly associated with the endpoint 
(adjHR Cox model (95%CI) vs adjHR joint model (95%CI)): Left ventricular (LV) ejection 
fraction: 1.47(0.93-2.31) vs 1.77(1.13-2.93), diastolic LV diameter: 1.64(1.09–2.47) vs 
1.68(1.12-2.57), systolic LV diameter: 1.72(1.10-2.69) vs 1.68(1.13-2.63), systolic left 
atrial diameter: 1.88(1.18-3.00) vs 2.60(1.48-4.97), E/A-ratio 2.73(1.42-5.26) vs 3.87(1.75-
10.13), and E/e’-ratio 2.30(1.38-3.84) vs 2.99(1.68-6.19). None of the trajectories from the 
investigated parameters showed worsening prior to events.
Conclusion: Although single baseline or repeatedly measured echocardiographic pa-
rameters were associated with the endpoint, all parameters remained on average stable 
during the 2.3 years follow-up in this, largely, minimally symptomatic CHF cohort. Thus, 
regular echocardiographic monitoring of systolic or diastolic LV function within this 
time-frame does not carry incremental prognostic information over a single baseline 
measurement.
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Abbreviations
CHF Chronic heart failure
LVEF Left ventricular ejection fraction
E Peak early filling velocities
A Peak late filling velocities
rEF Reduced ejection fraction
NT-proBNP N-terminal pro-Brain Natriuretic peptide
Bio-SHiFT  Serial Biomarker Measurements and New Echocardiographic Techniques 
in Chronic Heart Failure Patients Result in Tailored Prediction of Progno-
sis
TR Tricuspid regurgitation
e’ Early diastolic mitral annular velocity
SD Standard deviation
IQR Interquartile range
HR Hazard ratio
CI Confidence interval
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InTRODUCTIOn
Echocardiography plays a central role in chronic heart failure (CHF) and is used on a 
daily basis for diagnosis and follow-up.[1] Echocardiography is relatively inexpensive, 
has a high feasibility and is capable of producing robust and simple measurements, 
such as left ventricular ejection fraction (LVEF), the dimensions of the left ventricle 
and atria, and the ratio of peak early (E) and late (A) filling velocities. For many of 
these measurements, studies have shown that they carry prognostic value in patients 
with heart failure.[2-6] However, in these studies, single, baseline echocardiographic 
measurements were related to the clinical endpoints of interest. Single measurements 
merely provide a snapshot of a patient’s condition and fail to identify high-risk periods 
in individual patients. We hypothesize that repeating echocardiography may provide 
incremental insights into individual temporal patterns of systolic and diastolic function 
in CHF patients, and may herewith help identify periods in which an individual is at high 
risk of an event. If our hypothesis is confirmed and such periods exist, we could use 
dynamic predictions for updating the current risk of an event after each new echocar-
diogram, leading to an individual and up-to-date risk assessment which could be helpful 
for treatment adjustment.[7]
To investigate our hypothesis, we compared the prognostic value of a single ‘baseline’ 
echocardiogram with the prognostic value of repeated echocardiograms in clinically 
stable patients with CHF. In addition, we investigated if the repeatedly measured echo-
cardiographic parameters have incremental prognostic value over repeatedly measured 
N-terminal pro-Brain Natriuretic peptide (NT-proBNP).
MATERIAl AnD METHODS
Details on the design of the Serial Biomarker Measurements and New Echocardiographic 
Techniques in Chronic Heart Failure Patients Result in Tailored Prediction of Prognosis 
(Bio-SHiFT) study have been published previously.[8] In short, Bio-SHiFT is a prospec-
tive, observational cohort of stable patients with CHF, conducted in Erasmus MC, Rotter-
dam, and Northwest clinics, Alkmaar, The Netherlands. Patients were recruited during 
their regular outpatient visits while in clinically stable condition (i.e. they had not been 
hospitalized for HF in the three months prior to inclusion). The main inclusion criterion 
was a diagnosis of HF according to the guidelines of the European Society of Cardiology 
three or more months before inclusion.[9] We excluded patients younger than 18 years.
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After inclusion, the patients were followed for a maximum duration of 30 months, during 
which study follow-up visits were scheduled every three months (a window of +/- one 
month was allowed). At each follow-up visit, a short medical evaluation was performed, 
blood samples were drawn, and occurrence of adverse cardiovascular events since 
the previous visit were recorded. During the study, the routine outpatient follow-up 
by the treating physician continued for all patients, independently of the study visits. 
The study was approved by the medical ethics committees, conducted in accordance 
with the Declaration of Helsinki, and registered in ClinicalTrials.gov (NCT01851538). All 
patients signed informed consent for their participation in the study.
Three hundred ninety-eight patients were included in Bio-SHiFT. In this repeated echo 
substudy, we aimed to include 100 patients. The substudy was only performed at 
Erasmus MC, and consisted of repeated echocardiograms performed every six months 
during follow-up, additional to the tri-monthly blood sampling in Bio-SHiFT.
Echocardiography measurements and evaluation
Two-dimensional grayscale harmonic images were obtained in the left lateral decubitus 
position using a commercially available ultrasound system (iE33, Philips, Best, The 
Netherlands), equipped with a broadband (1-5MHz) S5-1 transducer (frequency trans-
mitted 1.7MHz, received 3.4MHz) and stored in the echo core lab of Erasmus MC. Using 
specialized software (TOMTEC imaging, Unterschleissheim, Germany), the following 
parameters were measured: left ventricular ejection fraction (LVEF, using triplane), end-
diastolic and end-systolic LV diameter, and end-systolic left atrial diameter.[10] The vena 
cava inferior diameter (including the results of the ‘sniff test’), the tricuspid regurgita-
tion (TR) velocity and the function of the aortic, mitral, and tricuspid valve, were also 
assessed but currently not evaluated in the longitudinal models.
The diastolic parameters were evaluated using Philips Excellera version R4.1 (Philips 
medical systems, the Netherlands). In order to assess diastolic function, the E/A ratio 
and the ratio of the E and early diastolic mitral annular velocity (e’) were calculated. For 
the e’, we used the average of the lateral and medial e’ when available; however, if only 
one of the two was available, this value was used.
All echocardiographic measurements were performed blinded to biomarker and clinical 
event data.
nT-proBnP measurement
Blood samples were processed and stored at a temperature of -80C within 2 hours after 
blood collection. To determine NT-proBNP levels, a batch analysis was performed using 
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an electrochemiluminescence immunoassay (Elecsys 2010; Roche Diagnostics, India-
napolis, IN). Accordingly, results of the biomarker assays were not available to treating 
physicians at the time of the outpatient visits and did not interfere with usual care.
Clinical study endpoints
The endpoint comprised the composite of hospitalization for the management of acute 
or worsened HF, left ventricular assist device implantation, cardiac transplantation, 
and cardiac death, whichever occurred first in time. All events were adjudicated by a 
clinical event committee blinded to the echocardiographic assessments and biomarker 
measurements, after reviewing corresponding hospital records and discharge letters.
Statistical analyses
Distributions of continuous variables were tested for normality using the Shapiro-Wilk 
test. Normally distributed continuous variables are presented as mean ± standard de-
viation (SD), and non-normally distributed variables as median and interquartile range 
(IQR). Categorical variables are presented as numbers and percentages. Differences 
in baseline characteristics between patients that experienced the endpoint and those 
who did not were tested using t-test and Mann-Whitney test respectively for continuous 
variables, and chi square tests and Fisher’s exact tests for categorical variables.
We first evaluated the association between the echo parameters from the first available 
echocardiogram with the time until the occurrence of the composite endpoint or censor-
ing using a Cox proportional hazard model corrected for baseline NT-proBNP. Hereafter, 
we assessed the incremental value of repeated echocardiographic measurements. For 
this purpose, we used the framework of joint models for longitudinal and survival data. 
In these joint models, a linear mixed-effects (longitudinal) model provided estimates 
of the individual temporal trajectories for each echo parameter, while accounting for 
the correlation in the repeated measurements. These estimated trajectories were then 
combined with a Cox proportional hazards model, to study their association with the 
risk of the study endpoint. The individual trajectories, resulting from the linear mixed 
models, were adjusted for all variables (age, sex, renal failure and heart rate) for whom 
the p-value for the difference between those reaching the endpoint and those remain-
ing endpoint-free was < 0.1. The associations between the temporal evolutions and the 
endpoint, resulting from the Cox model, were firstly adjusted for baseline NT-proBNP 
levels. In a second series of multivariable joint models, we combined the repeatedly per-
formed echocardiograms with repeatedly measured NT-proBNP, in order to investigate 
the incremental value of repeated echos when repeated biomarker measurements are 
also available.
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In order to compare effect sizes of different variables, all investigated echo parameters 
and the NT-proBNP measurements were firstly transformed to achieve a normal distri-
bution after which the corresponding Z-score was calculated. This standardization was 
performed on the entire dataset (containing all repeated measurements)., Hereafter, to 
obtain the HRs entailed by the first echoes only, first echoes were selected and entered 
into Cox models; whilst to obtain the HRs entailed by the repeatedly measured echoes, 
joint models were performed on all available echoes. Thus, the results of the regression 
analyses of the Cox and joint models can be directly compared and are presented as 
hazard ratios (HR) which represent risk per SD increase/decrease of the standardized 
variable, along with the corresponding 95% confidence intervals (CI). As interpretation 
of the unit of these HRs may not be straightforward, we back-transformed the mean and 
+/- SD of the transformed variables and depicted these values in the tables.
As described above, our aim was to investigate whether repeatedly assessed echocardio-
graphic parameters carry incremental predictive value to repeatedly measured NT-proBNP. 
We chose to present our results solely as hazard ratios adjusted for NT-proBNP and not 
combine them with C-statistics. Pepe et al. have demonstrated that testing for improve-
ment in prediction performance is actually redundant if a variable has already been shown 
to be an independent risk factor, and that standard testing procedures for C-indices are 
very conservative and thus insensitive to improvements in prediction performance.[11]
Missing values in echo parameters were, except for the A wave, always due to poor im-
age quality and were as such missing completely at random. Accordingly we chose to 
perform a complete case analysis. Missing values for the A wave were mostly due to 
atrial fibrillation during the echo or due to mitral valve replacement or clipping. In this 
specific patient group imputation of missing values is inappropriate, as the A wave can 
never be measured. Thus, we again chose for a complete case analysis here. The results 
of this analysis should not be extrapolated to patients excluded from the analysis.
All analyses were performed with R Statistical Software using packages ‘nlme’[12] and 
‘JMbayes’.[13] All tests were two-tailed and p-values <0.05 were considered statistically 
significant.
RESUlTS
Baseline characteristics and clinical endpoints
From 2011 to 2017, 106 patients were included in the echocardiography substudy. All 
patients had reduced ejection fraction (rEF). Specifically, all patients in whom EF was 
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measured by the automated software had EF <50%. In 2 patients, EF could not be 
measured in the first available echo by the automated software due to reduced image 
quality; based on the available images EF in these patients was classified as poor. A sum-
mary of the baseline characteristics is displayed in table 1. The majority of the included 
patients were men (78.3%), the mean age was 58 ±11 (SD) years and 40% had HF due to 
ischemic disease.
In total 25 (23.6%) patients reached the combined endpoint; 18 patients were re-hospi-
talized for acute or worsened heart failure; 2 patients received a left-ventricular assist 
device implantation, 2 patients received a heart transplantation, and 3 patients died 
from cardiovascular causes. Patients who later experienced an endpoint had a higher 
baseline heart rate, NT-proBNP, and were more likely to have renal failure than their 
counterparts who remained endpoint-free.
Echocardiography
In the 106 HFrEF patients, a total of 332 echocardiograms were performed with a median 
(IQR) of 3 (2-4) echocardiograms per patient during a median (IQR) follow-up time of 
2.3 (1.7-2.7) years. Missing exams mostly occurred due to logistic circumstances (e.g. 
the unavailability of an ultrasound technician during the study visit). The median time 
between the last echo and the moment that the event or censoring occurred was 69 
(37-165) days in patients in whom the event occurred and 180 (92-280) days in event-free 
patients.
Echocardiographic parameters were successfully measured in more than 90% of avail-
able echocardiograms except for E/A ratio. Due to atrial fibrillation and severe mitral 
valve disease, we were only able to determine E/A-ratio from 81.3% of the echos (270 
echos, 94 patients, 20 events). At least one measurement of each of the other repeatedly 
assessed parameters was available in all 106 patients, except for end-systolic left atrial 
diameter and E/e’-ratio, which were missing completely in one patient.
first available echocardiogram
Table 2 displays the characteristics of the first available echocardiogram for each in-
cluded patient. Because of logistic reasons, seventy-two percent of these echos were 
performed during the baseline visit (follow-up time zero), 14.2% during the first follow-
up visit (target follow-up time 3 months), 8.5% during the second follow-up visit (target 
6 months), and the remaining 5.7% hereafter.
Patients who experienced the endpoint had a lower LV ejection fraction and larger LV 
and atrial dimensions than patients who remained endpoint-free. In addition, those 
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Table 1. Baseline patient characteristics in relation to the occurrence of the composite endpoint
Composite endpoint reached
Variable Total No Yes P value
n 106 81 25
Demograhics
Age, years (mean (SD)) 58.1 (10.7)  57.8 (10.4)  59.3 (11.7)  0.56
Men, n (%) 83 (78.3) 63 (77.8) 20 (80.0) 1.00
Clinical characteristics, (mean (SD))
BMI, kg/m2 (median (IQR)) 26.8 (24.2-30.6) 26.8 (24.1-31.3) 26.5 (24.2-29.2) 0.46
Heart rate, bpm (mean (SD)) 65 (9)  64 (9)  66 (9)  0.05
Systolic blood pressure, mmHg (mean (SD)) 110 (19) 111 (19) 105 (19)  0.14
Diastolic blood pressure, mmHg (median (IQR)) 70 (60-79) 70 (61-79) 65 (60-70) 0.19
features of heart failure
NYHA class, n (%) 0.30
NYHA class I 32 (31.1) 27 (34.2) 5 (20.8) 
NYHA class II 58 (56.3) 43 (54.4) 15 (62.5) 
NYHA class III 13 (12.6) 9 (11.4) 4 (16.7) 
LVEF, % (mean (SD))  27 (9)  29 (9)  23 (6)  0.02
NT-proBNP, pmol/L (median (IQR)) 124.7 (37.5. 219.3)  86.0 (27.3. 192.5) 235.0 (139.6. 422.0) <0.01
Etiology of heart failure, n (%)
Ischemic 40 (39.6) 30 (38.5) 10 (43.5)  0.85
Hypertension 2 (2.1) 2 (2.7) 0 (0.0) 1.00
Secondary to valvular disease 3 (3.1) 1 (1.3) 2 (9.5)  0.23
Cardiomyopathy 51 (52.0) 39 (52.0) 12 (52.2) 1.00
Other 13 (13.5) 11 (14.7) 2 (9.5)  0.80
Unkown 6 (6.8) 5 (7.4) 1 (5.0) 1.00
Medical history, n (%)
Time since first HF episode, years (median(IQR)) 5.7 (2.2-10.2) 5.1 (2.2-9.4) 7.6 (4.3-11.6) 0.20
Prior MI 39 (36.8) 29 (35.8) 10 (40.0)  0.89
Prior PCI 36 (34.3) 27 (33.8) 9 (36.0) 1.00
Prior CABG 8 (7.5) 6 (7.4) 2 (8.0) 1.00
Atrial fibrillation 27 (25.7) 17 (21.2) 10 (40.0)  0.11
Diabetes 26 (24.5) 19 (23.5) 7 (28.0)  0.85
Renal failure 42 (40.0) 26 (32.1) 16 (66.7) <0.01
COPD 12 (11.4) 10 (12.3) 2 (8.3)  0.86
Medication use, n (%)
Beta-blocker 102 (97.1) 79 (97.5) 23 (95.8) 1.00
ACE-Inhibitor 77 (74.0) 59 (73.8) 18 (75.0) 1.00
ARB 26 (24.8) 22 (27.2) 4 (16.7)  0.44
Loop diuretics 96 (92.3) 72 (90.0) 24 (100.0)  0.24
Aldosterone antagonist 68 (65.4) 51 (63.7) 17 (70.8)  0.69
n: number; SD: standard deviation; IQR: interquartile range; BMI: body mass index; bpm: beats per minute; mmHg: Mil-
limeter of mercury; NYHA: New York Heart Association; LVEF: left ventricular ejection fraction; NT-proBNP: N-terminal pro 
brain natriuretic peptide; pmol/L: picomole per liter; HF: heart failure; MI: myocardial infarction; PCI: percutaneous coro-
nary intervention; CABG: coronary artery bypass grafting; COPD: chronic obstructive pulmonary disease; ACE: angiotensin 
converting enzyme; ARB: Angiotensin receptor blocker
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Table 2. Echocardiographic characteristics from first available echo in relation to the occurrence of the 
composite endpoint
 
N of echos in 
which 
variable was 
measured 
(%)
Composite endpoint reached
Total No Yes P value
N 106 81 25
Systolic parameters
LVEF (mean (sd)) 104 (98.1) 28 (9) 30 (9) 22 (7) <0.001
DiasLVD (median (IQR)) 101 (95.3) 64 (59, 73) 63 (58, 69) 73 (64, 79) 0.001
SysLVD (median (IQR)) 99 (93.4) 57 (49, 64) 53 (46, 62) 63 (56, 72) 0.001
SysLAD (mean (sd)) 97 (91.5) 43.28 (8.64) 41.38 (7.80) 49.39 (8.52) <0.001
Diastolic parameters (median (IQR))
E/A ratio 83 (78.3)  1.10 (0.80, 1.88)  0.99 (0.73, 1.24)  2.38 (1.29, 3.38) <0.001
E/E’ ratio 97 (91.5) 13.2 (9.7, 18.3) 11.0 (9.0, 14.7) 22.9 (17.9, 27.8) <0.001
TR velocity 70 (66.0)  2.50 (2.24, 2.86)  2.42 (2.14, 2.65)  2.89 (2.44, 3.32) 0.005
Vena Cava
VCI (median (IQR)) 84 (79.2) 16 (12, 19.25) 15 (12, 19) 20 (11, 22)  0.062
Valvular dysfunction (%)
Mitral valve regurgitation 101 (95.3) 0.002
none 31 (30.7) 29 (37.7) 2 (8.3) 
mild 41 (40.6) 29 (37.7) 12 (50.0) 
moderate 22 (21.8) 17 (22.1) 5 (20.8) 
severe 7 (6.9) 2 (2.6) 5 (20.8) 
Aorta valve regurgitation 101 (95.3)  0.121
none 90 (89.1) 71 (92.2) 19 (79.2) 
mild 8 (7.9) 5 (6.5) 3 (12.5) 
moderate 3 (3.0) 1 (1.3) 2 (8.3) 
Tricuspid valve regurgitation 101 (95.3) 0.004
none 55 (54.5) 46 (59.7) 9 (37.5) 
mild 37 (36.6) 28 (36.4) 9 (37.5) 
moderate 3 (3.0) 2 (2.6) 1 (4.2) 
severe 6 (5.9) 1 (1.3) 5 (20.8) 
P-values were based on T-test or Mann-Whitney test for continuous variables depending on their distribution. To test for 
differences in the categorical variables, chi-square tests were performed.
N: number; LVEF: left ventricular ejection fraction; sd: standard deviation; IQR: interquartile range; DiasLVD: diastolic left 
ventricular diameter; SysLVD: systolic left ventricular diameter; SysLAD: systolic left atrial diameter; E: peak early filling 
velocity; A: peak late filling velocity; e’: early diastolic mitral annular velocity; TR: tricuspid regurgitation; VCI: inferior vena 
cava
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who experienced an endpoint had higher E/A-ratios, E/e’-ratios, and TR-velocities and 
were more likely to have (severe) mitral valve regurgitation and tricuspid valve regurgi-
tation. All echocardiographic parameters except for LVEF, were significantly associated 
with the study endpoint, independently of the baseline NT-proBNP (table 3). Although 
the estimate did not reach statistical significance for LVEF, it was substantial (HR(95%CI): 
1.47 (0.93-2.31)). The E/A ratio and the E/e’ ratio (available in 97 of 106 patients), were 
the strongest predictors with hazard ratios per SD increase of 2.73 (95%CI 1.42 – 5.26) 
and 2.30 (95%CI 1.38 – 3.84) respectively.
Repeated echocardiograms
The individual trajectories of all of the investigated echo parameters were significantly 
associated with the clinical endpoint independently of baseline NT-proBNP. The cor-
responding HRs were comparable, or slightly larger, to those found for the first available 
measurements (Table 4). In line with the results from the ‘single measurement’ analysis, 
E/A-ratio and E/e’ ratio showed the greatest HR per SD increase.
Although the repeatedly measured echo parameters were associated with occurrence of 
the endpoint, we could not identify any increase or decrease of their average temporal 
patterns as the endpoint approached (Figure 1 & Figure 2). The average trajectories of 
the echo parameters remained stable as the composite endpoint or the moment of 
censoring approached.
Repeated echocardiograms and nT-proBnP measurements combined
During follow-up of the 106 patients a total of 819 (median 8 (IQR 7-10) per patient) 
blood samples were taken for NT-proBNP measurement. The results of the multivari-
able joint models in which both the repeatedly measured NT-proBNP and the repeat-
Table 3. Results from first available echo
Variable N of patients (N of events) mean ± SD HR (95%CI) P value
Left ventricular Ejection fraction* 104 pt (24) 29 (20, 38) 1.47 (0.93 - 2.31) 0.101
Diastolic left ventricular diameter† 101 pt (24) 65 (55, 77) 1.64 (1.09 - 2.47) 0.017
Systolic left ventricular diameter† 99 pt (24) 56 (45, 69) 1.72 (1.10 - 2.69) 0.017
Systolic left atrial diameter† 97 pt (23) 42 (35, 51) 1.88 (1.18 - 3.00) 0.008
E/A-ratio‡ 83 pt (20) 1.00 (0.65, 2.00) 2.73 (1.42 - 5.26) 0.003
E/e’-ratio† 97 pt (24) 12.9 (7.4, 22.5) 2.30 (1.38 - 3.84) 0.001
HRs represent change in risk of the endpoint for a 1 standard deviation change in the echo parameter at any point in time 
during follow-up.
All models are corrected for baseline NTproBNP
* HR per one SD decrease
† HR per one SD increase on the log2 scale
‡ HR per one SD increase after ^.66 transformation
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edly measured echo parameters were entered are shown in table 5. The HRs of all of 
the echo parameters somewhat decreased compared to the joint model adjusted 
solely for baseline NT-proBNP. Although repeatedly measured NT-proBNP was a much 
stronger predictor of the composite endpoint, all repeatedly assessed echo parameters 
except for LVEF were independently associated with the endpoint, and herewith clearly 
provided incremental prognostic value. LVEF was not an independent predictor but the 
corresponding estimate was still substantial (HR (95%CI): 1.52 (0.95-2.45)). Notably, of 
all investigated echo parameters, the E/A-ratio and the E/e’-ratio again were again the 
strongest predictors of the composite endpoint.
DISCUSSIOn
In our study in stable, minimally symptomatic, chronic HFrEF patients, repeatedly 
measured LV dimensions and left atrial dimensions, and E/A and E/E’-ratio were signifi-
cantly associated with adverse cardiac events during a median follow-up of 2.3 years, 
independent of both baseline and repeated NT-proBNP measurements. Higher E/A-ratio 
and E/E’-ratio, both representing diastolic function of the heart, were the strongest 
predictors. Although repeated echocardiographic measurements were associated with 
cardiovascular outcome, they remained stable during follow-up and did not worsen as 
an adverse event approached. Thus, patients with adverse cardiac events had lower 
LVEF, larger LV dimensions and larger ratios throughout the entire follow-up period, 
but the temporal trajectories of these parameters did not show diverging slopes in 
patients with events vs those without events. This stability of the echo parameters was 
Table 4. Results for repeatedly measured parameters
Variable N of available echos 
(N of patients, N of events)
mean ± SD HR (95%CI) P value
Left ventricular Ejection fraction* 327 (106 pt, 25 events) 29 (20, 38) 1.77 (1.13 - 2.93) 0.017
Diastolic left ventricular diameter† 325 (106 pt, 25 events) 65 (55, 77) 1.68 (1.12 - 2.57) 0.012
Systolic left ventricular diameter† 320 (106 pt, 25 events) 56 (45, 69) 1.68 (1.13 - 2.63) 0.011
Systolic left atrial diameter† 316 (105 pt, 24 events) 42 (35, 51) 2.60 (1.48 - 4.97) 0.001
E/A-ratio‡ 270 (94 pt, 20 events) 1.0 (0.65, 2.0) 3.87 (1.75 - 10.13) 0.001
E/e’-ratio† 311 (105 pt, 25 events) 12.9 (7.4, 22.5) 2.99 (1.68 - 6.19) <0.001
HRs represent change in risk of the endpoint for a 1 standard deviation change in the echo parameter at any point in time 
during follow-up.
* HR per one SD decrease
† HR per one SD increase on the log2 scale
‡ HR per one SD increase after ^.66 transformation
The survival part of the models, captured by the Cox-model, were corrected for NTproBNP at baseline. In addition the tra-
jectories of the biomarkers, captured by the linear mixed model, were corrected for age, sex, renal failure, and heart rate.
N: Number; HR: HR ratio; SD: standard deviation; pt: patient; E:peak early filling velocities; A: peak late filling velocities
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figure 1. Average levels of echocardiographic parameters at the first and last measurement
The results of each of the investigated echo parameters are depicted in two paired boxplots. In these pairs, the left boxplot 
shows the average echocardiographic parameter levels in patient with the endpoint; while the right boxplot shows the 
average biomarker levels in endpoint-free patients. Within each boxplot, the left box represents the average of the first 
‘baseline’ measurement. The right box depicts the average of the last available measurement for each patient. Abbrevia-
tions: LV: left ventricular; LA: left atrial; E: peak early filling velocity; A: peak late filling velocity; e’: early diastolic mitral 
annular velocity; mm: millimeter
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confirmed by the comparable HRs per SD increase found in the single measurement 
Cox models and the corresponding repeated measurements joint models, which further 
underscores the lack of incremental value of repeated echocardiograms compared to 
single echocardiographic assessment in this category of patients. Finally, we showed 
that repeated NT-proBNP measurements carry more prognostic information than re-
peated echo measurements do.
figure 2. Average levels of echo parameters until time of event
The X-axis represents the time remaining to the primary endpoint (for patients who experienced incident adverse events) 
or time remaining to censoring (for patients who remained event-free). Of note is that ‘time zero’ is defined as the occur-
rence of the endpoint and is depicted on the right side of the x-axis, so that the average echocardiographic parameter can 
be visualized as the endpoint approaches. The continuous lines represent the average temporal pattern for patients with 
the endpoint (red) and endpoint-free patients (blue) as extracted from the joint model. The corresponding dotted lines 
depict the 95% confidence intervals. Finally, each dot represents a single measurement. Abbreviations: LV: left ventricular; 
LA: left atrial; E: peak early filling velocity; A: peak late filling velocity; e’: early diastolic mitral annular velocity; mm: mil-
limeter
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The current HF guideline does not recommend periodically repeating echos in otherwise 
stable HF patients; reassessing myocardial structures and functions is only warranted 
when patients present with symptoms of worsening HF or experience any important 
cardiovascular event, prior to device implantations, and during exposure to cardiotoxic 
therapies.[14] However, this is primarily based on expert opinion. The results of our 
study are the first to explicitly substantiate that single echocardiographic assessment 
suffices in the context of prognosis. In our study we performed echocardiography each 
six months. Increasing the frequency of the echocardiographic assessments might 
improve the ability of echocardiography to reveal deterioration of myocardial function 
and structure prior to adverse events. However, the feasibility in clinical practice would 
be limited as this would significantly increase costs. Furthermore, subtle deterioration 
may not always be recognized as it cannot easily be distinguished from changes caused 
by normal intrapatient variability and intra and interobserver variability.[15] Finally, 
prolonging follow-up may also reveal incremental value of repeated echocardiography.
The prognostic value of baseline echo parameters, independent of baseline NT-proBNP, 
has been reported earlier in HF patients. In a prospective study by Hinderliter et al. 
Table 5. Results for repeatedly measured parameters, adjusted for repeatedly measured NT-proBNP
Variable N of available echos 
(N of patients, 
N of events)
mean ± SD HR (95%CI) P value
Left ventricular Ejection fraction* 327 (106 pt, 25 events) 29 (20, 38) 1.52 (0.95 - 2.45) 0.076
NT-proBNP† 84.4 (21.3, 334.2) 6.47 (3.24 - 13.60) <0.001
Diastolic left ventricular diameter† 325 (106 pt, 25 events) 65 (55, 77) 1.56 (1.04 - 2.38) 0.026
NT-proBNP† 84.4 (21.3, 334.2) 7.53 (3.67 -15.54) <0.001
Systolic left ventricular diameter† 320 (106 pt, 25 events) 56 (45, 69) 1.53 (1.05 - 2.41) 0.032
NT-proBNP† 84.4 (21.3, 334.2) 7.39 (3.60 - 15.76) <0.001
Systolic left atrial diameter† 316 (105 pt, 24 events) 42 (35, 51) 2.02 (1.15 - 3.76) 0.008
NT-proBNP† 84.4 (21.3, 334.2) 6.65 (3.35 - 14.15) <0.001
E/A-ratio‡ 270 (94 pt, 20 events) 1.0 (0.65, 2.0) 2.70 (1.16 - 8.32) 0.026
NT-proBNP† 84.4 (21.3, 334.2) 7.59 (3.16 - 19.82) <0.001
E/e’-ratio† 311 (105 pt, 25 events) 12.9 (7.4, 22.5) 2.51 (1.22 - 5.68) 0.012
NT-proBNP† 84.4 (21.3, 334.2) 5.00 (2.22 - 11.53) 0.002
HRs represent change in risk of the endpoint for a 1 standard deviation change in the echo parameter at any point in time 
during follow-up.
* HR per one SD decrease
† HR per one SD increase on the log2 scale
‡ HR per one SD increase after ^.66 transformation
The trajectories of both the echo biomarker and NT-proBNP, captured by the linear mixed model, were corrected for age, 
sex, renal failure and heart rate.
N: Number; HR: HR ratio; SD: standard deviation; pt: patient; E:peak early filling velocities; A: peak late filling velocities; 
NT-proBNP:  N-terminal pro-Brain Natriuretic peptide
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among 211 chronic HFrEF patients, baseline LVEF, LV end-diastolic volume and LV 
volume index were significantly associated with all-cause mortality during a median 
of 4 years follow-up.[4] Furthermore, a systematic review of risk prediction models in 
patients with heart failure showed that baseline LVEF was often incorporated in the final 
models together with (NTpro)BNP levels, indicating LVEF carried additional prognostic 
value.[16] In our analysis, LVEF went from being not predictive to predictive for single 
vs repeated measures (the latter being assessed by means of joint modeling). This was 
most likely caused by the fact that repeated measurements entail higher statistical 
power. Both analyses show similar point estimates, but in the repeated measurement 
analysis a much higher number of LVEF measurements were taken into account, leading 
to narrower 95%CIs and thus a statistically significant finding.
Although it is thus clear that echocardiographic parameters carry prognostic value inde-
pendent of NT-proBNP, in our study we extend the evidence by comparing effect sizes; 
by standardizing the variables we demonstrate that the association of NT-proBNP with 
adverse outcomes in CHF is much stronger than that of echocardiographic parameters. 
Several prior studies have already established that single baseline measurements of 
NT-proBNP are strongly associated with adverse outcomes in CHF.[17-19] In addition, 
an earlier study from our research group that used joint modeling has demonstrated 
that repeatedly measured NT-proBNP can identify high-risk periods in the Bio-SHiFT pa-
tients. [8] In that study, patients in whom the endpoint occurred had on average not only 
a higher baseline level of NT-proBNP, but also showed a significant rise of NT-proBNP 
levels as the endpoint approached. Similar results were reported in a study by Miller et 
al. among 190 NYHA III and IV CHF patients during a follow-up of 2 years, in whom BNP 
was measured every 3 months.[20] Altogether, previous studies taken together with the 
current study, suggest that for individualized assessment of CHF status and treatment, 
repeated NT-proBNP measurements are more useful than repeated echocardiographic 
assessments.
limitations
A first limitation is that the treating physicians were not blinded to the echocardiograms. 
Due to ethical considerations this was not possible. A second limitation is that the num-
ber of endpoints in the current investigation is limited, and consequently the number of 
variables that could be entered in the models. Although residual confounding will surely 
be present, all our models were corrected for either baseline level or repeated measure-
ments of NT-proBNP, which is a strong predictor of outcomes in chronic heart failure.
[21, 22] In addition, the longitudinal trajectories were also corrected for any differences 
in baseline characteristics between those who reached the endpoint and those who did 
not. The limited number of endpoints has also precluded us from investigating whether 
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there would be differences in the results as a function of etiology of heart failure. Thirdly, 
we did not examine global longitudinal strain nor the grade of diastolic function, al-
though these parameters could potentially predict clinical outcome. However, the use 
of GLS is limited in clinical practice and it is often not measured by default. As for grade 
of diastolic function, it is known that in practice classification of diastolic function is not 
always straightforward. When attempting to perform such a classification using the ASE 
guidelines [23], we were able to assign the grade in 61.3% of the echocardiograms only. 
This precluded performing a robust analysis. Finally, compared to previous CHF cohorts 
and also to the full Bio-SHiFT cohort, the patients in the our current echo study were 
relatively young and the proportion of HF patients in NYHA class I and II was high, which 
may have obscured an association that would be present in ‘sicker’ patients.
COnClUSIOnS
Although individual trajectories of echocardiographic parameters were associated with 
cardiovascular outcome independent of NT-proBNP levels, the parameters remained 
stable during 2.3 years follow-up and did not worsen as an adverse event approached. It 
thus seems that, in such a timeframe, routine frequent monitoring of systolic or diastolic 
function with echocardiography does not carry incremental prognostic information 
over a single measurement in a, largely, minimally symptomatic and relatively young 
patient group.
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ABSTRACT
The propagation velocity of shear waves relates to tissue stiffness. We prove that a 
regular clinical cardiac ultrasound system can determine shear wave velocity with a con-
ventional unmodified Tissue Doppler Imaging (TDI) application. The investigation was 
performed on five tissue phantoms with different stiffness using a research platform (R) 
capable of inducing and tracking shear waves, and a clinical (C) cardiac system (Philips 
iE33, achieving frame rates of 400-700Hz in TDI by tuning the normal system settings). 
We also tested the technique in vivo on a normal individual and on typical pathologies 
modifying the consistency of the left ventricular wall. The R scanner was used as refer-
ence. Shear wave velocities measured with TDI on the C system were very close to those 
measured by the R scanner. The mean difference between the clinical and the research 
system was 0.18±0.22 m/s, limits of agreement from -0.27 to +0.63 m/s. In vivo, the veloc-
ity of the wave induced by aortic valve closure in the interventricular septum increased 
in patients with expected increased wall stiffness.
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InTRODUCTIOn
Many fast mechanical phenomena have been described in the heart, such as elec-
tromechanical activation, blood flow noise, and shear waves generated in the heart 
walls by the closure of the valves (Kanai 2005, Cikes et al 2014). The shear waves could 
potentially be used to estimate non-invasively the stiffness of the myocardium (Brekke 
et al 2014, Couade et al 2011), with huge potential implications in multiple patholo-
gies characterized by a deterioration of the diastolic properties of the left ventricle. To 
track these fast mechanical waves, high frame rate (>200 frames per second) imaging is 
mandatory. The frame rate in conventional ultrasound imaging is limited by the finite 
velocity of sound in human tissue (around 1540 m/s), the imaging depth (15cm in an api-
cal view), as well as the reconstruction of one image frame from many transmit-receive 
events. This leads to a conventional recording time of about 30 ms per frame, implying 
a frame rate of around 30 Hz. Yet, modern clinical scanners achieve frame rates well 
over 50 Hz in gray-scale 2D imaging by multiline acquisition, in which multiple lines are 
reconstructed simultaneously from a single transmit-receive event (Tong et al 2012). 
Recent approaches to even further increase the frame rate include plane wave imaging 
or diverging waves, as well as high-level multiline transmit beam forming (Cikes et al 
2014), or selective field-of-view imaging (Kanai 2005, Brekke et al 2014) thereby reaching 
frame rates between 500 and 12,000Hz, depending on technology and the depth of the 
tissue imaged. Moreover, recent advances in full-channel capture systems show that 
high frame rates can be achieved with relatively high contrast, signal-noise ratio (SNR) 
and sector size (Papadacci et al 2014), albeit with similar resolution as in conventional 
or multiline acquisition (MLA) beamforming techniques. However, up to now, none of 
these technologies have been implemented in a clinical cardiac ultrasound system 
(Couade et al 2011, Konofagou et al 2011, Lee et al 2012, Song et al 2013). On the other 
hand, current clinical Tissue Doppler Imaging (TDI) applications use frame rates up to 
200 Hz, by multiline acquisition and reduced resolution (Cikes et al 2014, Sutherland 
et al 1999). The use of a clinical scanner to track waves in the human heart has already 
been described (Pislaru et al 2014) at frame rates of 350-450 Hz. In this study, we reached 
higher frame rates in TDI using a clinical cardiac ultrasound system, by carefully tuning 
the imaging parameters, and hypothesized that this fast TDI modality could allow the 
detection and quantification of shear waves after valve closure. Similar to any other 
measurement method, both accuracy and precision of the measurement are important 
in clinical practice. However, measuring this in vivo is very difficult because of absence 
of any ground truth method for cardiac shear wave tracking, thus preventing estimation 
of accuracy, and because every heart beat is different, thus preventing estimation of 
single-shot precision. The core aim of our study therefore is assessing the accuracy and 
precision of the clinical TDI method to track shear waves. To get a reliable ground truth, 
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we used a phantom setup where the propagation velocity of shear waves is constant and 
verified by using a high frame rate research scanner.
METHODS
Shear parameters. The propagation velocity of shear waves in an isotropic, homoge-
neous, elastic bulk material is related to the shear modulus μ and density ρ (Shiina et al 
2015), by
Vs = √(μ/ρ) (1)
The simplifying conditions (isotropic, homogeneous, elastic, bulk material) will not be 
met in cardiac tissue, and therefore we refrain from converting the measured shear wave 
velocity to shear modulus or Young’s modulus E (E ≈ 3 μ in soft biological tissue, Couade 
et al. 2011) in the in vivo pilot data. However, we presume a monotonic relation between 
shear wave velocity and tissue stiffness. In the phantom experiment described below, 
the conditions are well met and this relation will be used to convert Young’s modulus 
into an expected shear wave propagation velocity.
Materials. The investigation was carried out on 5 different tissue ultrasound phantoms 
(CIRS inc., Norfolk, Virginia, USA). The physical properties of these phantoms are 
presented in Table 1. Baseline calibration was performed on the multi-purpose 40GSE 
model, and further testing for different tissue stiffness was performed on the Model 039 
phantom set.
Table 1. Tissue phantoms properties
Tissue phantom properties Model 40GSE
Calibration phantom
Model 039 
Phantom 1
Model 039 
Phantom 2
Model 039 
Phantom 3
Model 039 
Phantom 4
Expected shear wave velocity 2,80m/s 1,01m/s 1,57m/s 2,43m/s 3,56m/s
Young’s modulus E 25 kPa 2,7 kPa 11 kPa 20 kPa 48 kPa
Density 1030 kg/m3
Poisson ratio 0,5
Attenuation 0,5 dB/cm/MHz
Velocity of sound 1540m/s
We used two ultrasound scanners. The first was a research platform (R) inducing a shear 
wave through an acoustic radiation force push pulse, and tracking it (as reference). It 
was a Verasonics Vantage system with extended burst option (Verasonics, Kirkland, WA, 
USA), equipped with a linear array L7-4 probe (Philips, Bothell, WA 98041-3003 USA). Re-
corded raw channel RF data and reconstructed ultrasound images were stored for offline 
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analysis. The second scanner was a normal clinical cardiac ultrasound system(C). This 
was a Philips iE33 system (Philips Medical, Best, The Netherlands) with an S5-1 probe. 
A 2-heartbeat TDI movie was recorded and stored in DICOM format for offline analysis. 
Philips Qlab 9 post-processing software was used for the data analysis.
Setup. In preparation for the measurements, the probes were placed on the upper sur-
face of the phantom, using clinical ultrasound gel as a contact medium. The probes were 
carefully aligned with their 2D sectors in-line, thus oriented perpendicularly to the direc-
tion of propagation of the shear wave. The leads of both an external Cardiotachometer 
(CWE CT-1000) and the clinical scanner were attached to one of the researchers (M.S.) for 
the purpose of synchronisation of the R and C scanners through the ECG signal. The car-
diotachometer produced a trigger signal at the QRS-peak, which initiated the R system 
to generate an acoustic radiation force push pulse at a depth of 32 mm. In alternating 
paired recordings, the resulting shear wave was detected either with the R scanner for 
reference, or with the C scanner for its characterisation. In order to avoid cross-talk 
between the tracking pulses of the two scanners, the imaging of the shear wave with 
the R scanner was performed with C in freeze mode. Reciprocally, when investigating 
the waves with the C system, the R scanner was used to induce the acoustic push only.
The acquisitions were performed on separate days, with intermittent probe reposition-
ing, varied locations of the push pulse, and variation of the acquisition settings. In order 
to obtain maximum frame rate with the C system, a depth of 6 cm was investigated. 
The XRes image enhancement modality was turned off, the 2D line density was set to 
minimum and TDI frame rate to maximum. Smoothing and persistence settings were 
also minimized. The ultrasound frequency was set to 3.4 MHz, and the velocity range to ± 
1.5 cm/s. The frame rate range achieved was between 420 and 645 Hz, depending mainly 
on the opening of the TDI field of view. At this depth, a 4cm maximal opening (40º) of 
the TDI sector can provide 470 Hz, a 3 cm opening (30º) 570 Hz and a 2 cm opening (20º) 
645 Hz. The maximal frame rate is thus highly dependent on sector opening. Yet, since 
the shear wave tracking needs both a high temporal resolution and a wide field of view, 
there may be an optimal setting in which the combination of frame rate and sector width 
produces the most accurate and precise results. This optimal setting was investigated by 
analysing three frame rates ranges (400-500 Hz, 500 – 600 Hz, 600 – 700 Hz).
In vivo data. A normal healthy volunteer and two patients were tested using the same 
setup of the clinical scanner. This research was approved by the local Medical Ethical 
Committee and informed consent was obtained from all subjects. At 9 cm depth, we 
obtained over 500 Hz for a window opening of 3 cm (20º) (suitable for parasternal ap-
plication).
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Data processing
Research scanner setup
The characteristics of the acoustic radiation force push pulse and the tracking pulses are 
displayed in Table 2.
Table 2. Research scanner setup and parameters
Acoustic radiation force pulse Center frequency 4 MHz
Duration 1.4 ms (5600 cycles)
F number 1.5
Driving voltage 60 V
Tracking Center frequency 5.2 MHz
Duration 0.4 μs (2 cycles)
Transmit type Three angled plane waves
Driving voltage 60 V
Frame rate 4762 Hz
Data processing for the research scanner
The analytical signal S(x, z, i) in frame i for every pixel at (x, z) was generated by the in-
ternal Verasonics image reconstruction algorithm. In the following, the (x, z) coordinates 
within the brackets are omitted for simplicity of the equations. Local tissue velocity v(i) 
was obtained with a phase estimator for every pixel based on the cross-correlation of 
the analytic signal with temporal lag one (Brekke et al 2014),
R1(i) = S(i) ∙ S* (i-1)  (2)
v(i) = vN ∙ ∠R1(i)  / π  (3)
vN = c ∙ F / (4 ∙ fc ),  (4)
in which R1 is the cross-correlation value per pixel for a time offset of 1 frame, an * de-
notes the complex conjugate, ∠ denotes the angle [rad], vN is the Nyquist velocity, fc is 
the center frequency of the pulse, c is the velocity of sound in the medium and F is the 
frame rate. The value of the Nyquist velocity was 0.35 m/s, which was high enough to 
avoid any aliasing effect in the local tissue velocity measurements.
Similar to Brekke et al (2014), we applied a spatial smoothing filter to the cross-corre-
lation frames R1 (Eq. 2) before calculating the phase (Eq. 3) to remove the influence of 
speckle. This smoothing consisted of a moving average filter with a size of 1.5 mm in 
both axial and lateral direction, which is on the same order as the speckle size in the 
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research system. Since the wavelength of the mechanical waves was around 10 mm, the 
chosen kernel size did not reduce the signal levels significantly.
The resulting local particle velocity v(i) is a dataset containing subsequent TDI frames 
at a framerate equal to the original frame rate. Along a horizontal virtual M-mode line 
located at the depth of the push pulse (32 mm), the forward propagating wave was 
extracted and gathered in a 2D panel. This panel thus shows the wavelet propagating as 
function of time and distance along the M-mode line (Fig. 1).
figure 1. Illustration of shear wave propagation as detected by the research system. A: high-framerate TDI 
images of travelling shear waves. The shear waves are displacing away from the external acoustic radiation 
force push focal zone, in a few selected successive frames; time is noted, with t = 0 ms at the push. The white 
arrow represents the virtual M-mode line. B: Virtual M-mode along the line in A. The slope of the wave front 
is tracked with a Radon transform in a region of interest with the research system, giving a velocity estimate 
of 2.95 m/s in this recording.
The slope Δx/Δt with which this wave propagates is the propagation velocity that acts as 
the ground truth to the wave propagation measured with the clinical scanner. Yet, in the 
data processing of the clinical scanner, we tracked the wave front which is most clearly 
visible for the observer. In the data processing of the research scanner, we wanted to au-
tomate the tracking, for which the Radon transform produces accurate outcome (Rouze 
et al 2010, Urban and Greenleaf 2012). The Radon transform tracks the wave peak path. 
To match the wave front tracking in the clinical scanner with the wave peak tracking 
in the research scanner, we first took a time derivative of the local particle velocity in 
the research scanner. This effectively yielded a map containing the local particle ac-
celeration, with the rationale that the wave front correlates to the first trace of highest 
magnitude in this acceleration map. Next we extracted the slope of the trace using a 
Radon transform in the region of interest (Rouze et al 2010, Urban and Greenleaf 2012, 
Vos et al 2015).
Data processing for the clinical scanner
The DICOM TDI loops (DICOM pixel array of 768 rows and 1024 columns, with a pixel 
spacing of 0.088/0.088mm) were processed using Qlab 9. A virtual M-mode line was hori-
zontally traced across the TDI sector at the depth of the focal point of the push pulse, 
which was applied to the left, immediately outside the sector (Figure 2A). Its length and 
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direction was pre-defined by the user. For consistency, we chose the direction of the 
M-mode line to always point towards the shear wave source, perpendicular to the wave 
front. The velocity propagation of the wave front was estimated through
Vs = D/T, (5)
where D is the (user-defined) length of the M-mode line and T is the time the wave travels 
along the M-mode line.
The software provides a virtual M-Mode map (Figure 2B), allowing to manually trace the 
slope of the propagating wave. This map does not display a time axis in QLab. Yet, the 
propagation time T can be obtained through a work-around. By manually clicking on the 
base and top of the slope of the wave, the program returned the corresponding active 
points on the time-velocity curve that is automatically computed by the software (Figure 
2C). The time interval T between these points is then displayed automatically (Figure 
2D). From this time, and pre-defined M-mode length, the velocity is calculated (Figure 2 
and Equation 5).
Statistical analysis. Baseline testing and calibration was performed on the 40GSE 
phantom. Thirty independent paired measurements were performed on this tissue 
phantom. The resulting velocities were represented as mean ± standard deviation (SD). 
The differences between mean values were estimated by paired-samples T-test. If not 
normally distributed, the data sets were also compared using the Wilcoxon signed-rank 
test. The distribution was represented by box plots. Testing for other stiffness values 
(other shear wave velocities) was performed by additional five to seven paired measure-
ments for each of the five phantoms. Variability was calculated as 1.96 SD of the mean 
arithmetic difference according to Bland and Altman. Accuracy was defined as the prox-
imity of the mean value to the reference value; precision as the closeness of the agree-
ment between results (represented by the standard deviation). For the calibration study, 
standard error was also calculated to support the assessment of accuracy. Inter- and 
intra-observer variability for the clinical scanner was assessed on 10 randomly chosen 
acquisitions. Intra-observer test-retest variability was evaluated on the initial measure-
ments performed by M.S. with a new measurement set one month later, blinded to the 
first result. Inter-observer variability was estimated between the result of M.S., and the 
results obtained by a first-time user, without any prior knowledge of the experiment or 
the software application (L.G.). SPSS software (version 21, IBM 2012) was used for all 
analyses, with a p-value of <0.05 considered significant.
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figure 2. Detailed view (modified to indicate the main elements) of the data obtained in the tissue phan-
tom, using offline processing in Philips Qlab. The ECG signal belongs to one of the researchers (M.S.) and 
was only used to synchronize the two ultrasound systems. In the spatiotemporal color map, we have high-
lighted the moving wavefront with dotted arrows for clarity. A: virtual M-mode line (#1) traced across the 
TDI sector; B: virtual M-mode map of a shear wave demonstrating the wave front (leftmost dotted arrow) 
and the first velocity zero crossing (rightmost dotted arrow); C: mean velocity curve (averaged over the M-
mode line). The time interval in which the wave occurs is marked with the solid white lines; D: results panel, 
showing the time interval.
RESUlTS
Both scanners detected the waves propagating away from the push region in a time 
span variable according to the phantom’s stiffness (Figure 1 and 2, and Movie 1). We 
measured the propagation velocity of the wave front.
Research scanner. The automated detection algorithm was used to track the wave 
front, resulting in a velocity of 2.87 ± 0.07 m/s in the calibration phantom and different 
velocities in the Model 039 phantoms (Table 3).
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Table 3. Tissue phantoms shear wave velocities according to the clinical (C) and research (R) scanner
Phantom Model 40GSE Model 039 
Phantom 1
Model 039 
Phantom 2
Model 039 
Phantom 3
Model 039 
Phantom 4
Expected shear wave velocity 2,80 m/s 1,01 m/s 1,57 m/s 2,43 m/s 3,56 m/s
Clinical scanner velocity 2,85±0,21 m/s
(N=7)
1,06±0,05 m/s
(N=7)
1,59±0,08 m/s
(N=6)
2,76±0,17 m/s
(N=5)
3,87±0,21 m/s
(N=7)
Research scanner velocity 2,87±0,07 m/s 0,87±0,01 m/s 1,51±0,02 m/s 2,34±0,01 m/s 3,56±0,07 m/s
Clinical scanner.
Frame Rate Calibration
The propagation velocities of the wave front of the shear wave in the calibration 
phantom at different frame rate ranges of the C scanner are summarized in Table 4. The 
velocity ranged between 2.77 ± 0.14 m/s and 2.83 ± 0.18 m/s, depending on the frame 
rate (Figure 3). The velocities recorded at frame rates of 500 - 600 Hz and 600 - 700 Hz 
were statistically similar to the R scanner results (lowest mean difference of -0.04 ± 0.20 
m/s, Wilcoxon Z=-0.99; p=0.318 for the frame rate range 500 to 600 Hz ). The limits of 
agreement were smaller than ± 0.45 m/s (Table 4).
Table 4. The difference between velocities calculated by the clinical and research scanner, according to the 
frame rate range of the clinical system, for calibration
Statistical
method
Paired-samples T-test Bland-Altman Wilcoxon signed-rank test
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400-500 Hz 2.77 ± 0.14 0.028 0.04-0.16 0.002 -0.09 ± 0.16 -0.39 to 0.22 8 -2.75 0.006 -0.50
500-600 Hz 2.83 ± 0.18 0.037 -0.04-0.12 0.298 -0.04 ± 0.20 -0.43 to 0.35 14 -0.99 0.318 -0.18
600-700 Hz 2.80 ± 0.18 0.037 -0.01-0.14 0.075 -0.06 ± 0.20 -0.30 to 0.45 13 -1.80 0.072 -0.33
The non-significant p values were highlighted in bold
C=clinical; CI=confidence interval; R=research; SD= standard deviation
# R scanner speed was 2.87 ± 0.07 m/s
Velocity measurements using the calibrated settings
A new measurement set was performed on all 5 phantoms, using the best fitted settings 
from the calibration (frame rate of 513 Hz). The results are displayed in Table 3. Veloci-
ties measured with the two scanners were similar and close to the reference values.
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Intra and inter-observer variability
For intra-observer test-retest variability (No=10 readings), the first reading displayed a 
velocity of 2.73 ± 0.13 m/s. At the second reading, the mean value was 2.81 ± 0.08 m/s 
(p=0.10). The mean difference was -0.07 ± 0.13 m/s. The limits of agreement were -0.33 
to +0.18 m/s.
For inter-observer variability, the mean value of velocity obtained by the second ob-
server (No=10 readings) was 2.92 ± 0.25 m/s (p=0.08). The mean difference between 
observers was -0.19 ± 0.29 m/s. The limits of agreement were -0.76 to +0.38 m/s.
figure 3. Calibration study. The distribution of velocities (A, B, C) measured at different frame rate ranges 
and the difference in measured velocity between the clinical and the research system (D,E, F), comparing 
the results in box plots, demonstrating the bias and the distribution of the differences. A, D: frame rate 
range=400 to 500 Hz; B, E: frame rate range=500 to 600 Hz; C, F: frame rate range=600 to 700 Hz. The mean 
velocity is marked with a vertical line in panels A, B, C. The horizontal line in the lower panels marks the 
zero point (perfect agreement).
Accuracy
Taking the measurements of the R scanner as reference, the difference in the measure-
ments obtained by the clinical scanner was assessed on the last set of 5 to 7 paired mea-
surements performed with each of the 5 phantoms. The correlation between the two 
scanners (Figure 4A) was excellent (R2=0.952; p<0.0001). The mean difference between 
the clinical and the research system was 0.18±0.22 m/s, limits of agreement from -0.27 
to +0.63 m/s (Figure 4B).
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figure 4. Accuracy study. A: The correlation of the velocities measured with the two systems; B: Bland-
Altman analysis of the agreement between the two scanners.
In vivo detection of shear waves in patients. A 28-year-old healthy male underwent 
a cardiac ultrasound exam, while simultaneously recording the ECG and phonocardio-
gram. High frame rate TDI (510 Hz at 8 cm depth, velocity scale 3.5 cm/s) signals were 
acquired from the parasternal window, from the proximal part of the interventricular 
septum. The velocity of the shear wave travelling into the septal wall after aortic valve 
closure was 3.0 m/s for an M-mode line traced at mid-wall level (Figure 5A).
In a 43-year-old female patient with a dilated ischemic cardiomyopathy, high frame rate 
TDI (513 Hz at 8 cm depth, velocity scale of 2.5 cm/s) showed a velocity of 4.4 m/s (Figure 
5B and Movie 2). The shear wave is clearly separated from the myocardial displacement 
occurring in early isovolumetric relaxation.
A 48-year-old male patient having received a heart transplant 9 months before, with 
signs of rejection, underwent a routine ultrasound examination. Although the image 
quality was poor, it still allowed visualization of left ventricular walls. A high frame rate 
TDI acquisition (541 Hz, 9cm depth, velocity scale of 1.5 cm/s) in the parasternal view 
was added, that showed a fast wave travelling into the septum after the aortic valve 
closure, similar to the other cases, but at a velocity of 5.4 m/s (Figure 5C).
DISCUSSIOn
The main findings of this study were: 1) the visualization of shear waves induced by 
acoustic radiation force into a tissue phantom is possible with a clinical TDI application, 
at a surprisingly high frame rate (400-645Hz); 2) the waves can be tracked and their ve-
locity quantified in this in vitro setting, with sufficient precision and accuracy at a frame 
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rate range above 500 Hz; 3) In vivo tracking is feasible in patients, and the results seem 
to confirm that the velocity of the waves is increasing where increased wall stiff ness is 
expected based on pathology.
In several studies the detection of fast phenomena in the heart has been described 
(Brekke et al 2014, Cikes et al 2014, Kanai et al 2000, Kanai 2005,Pernot et al 2011), us-
ing experimental systems or modified soft ware. In our study a normal modern clinical 
scanner achieved surprisingly high TDI frame rates, between 400 and 700 Hz at depths 
less than 10 cm, by turning off  image enhancement modalities and by carefully tuning 
the relationship between the depth of the image, the 2D line density and aperture and 
the TDI field of view. We hypothesized that the time resolution of 2ms (500Hz frame rate) 
could allow the detection and quantification of the very fast phenomena that are natu-
rally occurring in the heart such as shear-like waves caused by the closure of the valves. 
The present study shows that shear waves in a tissue phantom are accurately detected 
by the TDI clinical application. As the reference wave velocity could be validated by the 
research scanner, both the accuracy and precision of the method were investigated.
figure 5. Clinical application of the high frame rate tissue Doppler technique. A: normal male subject. The 
wave front is synchronous to the onset of the second heart sound (S2) on the phonocardiogram (PCG); the 
velocity is computed at 3.0m/s; the shear wave aft er mitral valve closure is also visible synchronous to the 
first heart sound (S1). The upper panels show the classical echocardiographic image and the focused TDI 
window over the interventricular septum; In the lower panel one full cardiac cycle was reconstructed of-
fline; the slope of the aortic shear wave (black arrow), extracted from the virtual M-mode, is marked with a 
dashed line. B: dilated cardiomyopathy. The velocity of the wave front reaches 4.4m/s. C: heart transplant 
patient; the velocity of the shear wave is even higher, computed at 5.4m/s. At a velocity scale of 1.5 cm/s a 
velocity shift  (zero crossing) is seen separating the shear wave (black arrow). Time intervals are extracted 
from the velocity/time curves, and underlined by vertical white lines. The M-mode map displays only a 
fraction of the cardiac cycle around the closure of the aortic valve (depending on the relation frame rate 
versus heart rate). This corresponds to the clear window in the velocity/time/ECG panels and is indicated 
with white dashed arrows.
The precision of the measurement is restricted by the field of view (represented by M-
mode length D) and frame rate (F) in the clinical scanner. With reference to Eq. 5, the 
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standard deviation in the propagation speed δVs can be caused by variance in both D 
and T. Standard deviation in D, is caused by limited lateral resolution R (Elegbe and 
McAleavey 2013 ) in the sector of the phased array probe (despite the fixed length of the 
virtual M-mode line). Variance in T is caused by rounding off to integer frame intervals. 
Applying the generic equations of statistically independent variables to Eq. 5 gives the 
approximate equation (see Appendix A for details)
δVs = Vs/D √{(R/2)2 + 1/6 · (Vs/ F)2}. (6)
For example, when taking a width of 3.5 cm of the TDI window, a frame rate of 500 Hz, 
and a typical speckle size of 5 mm, a wave with 2.8 m/s propagation velocity has an 
expected standard deviation of 10%, which is similar to the actually observed value (6 
%). For a wave travelling with 5 m/s, the expected value increases to 14%, due to the 
relatively increased influence of frame rate (see also Table 3). The standard deviation 
can only be improved by taking the average over multiple recordings. On the contrary, 
the research system has both a higher temporal and spatial resolution, thanks to a larger 
linear probe, higher imaging frequency, and full channel acquisition. This allows for very 
precise single measurements.
In the calibration measurements the average propagation velocities yielded by the clini-
cal scanner were statistically similar to the research ones in the frame rate range 500-
600Hz (2.83±0.18m/s, p=0.298) and 600-700 Hz (2.80±0.18m/s, p=0.075). In conventional 
echocardiographic measurement (Chukwu et al 2008, Lang et al 2015), mean percent er-
rors are reported to be around 10-20%, which is similar to the errors in our findings. The 
precision was increased in the calibration study by averaging 30 measurements, leading 
to a standard error of around 0.04 m/s (1% relative error). These settings were used for 
the accuracy study, which demonstrated tight limits of agreement, comparable with the 
measurement variability. The inter-observer variability was of the same magnitude as 
the difference between individual measures. Based on these values, the accuracy and 
precision can be considered acceptable for research purposes. The clinical relevance 
of this variability remains to be established, being dependent on the physiological or 
pathological range of velocities.
Clinical application
In the past years we have developed a high frame rate ultrasound imaging modality 
which determined the propagation velocity of Lamb waves (which are shear wave-like) 
in the septal wall (Vos et al 2016) that are naturally caused by the aortic and mitral valve 
closure. The recorded velocities are in close agreement with those reported with an 
alternative method that uses externally induced shear waves, which however is either 
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insensitive (Song et al 2013) or invasive (Hollender et al 2012). Other teams have been 
working on clinical TDI with modified software in order to achieve the very high frame 
rate needed to image these phenomena (Brekke 2014). Our in vivo data shows that shear 
waves can be measured with a clinical system in cardiac mode, which could, in one step, 
make the translation from lab research to clinical research or even everyday clinical 
practice, without major investments in new equipment or software.
Since Doppler is most sensitive for axial motion, it has the highest detection sensitivity 
for shear waves propagating laterally in the field of view, at a TDI velocity scale adapted 
to match the particle velocity. Please note that although the angle between the propa-
gation direction and the ultrasound beam may influence the apparent amplitude of the 
shear wave, it has no influence on the apparent propagation velocity, the latter being 
the property of interest in the current study. Translating these properties into clinical 
echocardiography, a TDI system would be most sensitive for shear waves traveling 
through the interventricular septal wall in a parasternal view, rather than in an apical 
view. We have tested the technique (using the same clinical scanner, probe and TDI set-
tings as the experimental results) on a normal individual and several typical pathologies 
modifying the consistency of the left ventricular wall. The velocity scale allowing for clear 
visualization of the shear wave matches the particle displacement velocity observed in 
previous studies (1.5 - 3 cm/s) (Brekke et al 2014, Vos et al 2015). The velocity of the wave 
induced in the interventricular septum seems to increase in the cases where the stiff-
ness of the wall is expected to increase, as compared to the normal individual. Although 
no definitive conclusion can be drawn from this limited data, it shows that the detection 
and quantification of these naturally-occurring shear-like waves is feasible in patients, 
and could represent a direct measurement of wall stiffness, with potential implications 
in multiple pathologies characterized by a deterioration of the left ventricular function.
In the present in vivo study we focused on the aortic valve closure. However, the waves 
after mitral valve closure were also detectable in our study subjects, as can be noticed 
on the M-mode map in Figure 5A and Movie 2 (online; leftmost at the beginning of the 
movie). Thus, the detection method is able to record the stiffness during two moments in 
the cardiac cycle, when the muscle is dilated, and when it is compact. Specific relations 
of the two points (ratio, difference) may have an additional clinical relevance next to 
their individual values because of cancellation of possible confounding factors such as 
pre-load, afterload, and wall thickness, although such relevance needs to be thoroughly 
tested in a larger study population. During the short isovolumetric periods in which the 
waves propagate there is only minor motion of the myocardial walls, making shear wave 
quantification presumably easier and more reliable. On the other hand, the intrinsic 
myocardial stiffness may vary over the short period in which the waves propagate (order 
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10 – 20 ms), thus changing the instantaneous shear wave speed. Although Kanai showed 
a time dependency of the wave propagation velocity after aortic valve closure (Kanai 
2005), we have not observed such a phenomenon in our data. Yet, to further elucidate 
this phenomenon, the dynamic components of stiffness may be studied, for example, 
in a more experimental setup involving accurately-timed acoustic-radiation force shear 
wave elastography.
Strain, strain-rate and data derived from TDI velocities are recent applications that as-
sess myocardial deformation and, indirectly, elasticity. A down-side of these methods 
is a large dependence on hydrodynamic parameters (preload, afterload), as the strain 
is a ratio of pressure and myocardial stiffness. Although a dependency may also exist in 
the shear wave method, it is expected to be weaker since hydrodynamic pressure is not 
found in the principal relation between shear wave propagation velocity and stiffness. 
A comparison with the high frame-rate TDI derived shear wave velocity may be further 
studied based on data that is recorded with the same clinical scanner.
The myocardial wall exhibits a complex fiber structure, so shear wave propagation 
might be inhomogeneous across the width of the septum. For simplicity, in our in vivo 
data, we have chosen the mid-wall position, having presumably the highest consistency 
in placement. Further clinical studies are warranted in order to detect and characterize 
this phenomenon.
The propagation velocity in our healthy subject is lower than that found in a group of 10 
human subjects by Brekke et al (2014) (5.41 ± 1.28 m/s) specifically, and more generally 
found in human and animal studies (Hollender et al 2012). We speculate that this differ-
ence is originating from the different probe positioning: parasternal in our study, and 
apical in Brekke et al (2014) and Kanai et al (2000).
The longitudinal myocardial stretch during late diastole as described by Pislaru et al 
(2014), was also visible in our human subjects. The expected velocity of these phenom-
ena is between 1 and 2 m/s, which can be easier to track with lower frame rates than the 
faster waves after aortic valve closure.
Unfortunately, the exact TDI beamforming technique and settings are not disclosed on the 
clinical system, although it is known that the Philips iE33 implements an MLA technique. 
Yet, we could make a general estimation based on the work by Tong et al. (2012) who 
compared various fundamental-frequency MLA beamforming techniques. The speckle 
size in our color TDI movies was 4-5 mm in lateral direction. Tong et al. calculated lateral 
beamwidths in the order of 2-3 mm up to 50 mm depth, and 3-5 mm for imaging depth 
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> 50 mm. Although significant differences exist between the specific implementations of 
MLA, the differences are relatively small, and the values are very similar to our measure-
ments. This implies a reasonably good resolution in our current TDI measurements. As 
discussed by Papadacci et al, more recent full-channel capture systems -which enable 
an extremely high degree of MLA and compounding- do not improve on resolution but 
they will simultaneously improve on contrast, SNR, imaging sector size and framerate. Of 
these aspects, SNR proved to be sufficient in our measurements, but a larger image sec-
tor and slightly higher frame rate (order 1000 frames/second) would reduce the variance 
in the measurements, according to Eq. 6. The effect of a higher image contrast has yet to 
be studied in a more realistic phantom with higher tissue contrast. Therefore, although 
measurement precision may be improved with recent full-channel capture systems, the 
performance of the currently used clinical scanner is reasonably good.
Study limitations and future directions
A limitation of the study may be the limited velocity range of the phantom set (1 – 4 m/s), 
although the results show neither signs nor trends of bias for these velocities. Further 
confirmation of the strength of the method should come from clinical studies with a 
large pathology spectrum. The present work shows that shear waves can be measured 
with good consistency with a regular clinical scanner, thus opening the way to more in 
vitro and in vivo studies.
As demonstrated above, a TDI frame rate of 500 Hz could be insufficient when it comes 
to higher velocities, because such waves would quickly travel through the limited field 
of view. We hope that the advancement in technology, with even higher frame rates 
becoming available, and/or the changes in data processing would allow for the use of 
wider fields of view.
Manual tracking as allowed by the manufacturer-designed software is time consuming 
and prone to errors. Therefore, future research should focus on a robust method of au-
tomated velocity tracking from the DICOM frames. A possible candidate for such robust 
analysis is the Radon transform as illustrated in this study for the research scanner data.
COnClUSIOn
A regular clinical cardiac TDI application can visualize and quantify shear waves induced 
by acoustic radiation force in a tissue phantom at sufficiently high frame rates (order 500 
Hz). In vivo tracking is feasible in patients, and the results seem to confirm that the velocity 
of the waves is increasing where increased wall stiffness is expected based on pathology.
174 Part 2
APPEnDIX A
In this appendix we derive the standard deviation of the measured propagation velocity, 
based on both the temporal and spatial uncertainties in values by which the propaga-
tion velocity is calculated.
The wave propagation velocity in the measurements is calculated by
Vs = D/T. (A.1)
Conventionally, the standard deviation δVs in the propagation velocity is derived from 
the respective standard deviation of the statistically independent D and T:
δVs = √{ (∂Vs/∂D δD)^2 + (∂Vs/∂T δT)^2 },  (A.2)
with ∂·/∂· denoting the partial difference.
Inserting Eq. A1 in Eq. A2 yields the equation for relative standard deviation
δVs / Vs = √{ (δD / D)^2 + (δT / T)^2 }. (A.3)
The value of δD can be estimated by first approach from the speckle size as speckle 
prevents exact localisation of the wave (Elegbe and McAleavey 2013). With R defined as 
the typical (lateral) speckle size, the value of δD is approximated by R/2.
The value of δT can be estimated from the frame rate F. The travel time T is determined 
from the time interval between the frames where the waves enter and exit the field of 
view. In both cases, the times are rounded off to discrete values of T (=n/F, n integer) in 
our manual tracking. From conventional theory, each rounding gives a standard devia-
tion of 1/√12 · 1/F , and the independently combined standard deviation for the time 
interval between entering and exiting is δT = 1/√6 · 1/F . The value of T is derived from Vs, 
T = D / Vs. Inserting these values in (A.3) yields
δVs /Vs= √{ (R / (2·D) )^2 + 1/6 · (Vs/ (F·D) )^2 }, (A.4)
or
δVs = Vs/D √{ (R/2)^2 + 1/6 · (Vs/ F)^2 }. (A.5)
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Figure A1 shows the resulting absolute and relative standard deviation for given propa-
gation velocities in the typical range of 1 – 10 m/s. Typical values of F = 500 Hz, D = 3.5 
cm, and R = 5 mm are used to obtain this graph.
figure A.1. Estimated theoretical standard deviation of Vs, and its relative value, based on the variance in 
both the temporal and spatial measurement.
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ABSTRACT
For the quantification of myocardial function, myocardial stiffness can potentially be 
measured non-invasively using shear wave elastography. Clinical diagnosis requires 
high precision. In ten healthy volunteers, we studied the reproducibility of the measure-
ment of propagation speeds of shear waves induced by aortic and mitral valve closure 
(AVC, MVC). Inter-scan was slightly higher but in similar ranges as intra-scan variability 
(AVC: 0.67m/s (IQR: 0.40 – 0.86m/s) versus 0.38m/s (IQR: 0.26 – 0.68m/s); MVC: 0.61m/s 
(IQR: 0.26 – 0.94m/s) versus 0.26m/s (IQR: 0.15 – 0.46m/s)). For AVC, the propagation 
speeds obtained on different days were not statistically different (p=0.13). We found 
different propagation speeds between two systems (AVC: 3.23 – 4.25m/s (Zonare ZS3) 
versus 1.82 – 4.76m/s (Philips iE33), p=0.04). No statistical difference was found between 
observers (AVC: p=0.35). Our results suggest that measurement inaccuracies dominate 
the variabilities measured among healthy volunteers. Therefore, measurement preci-
sion can be improved by averaging over multiple heartbeats.
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InTRODUCTIOn
In developed countries, about 1-2% of the adult population has heart failure. The preva-
lence is even rising to >10% among people older than 70 years (Ponikowski et al. 2016). 
Currently, geometrical volumes and non-invasive Doppler measurements of tissue and 
blood are used for the echocardiographic evaluation of cardiac myocardial function 
(Lang et al. 2015; Nagueh et al. 2016). Nonetheless, these parameters mainly measure 
effects of myocardial function are load dependent (Voigt 2019). No accurate method cur-
rently exists for non-invasive cardiac stiffness measurements. Measuring the stiffness 
of the myocardium likely gives more direct insights in the condition of the myocardium 
(Voigt 2019), as recently shown by Villemain et al. (2018) in a group of volunteers and 
hypertrophic cardiomyopathy patients using shear wave elastography measurements 
(SWE). To distinguish different types of diastolic and systolic dysfunctions and to accom-
modate more personalized treatments, noninvasive stiffness measurements could be a 
valuable tool.
Several studies have shown the potential of shear waves (SWs) to be used for measuring 
the stiffness of the myocardium non-invasively (Arani et al. 2017a; Petrescu et al. 2019; 
Santos et al. 2019; Strachinaru et al. 2019; Villemain et al. 2019; Wassenaar et al. 2016). 
The propagation speed of these SWs is expected to be linked to Young’s modulus of the 
myocardium.
Magnetic resonance and ultrasound imaging have been used in different animal and 
human studies to perform SWE measurements. The advantage of using magnetic 
resonance imaging is that the 3-D displacement field of the SWs in the complex cardiac 
geometry can be measured (Arani et al. 2017b). However, MRI is expensive, uncomfort-
able and slow; moreover, it cannot be used for patients with arrhythmia because of 
cardiac gating. For SWE using ultrasound imaging, several studies have used external 
sources such as mechanical shakers (Pislaru et al. 2014b; Tzschätzsch et al. 2012; Urban 
et al. 2013) or acoustic radiation forces (ARF) (Bouchard et al. 2009; Couade et al. 2011; 
Hollender et al. 2012; Pernot et al. 2011; Pernot et al. 2016; Song et al. 2016; Villemain et 
al. 2019) to induce SWs. The SWs naturally occurring due to aortic valve closure (AVC) or 
mitral valve closure (MVC) have been investigated as well (Brekke et al. 2014; Kanai 2005; 
Pernot et al. 2007; Pislaru et al. 2014a; Santos et al. 2019; Strachinaru et al. 2019; Vos et 
al. 2017). An advantage of exploiting the SWs induced by valve closure is that these SWs 
were found to have larger tissue velocity amplitudes (~40 mm/s) (Vos et al. 2017) than 
the SWs induced by an external acoustical force (~10 mm/s) (Couade et al. 2011), likely 
leading to higher signal to noise ratios. However, the low frequency content of natu-
ral SWs (Kanai 2005; Santos et al. 2019; Vos et al. 2017) compared to external sources 
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(Couade et al. 2011; Hollender et al. 2012; Pislaru et al. 2014b) and thus the inherently 
larger wavelengths form a disadvantage of natural shear wave speed (SWS) measure-
ments. Since the SWs can only be tracked over the limited length of a few centimeters of 
the interventricular septum (IVS), smaller fractions of the wavelength can be tracked for 
SWs with low frequencies, causing measurement inaccuracy. Additionally, for 2D natural 
SWS measurements, the source of the SWs is not assured to be in plane with the field of 
view, as is the case for ARF-based measurements, and therefore out-of-plane propaga-
tion could also induce measurement inaccuracy (Vos et al. 2017). These measurement 
inaccuracies should be minimized for clinical diagnosis where high precision of the SWS 
measurements is needed.
Besides measurement inaccuracies, SWS measurements are expected to be affected 
by various phenomena. First of all, the myocardial stiffness measured depends on 
the intrinsic viscoelastic material characteristics of the myocardium independent of 
loading-conditions. Significant different propagation speeds have been measured after 
AVC and MVC for pathological stiff myocardium as in hypertrophic cardiomyopathy 
(Strachinaru et al. 2019) and amyloidosis patients (Petrescu et al. 2019) compared to 
healthy volunteers. Second, the moment in the cardiac cycle will determine to what ex-
tent passive myocardial stiffness and additional myocardial contractility are measured. 
This is opposite to the alternative method of using ARF to induce SWs, as the ARF push 
can be timed throughout the cardiac cycle and hence is able to capture the myocardium 
in a relaxed state. The variations in myocardial stiffness during the cardiac cycle have 
been measured in several studies (Couade et al. 2011; Hollender et al. 2017). However, 
SWs induced by valve closure only occur at two stages of the cardiac cycle, during which 
the heart is not completely relaxed. Therefore, natural SWS measurements probably 
measure a combination of passive myocardial stiffness and contractility, potentially 
giving information about diastolic and systolic function, albeit that the disentangling 
is a challenge. Third, due to the non-linear stress-strain relation of biological materials 
(Mirsky and Parmley 1973), the filling state of the ventricle is still expected to influence 
SWS measurements, even when measured at end-diastole (Voigt 2018). Furthermore, 
contractility is also known to be affected by pre-load via the Frank-Starling mechanism. 
Therefore, besides measurement inaccuracies, hemodynamic variations are also ex-
pected to affect reproducibility.
For the application of clinical diagnosis, knowledge on measurement reproducibility is 
needed in order to distinguish normal and pathological myocardial function. This study 
tests the reproducibility of determining the propagation speed of natural SWs induced 
in the IVS by AVC and MVC in healthy volunteers. Previous studies have shown that 
propagation speeds after AVC can be determined in-vivo by using a clinical ultrasound 
Chapter 9 183
Reproducibility of Natural Shear Wave Elastography Measurements
system using conventional or adapted Tissue Doppler Imaging (TDI) (Brekke et al. 2014; 
Kanai 2005; Strachinaru et al. 2017). Other studies have demonstrated the feasibility of 
measuring the SWs induced by AVC and MVC in a single recording using diverging waves 
(Petrescu et al. 2019; Santos et al. 2019; Vos et al. 2017). Slope-estimator, intra-observer, 
inter-observer and test-retest variabilities have been recently tested for natural SWs in 
healthy volunteers (Santos et al. 2019). However, we previously found that anatomi-
cal M-line location on the IVS, along which the SWs are tracked, affects the measured 
propagation speed in pigs, causing intra-scan variability (Keijzer et al. 2018). Further-
more, besides test-retest variabilities between measurements performed on different 
days, variabilities between subsequently performed measurements could have been 
present. In addition, Santos et al. (2018) performed SWS measurements with only one 
(non-clinical) echographic scanning system, while inter-system variability should be 
limited for clinical diagnosis. Also, hemodynamic variations could have caused variabili-
ties in SWS measurements. When patients undergo an echocardiographic exam, they 
may experience different levels of psychological and/or physiological stress, potentially 
changing loading conditions and thus affecting SWS measurements.
To the best of our knowledge, our study is the first to simultaneously report on inter-
system, test-retest, inter-scan, intra-scan and inter-observer variabilities of natural SWS 
measurements after AVC and MVC in healthy volunteers and to report on the effect of 
stress causing hemodynamic variations. To test inter-system variability, we directly 
compared the results obtained by using a clinical system in a conventional Tissue-Dop-
pler-Imaging (TDI) mode (Philips) with a second clinical system with a customized high 
frame rate mode using a diverging-wave pulse-inversion transmission scheme (Zonare).
MATERIAlS AnD METHODS
Study population
The study included 10 volunteers aged 24 to 45 years, existing of 5 males and 5 females. 
Table 1 gives an overview of the demographic characteristics of the volunteers. The 
study was approved by the local medical ethics committee (Erasmus MC MEC-2014-611) 
and all volunteers gave informed consent. The following exclusion criteria were used; 
a history of cardiovascular disease, cardiovascular risk factors including hypertension 
(cutoff value of 140/90 mmHg), being pregnant or being morbidly obese (BMI > 40 kg/
m2).
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Table 1. Overview of the demographics of the study population. The characteristics are averaged over all 
volunteers during both scanning sessions.
Characteristic Mean ± standard deviation Range
Age [years] 29.8 ± 6.2 24 - 45
Weight [kg] 67 ± 9.5 55 - 90
Body length [m] 1.75 ± 0.06 1.65 - 1.83
BMI (Weight/Body length2) [kg/m2] 21.9 ± 2.3 19.4 – 27.5
Heartrate in rest [bpm] 62 ± 7 50 - 73
Systolic blood pressure in rest [mmHg] 106 ± 13 90 - 138
Diastolic blood pressure in rest [mmHg] 62 ± 9 50 - 81
Heartrate during handgrip test [bpm] 67 ± 8 51 - 81
Systolic blood pressure during handgrip test [mmHg] 110 ± 10 94 - 138
Diastolic blood pressure during handgrip test [mmHg] 67 ± 9 52 - 85
Data acquisition
An overview of the study design and the tested variabilities are shown in Figure 1. 
Measurements were performed with two echographic scanning systems. First, a clini-
cal system programmed by the manufacturer to have a high frame rate imaging mode 
(Zonare ZS3, P4-1C probe, Mindray Innovation Center, San Jose, California) was used. 
Live B-mode images with a low frame rate (LFR) were used to position the probe. Then a 
smaller box (approximately 5 x 7 cm) was selected within these LFR images for the high 
frame rate (HFR) acquisition. During these recordings the LFR images were frozen on the 
screen of the system and no live feedback was present. A diverging-wave pulse-inversion 
transmission sequence was used for the HFR acquisition, and beamformed in-phase 
and quadrature components (IQ-based data) with a frame rate of 1000 frames/second 
during 1.2 seconds were saved for offline processing. In this way, at least a full cardiac 
cycle was measured for a minimum heartrate of 50 bpm. The acquisitions with this ma-
chine were carried out by a sonographer (D.J.B.). Second, acquisitions were performed 
by a cardiologist (M.S.) with a clinical echographic scanner in conventional TDI mode 
(Philips iE33, S5-1 probe, Philips, Bothell, WA, USA). To obtain maximum frame rates, a 
balance between opening angle and depth of TDI field was searched for, as described by 
Strachinaru et al. (2017). In this way frame rates from 490 – 570 frames/second were real-
ized. Simultaneously a phonocardiogram (PCG) (Fukuda Denshi MA-300HDS(V), Fukuda 
Denshi Co., Tokyo, Japan) was recorded and the electrocardiographic (ECG) signal was 
used as trigger. All data during 2 cardiac cycles were saved in DICOM format for offline 
processing.
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figure 1 Schematic overview of the study design. The same measurements were performed during Session 
1 and Session 2. Rest and handgrip test measurements were performed with the Zonare and the Philips 
system. Inter-observer variability was tested for the Philips system only, while intra-scan variability was 
only tested for the Zonare system.
For every volunteer, first 5 long-axis parasternal view measurements, with intermittent 
probe repositioning, were performed with the Zonare system. It was ascertained that 
both aortic and mitral valves were in the image plane. Directly aft er the measurements 
with the Zonare system, measurements were repeated with the Philips system. Subse-
quently, the eff ect of physiological stress causing hemodynamic variations on the SWS 
measurements was tested by performing handgrip tests. During the handgrip measure-
ments, the volunteers were asked to keep a stress ball continuously squeezed with 
their left  hand. While volunteers kept on squeezing, measurements were repeated with 
both machines. All measurements were performed within 30 minutes per volunteer. 
Furthermore, to investigate test-retest variability, all measurements were repeated per 
volunteer during a second scanning session on a separate day. The time period between 
the first and second session for the volunteers varied between 21 and 93 days.
Shear wave propagation speed analysis
The propagation speeds of the SWs induced by the AVC and MVC were determined by 
using diff erent methods for the Zonare and Philips system. Although one method ap-
plicable to the data of both systems could be searched for, we choose to use diff erent 
methods that were more suitable for the data format of the individual systems.
Clinical system with custom HFR mode
Off line IQ-based data stored from the Zonare system were analyzed in Matlab R2017a 
(The Mathworks, Natick, MA, USA). To remove high frequency TDI information mainly 
corresponding to blood and noise, a 6th order lowpass Butterworth filter with a cutoff  
frequency of 250 Hz was applied to the IQ data in slowtime. Axial tissue velocities were 
obtained by using a one-lag autocorrelation technique (Brekke et al. 2014). To reduce 
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the effect of speckle and noise, a Gaussian spatial smoothing filter with a size of 4 mm by 
6.7° was applied to the autocorrelation frames before calculating the phase (Brekke et al. 
2014; Strachinaru et al. 2017; Vos et al. 2017). The moments of AVC and MVC were visible 
in the B-mode images. However, since the HFR box was relatively small, the aortic valves 
were not visible in all recordings, while they were visible in the LFR overview images 
captured in the seconds before and after the HFR recordings. Therefore, the moments 
of valve closure in the HFR acquisitions were determined based on the movement of the 
mitral valves, on the overall motion of the heart and on the derived TDI movies. For each 
recording, an anatomical M-line was manually drawn on the basal-mid part of the IVS at 
the moment of valve closure, see Figure 2 A and D. Depending on the position of the IVS 
in the field of view and on the visible propagation length of the SWs, the length of the 
M-line varied between 1.9 - 4.1 cm (AVC) and 2.1 - 5.7 cm (MVC). Then, the axial particle 
velocities over the M-line were assembled in a motion-panel (M-panel) for a period of 
75 ms around the moment of valve closure. The SWs induced by the AVC and MVC are 
depicted as wave patterns propagating over slowtime along the M-lines in the M-panels, 
see Figure 2 B and E. The slope of these patterns represents the propagation speed of 
these SWs. The AVC and MVC occur during the isovolumetric relaxation and isovolumet-
ric contraction phase respectively and therefore no gross motion was assumed nor seen 
to be present. Nonetheless, a 6th order bandpass Butterworth filter between 15 and 100 
Hz was applied to the axial tissue velocities in slowtime, since the SWs were found to be 
in this frequency range. Therefore, also any offset due to gross motion was removed. To 
obtain the propagation speeds of the SWs induced by the different valve closures, the 
slope of the patterns shown in the M-panels was determined by using a Radon transform 
(Rouze et al. 2010; Song et al. 2013; Vos et al. 2017), see Figure 2 C and F. Before applying 
the Radon transform, the M-panels were first resampled to have an equal number of 
pixels in space and time and then tapered in both directions. Furthermore, the Radon 
domain was normalized, as described by Vos et al. (2017). The minimum intensity, cor-
responding to the particle motion away from the transducer, was selected in the Radon 
domain to determine the propagation speed. As also reported in pig data (Keijzer et al. 
2018), the location of the manually drawn M-line was found to affect the results. There-
fore to test intra-scan variability, for every recording the M-lines were drawn 10 times. 
The location of these M-lines was chosen based on the visibility of the SW propagation. 
When the SW propagation was found to be less reliable on the right and left ventricle 
sides of the IVS, M-lines were drawn more to the middle. Data analysis of the Zonare data 
was done by the researcher who wrote the Matlab analysis script (L.B.H.K.). Except from 
determining the moments of valves closure and drawing the M-lines, the data analysis 
process was fully automated. Since 10 M-lines were already drawn for every recording, 
inter-observer variability testing was not considered meaningful for the Zonare system.
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figure 2. Zonare: Example of an M-line drawn at AVC (A) and MVC (D). The corresponding M-panels are 
shown in (B) and(E) respectively. After applying a BPF, a Radon transform was applied to obtain the propa-
gation velocities as shown in (C) and (F).
For every volunteer 7 measurements were performed per session leading to 140 mea-
surements in total. SWs after AVC and MVC were tracked in 122/140 (87%) and 92/140 
(66%) measurements respectively. Main reasons to exclude recordings from the mea-
surements were a poor B-mode quality (approx. 5% of measurements after AVC and/or 
MVC), or the IVS moving out of the field of view (approx. 5%). Furthermore, acquisitions 
with no visible propagating SWs or with propagation over only short distances (<1.8 cm) 
(approx. 20%) were excluded. In one of the volunteers (volunteer 8), propagating SWs 
after MVC could not be seen in any recording.
Clinical system with clinical HFR mode
The Philips QLab8 software program (Philips, Bothell, WA, USA) was used for post-
processing of the Philips DICOM data as described before (Strachinaru et al. 2017). The 
method is repeated here in brief. Since the depth and width of the TDI was minimized to 
obtain high frame rates, valves were not visible in the measurements. Therefore, the mo-
ments of valve closure were determined based on the PCG signals (onset of S1 and S2) 
and the appearance of SWs in TDI, see Figure 3. Although the moment of valve closure 
could not visually be determined in the B-mode images, the onset of heart sounds are 
well known to correspond to valve closure. Furthermore, natural SWS induced by valve 
closure propagate from the aortic root to the apex (Strachinaru et al. 2019; Vos et al. 
2017), unlike electromechanical waves starting at midlevel of the IVS and propagating 
towards base and apex (Provost et al. 2011). Anatomical M-lines were manually drawn 
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over the IVS and the length of these M-lines was defined based on the width of the TDI 
field of view. This length ranged between 2 and 3 cm. Subsequently, an M-panel and 
a mean tissue velocity curve were provided by the soft ware, see Figure 3. By visually 
checking the pattern shown on the M-panel (B), the tissue velocity curve (C) and the 
TDI movie (A) itself, the time period needed for the SW to propagate over the M-line 
was determined. Since data analysis was not automated and the TDI data of the entire 
septum could be used as a reference by visually checking the TDI movies, the eff ect of 
M-line location was minimal. Therefore, only 1 M-line was drawn per recording. The 
transition from positive to negative TDI values of the SWs were tracked, since these were 
most visible to the observer. Since the SWs were tracked visually, inter-observer vari-
ability was considered as an important factor. Data analysis of the Philips data was done 
by the same researcher who analyzed the Zonare data (L.B.H.K). To test inter-observer 
variability, data analysis of the Philips measurements was repeated by a cardiologist 
experienced with the post-processing soft ware (M.S.) blinded to earlier values.
figure 3 Philips: Example of a measurement where SWs were tracked aft er AVC and MVC. The Philips QLab8 
soft ware program shows the TDI movie (A), the M-panel (B) and the mean velocity curve (C).
For the Philips system, SWs could be tracked aft er AVC in 365/474 (77%) and aft er MVC in 
71/474 (15%) recorded cardiac cycles. In this study we measured the SWs aft er AVC and 
MVC in single recordings. TDI limits were chosen for the visualization of the SWs aft er 
AVC, as these had our focus for the measurements. Lower TDI limits might have been 
chosen when focusing on the SWs induced by MVC, as these have lower magnitudes. 
Therefore, the transition from positive to negative TDI values aft er MVC was not visible 
in many DICOM images and we obtained a low feasibility for the MVC measurements 
compared to MVC data with this method (Strachinaru et al. 2019). Furthermore, values 
above 10 m/s were removed since they were assumed to be non-physical, as was done 
by Vos et al. (2017).
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Statistics
Statistical analysis was done by using a statistical toolbox in Matlab R2017a (The 
Mathworks, Natick, MA, USA). Kolmogorov-Smirnov tests were used to test for normal 
distributions. Propagation speeds are presented as median values and inter-quartile 
ranges (IQR). To compare our results with literature values, also mean and standard 
deviations were reported. We noticed that some volunteers were nervous when entering 
the scanning room. To test whether all measurements in rest could be grouped, the first 
and last of five rest measurements were compared. A Wilcoxon signed-rank test was ap-
plied to the median values per recording for the Zonare data and to the individual values 
per heart cycle for the Philips data. Also a Bland-Altman analysis was used to depict 
differences (mean differences, limits of agreement (LOA) and range). A similar analysis 
was done to test the effect of the handgrip test and the test-retest and inter-system vari-
ability. For the Zonare data, intra-scan variability was investigated by computing the 
median of all IQRs of the values obtained per measurement for the 10 M-lines of all rest 
and stress measurements. The median value of the IQRs of the median recording values 
was used to measure inter-scan variability.
RESUlTS
Hemodynamic characteristics
Average blood pressures of 106 ± 13 mmHg (systolic) and 62 ± 9 mmHg (diastolic) were 
measured in rest, while average pressures of 110 ± 10 mmHg and 67 ± 9 mmHg were 
measured during the handgrip test. The diastolic blood pressure was statistically sig-
nificantly different during the handgrip test (p=0.0088) while the systolic blood pressure 
was not (p=0.077). Also the heart rate, measured with the ECG connected to the Philips 
system, was found to increase significantly (p<0.01) from 62 ± 7 bpm to 67 ± 8 bpm.
Clinical system with custom HfR mode
Figure 4 shows the results obtained for the 10 volunteers for the AVC and MVC respec-
tively. The median values in rest ranged from 3.23 to 4.25 m/s for AVC and from 2.06 to 
4.72 m/s for MVC. These median values were not normally distribution. Furthermore, we 
cannot assume that all volunteers have the same SW propagation speeds. Nevertheless, 
for comparison with other studies, the mean and standard deviations of these median 
values were computed to be 3.8 ± 0.4 m/s (AVC) and 3.4 ± 1.0 m/s (MVC). Table 2 gives an 
overview of the statistical characteristics of all measurements. For every measurement, 
10 M-lines were drawn over the IVS. The IQRs per measurement shown in Figure 4 thus 
represent the intra-scan variabilities. For the AVC measurements in rest, a median value 
of 0.38 m/s (IQR: 0.26 – 0.68 m/s) was found for all IQRs, for the MVC measurements 
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in rest this was found to be 0.26 m/s (IQR: 0.15 – 0.46 m/s). The variations in median 
values per recording per volunteer were used as measure for the inter-scan variability. 
The median IQRs of median values in rest per volunteer per session were found to be 
0.67 m/s (IQR: 0.40 – 0.86 m/s) for the AVC and 0.61 m/s (IQR: 0.26 – 0.94 m/s) for the 
MVC. To test whether all rest measurements could be grouped despite a possible time-
dependency during the period of the exam, the medians obtained for the first and last 
rest measurement per volunteer for both sessions were compared (Figure 5 A and D).
Table 2 Overview of the statistical characteristics of the Zonare and Philips data. P-values denoted with 
an asterisk(*) correspond to a statistically significant difference (p<0.05). LOA: limits of agreement Bland-
Altman analysis (±1.96 SD).
Type of 
variability
Performed test zonare Philips
AVC MVC AVC
Intra-scan Median of all IQRs of 
the values obtained per 
measurement for the 10 
M-lines
0.38 m/s, n=136
(IQR: 0.26 – 
0.68m/s)
0.26 m/s, n=99
(IQR: 0.15 – 0.46 
m/s)
-
Inter-scan Wilcoxon signed-rank test 
on medians of first and 
last rest measurement per 
volunteer per session
p=0.90, n=19 p=0.53, n=16 p=0.15, n=20
Bland-Altman: medians of 
first – medians of last rest 
measurement per volunteer 
per session
Mean: -0.0017 m/s, 
n=19
(LOA: -1.22 – 1.23 
m/s)
(Range: -1.06 – 0.96 
m/s)
Mean: -0.10 m/s, 
n=16
(LOA: -1.85 – 1.64 
m/s)
(Range: -1.56 – 2.36 
m/s)
Mean: -0.36 m/s, 
n= 20
(LOA: -2.29 – 1.58 
m/s)
(Range: -2.63 – 1.06 
m/s)
Inter-scan Median of all IQRs of 
(median) rest values per 
volunteer per session
0.67 m/s, n=19
(IQR: 0.40 – 0.86 
m/s)
0.61 m/s, n=16, 
(IQR: 0.26 – 0.94 
m/s)
0.71 m/s, n=19
(IQR: 0.33 – 1.07 
m/s)
Test-retest Wilcoxon signed-rank 
test on medians of all 
rest measurements per 
volunteer for Session 1 and 
Session 2
p=0.13, n=10 p=0.047*, n=7 p=0.28, n=10
Bland-Altman: medians of 
all rest measurements per 
volunteer for Session 1- for 
Session 2
Mean: -0.51 m/s, 
n=10
(LOA: -2.05 – 1.02 
m/s)
(Range: -1.81 – 0.45 
m/s)
Mean: 0.37 m/s, n=7
(LOA: -0.35 – 1.08 
m/s)
(Range: -0.034 – 
1.04 m/s)
Mean: -0.19 m/s, 
n=10
(LOA: -1.59 – 1.21 
m/s)
(Range: -1.44 – 1.19 
m/s)
Inter-
volunteer
Range of median rest values 
per volunteer
3.23 – 4.25 m/s, 
n=10
2.06 – 4.72 m/s, n=9 1.82 – 4.76 m/s, 
n=10
Handgrip test Wilcoxon signed-rank 
test on medians of all 
rest and all handgrip 
test measurements per 
volunteer per session
p=0.073 , n=20 p=0.56, n=15 p=0.079, n=19
Chapter 9 191
Reproducibility of Natural Shear Wave Elastography Measurements
Table 2 Overview of the statistical characteristics of the Zonare and Philips data. P-values denoted with 
an asterisk(*) correspond to a statistically significant difference (p<0.05). LOA: limits of agreement Bland-
Altman analysis (±1.96 SD). (continued)
Type of 
variability
Performed test zonare Philips
AVC MVC AVC
Bland-Altman: medians 
of all rest – medians 
of all handgrip test 
measurements per 
volunteer per session
Mean: -0.33 m/s, 
n=20
(LOA: -1.94 – 1.27 
m/s)
(Range: -3.07 – 0.74 
m/s)
Mean: -0.0723m/s, 
n=15
(LOA: -1.82 – 1.68 
m/s)
(Range: -2.22 – 0.93 
m/s)
Mean: -0.39 m/s, 
n=19
(LOA: -2.22 – 1.44 
m/s)
(Range: -2.38 – 1.49 
m/s)
Inter-observer Wilcoxon signed-rank 
test on medians of rest 
measurement per volunteer 
per session analyzed by 
Observer 1 and Observer 2
- - p=0.35, n= 20
Bland-Altman: medians of 
all rest measurements per 
volunteer per session for 
Observer 1 – for Observer 2
- - Mean: 0.11 m/s, 
n=20
(LOA: -1.42 – 1.65 
m/s)
(Range: -1.55 – 1.21 
m/s)
AVC
Inter-system Wilcoxon signed-rank test on median rest values per volunteer per 
echographic scanner
p=0.044*, n=20
Bland-Altman on median rest values per volunteer per echographic 
scanner bias + limits of agreement
Mean -0.43 m/s, 
n=20
(LOA: -2.23 – 1.37 
m/s)
(Range: -1.95 – 1.08 
m/s)
zonare
AVC vs MVC Median ratio of median rest values per volunteer per session for AVC and 
MVC
1.20, n=16
(IQR: 1.00 – 1.58)
Median difference of median rest values per volunteer per session for AVC 
and MVC
0.64 m/s, n=16
(IQR: -0.019 – 1.50 
m/s)
Average differences of -0.0017 m/s (LOA: -1.22 – 1.03 m/s) (AVC) and -0.10 m/s (LOA: -1.85 
– 1.64 m/s) (MVC) were found with a Bland-Altman analysis. No statistically significant 
differences were found (p=0.90 for AVC and p=0.53 for MVC). Therefore, we grouped all 
rest measurement per volunteer per session to compute the test-retest variability, see 
Figure 5. Mean differences of -0.51 m/s (LOA: -2.05 – 1.02 m/s) (AVC) and 0.37 m/s (LOA: 
-0.35 – 1.08 m/s) (MVC) were found for the test-retest variability of all measurements, 
(Figure 5 B and E).
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figure 4 Zonare: Median values and IQRs of the measurements in rest performed for the AVC (A) and the 
MVC (B). For every recording, 10 M-lines were drawn over the IVS. The IQRs depict the intra-scan variabili-
ties. Inter-scan variabilities (median values and IQRs) per volunteer for every session are depicted in box-
plots. Inter-scan variabilities were found to be slightly higher than, but in similar ranges as, intra-scan vari-
abilities.
figure 5 Zonare: Bland-Altman analysis of the inter-scan variability, the test-retest variability and the effect 
of the handgrip test for the AVC (A, B and C) and MVC (D, E and F). No significant differences were found 
between the first and last rest measurement per volunteer per session. Test-retest differences were found 
to be just significant for the MVC, but not for the AVC. No significant effect was found for the handgrip test.
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These differences were found to be just significant for the MVC (p=0.047) but not for 
the AVC (p=0.13). We grouped both sessions before computing the inter-volunteer vari-
ability. The median values of the rest measurements per volunteer were found to be 
in the ranges of 3.23 - 4.25 m/s and 2.06 - 4.72 m/s for the AVC and MVC respectively. 
Subsequently, rest and handgrip measurements are compared (Figure 5 C and F). Aver-
age differences of -0.33 m/s (LOA: -1.94 – 1.27 m/s) for the AVC measurements and -0.072 
m/s (LOA: -1.82 – 1.68 m/s) for the MVC measurements were found. These differences 
were not found to be significant (p=0.073 for AVC and p=0.56 for MVC), see Figure 6.
figure 6 Zonare: Comparison of the median values and IQRs of the rest and stress measurements of Ses-
sion 1 and Session 2 per volunteer for AVC (A) and MVC (B). Test-retest differences were found to be just sig-
nificant for the MVC, but not for the AVC. No significant effect was found for the handgrip test (rest vs stress).
Clinical system with clinical HfR mode
The propagation speeds obtained from the Philips data are shown in Figure 7. Since 
the feasibility of the MVC measurements was low, no statistical tests were performed on 
these few MVC measurements. Therefore only the statistics of the AVC measurements 
are described in this paragraph. The median values in rest ranged from 1.82 to 4.76 m/s, 
see Table 2. As done for the Zonare, mean and standard deviation was computed for 
illustrative purposes (3.2 ± 0.9 m/s). A median value of the IQRs of the propagation speed 
values in rest per session per volunteer of 0.71 m/s (IQR: 0.33 – 1.07 m/s) was found, 
representing the inter-scan variability. It should be noted that these values seem to be 
higher than the inter-scan variability values of the Zonare data, where first median val-
ues over the 10 M-lines per scan were obtained before computing inter-scan variability. 
As for the Zonare data, no statistically significant difference was found between the first 
and last rest measurement per volunteer per session (p=0.15).
194 Part 2
figure 7 Philips: Comparison of the median values and IQRs of the rest and stress measurements of Ses-
sion 1 and Session 2 per volunteer for AVC (A) and MVC (B). No statistical tests were performed on the MVC 
measurements because of a low feasibility. For the AVC measurements, no significant effects were found 
for test-retest and the handgrip test.
A Bland-Altman analysis showed a mean difference between the first and last rest 
measurement of -0.36 m/s (LOA: -2.29 – 1.58 m/s) (Figure 8 A). Therefore, all rest mea-
surements were grouped for measuring the test-retest variability. A mean difference 
of -0.19 m/s (LOA of -1.59 – 1.21 m/s) was found, which was not statistically significant 
(p=0.28) (Figure 8 B). Therefore, as for the Zonare data, the measurements in Session 1 
and Session 2 were grouped to obtain inter-volunteer variability ranges. The median rest 
values per volunteer were found to be in the range of 1.82 – 4.76 m/s. Also similar to the 
Zonare data, the difference between rest and stress measurements was not found to be 
significant (p=0.079). A mean differences of -0.39 m/s (LOA: -2.22 – 1.44 m/s) was found.
figure 8 Philips: Bland-Altman analysis of the inter-scan variability (A), the test-retest variability (B) and 
the effect of the handgrip test (C) of the AVC measurements. No statistical tests were performed on the MVC 
measurements because of a low feasibility. For the AVC measurements, the first and last rest measurement 
per volunteer per session were not found to be statistically significantly different. Also no significant effect 
was found for the handgrip test.
Intra-scan variability was not tested for the Philips data, since only 1 M-line curve and 
thus 1 propagation speed value was obtained per heart cycle with the Philips system. 
Chapter 9 195
Reproducibility of Natural Shear Wave Elastography Measurements
Instead of intra-scan variability, inter-observer variability was measured for the Philips 
data. The second observer computed propagation speeds per volunteer per session 
averaged over 3 heart cycles. These propagation speeds were compared with the me-
dian rest values obtained by the first observer. An average difference of 0.11 m/s (LOA: 
-1.42 – 1.65 m/s) was found (Figure 9), which was not found to be significant (p=0.35). 
The feasibility of the MVC measurements was higher for the second than for the first 
observer. While the first observer obtained propagation speeds in 7 sessions, the second 
observer obtained values for 14 sessions. Nonetheless, for consistency, also no statisti-
cal tests were performed on the MVC measurements analyzed by the second observer.
figure 9 Philips: Bland-Altman analysis of the inter-
observer variability for the AVC measurements per 
session. No statistically significant effect was found.
figure 10 Zonare and Philips: Bland-Altman 
analysis of the inter-system variability for the AVC 
measurements per session. Statistically different 
propagation speeds were obtained with the differ-
ent systems.
Comparison of the systems
Due to the low feasibility of the MVC measurements with the current settings on the 
Philips system, only the AVC measurements of the Zonare and the Philips system were 
compared. The difference in results obtained with the Zonare and the Philips system 
was found to be statistically significant (p=0.044). The Bland-Altman analysis shows a 
median bias of -0.43 m/s (LOA: -2.23 – 1.37 m/s), indicating that we consistently mea-
sured a lower propagation speed with the Philips system (Figure 10).
As suggested by others (Santos et al. 2019; Vos et al. 2017), the difference and ratio of 
the propagation speeds obtained for the AVC and MVC might be of clinical relevance due 
to hemodynamics. Due to the low feasibility of the MVC measurements with the Philips 
system, these ratios and differences were only computed for the Zonare system (Figure 
11). The median ratio and difference were found to be 1.20 (IQR: 1.00 – 1.58) and 0.64 
m/s (IQR: -0.019 – 1.50 m/s) respectively.
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figure 11 Zonare: Ratio (A) and difference (B) between propagation speeds obtained after AVC and after 
MVC for all volunteers. Due to the low feasibility of the MVC measurements with the Philips system, only the 
ratio’s and differences for the Zonare system are shown.
DISCUSSIOn
In this study, we tested the reproducibility of the propagation speeds of natural SWs 
induced by the aortic valve closure (AVC) and mitral valve closure (MVC) in 10 healthy 
volunteers. For the AVC measurements, no statistically different propagation speeds 
were obtained on different days. Our results suggest that the variabilities of natural 
shear wave speed (SWS) measurements are dominated by measurement inaccuracies 
rather than mild hemodynamic variations. Statistically, different propagation speeds 
after AVC were obtained for two different systems.
Measurement variations can have physiological causes or can arise due to measure-
ment inaccuracies. Intra-scan variability is measured within individual recordings, and, 
therefore, physiological causes are assumed to be non-existing. Inter-scan variabilities 
can also occur because of physiological variations, and these variations are expected 
to be even larger when comparing different sessions. We found inter-scan variabilities 
(Zonare: 0.67 m/s (IQR: 0.40 – 0.86 m/s) for AVC and 0.61 m/s (IQR: 0.26 – 0.94 m/s) for 
MVC) to be slightly higher than, but in similar ranges as, intra-scan variabilities (Zonare: 
0.38 m/s (IQR: 0.26 – 0.68 m/s) for AVC and 0.26 m/s (IQR: 0.15 – 0.46 m/s) for MVC). 
Moreover, test-retest variabilities were found to also be in similar ranges as inter-scan 
variabilities (Figure 5 and 8). Therefore, our results suggest that the measurement varia-
tions were dominated by several measurement inaccuracies, which are expected to have 
different causes. First of all, we found qualitatively that contrast in the B-mode images 
affected the results. For recordings with a low visible contrast between tissue and blood, 
we experienced that positioning the M-lines on the IVS was more challenging. This 
was especially important for the Zonare system, where a diverging-wave transmission 
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scheme was used and therefore B-mode contrast was sometimes limited due to clutter. 
Furthermore, clutter could have affected the determination of tissue velocities. Second, 
the SWs could only be tracked over the limited visible length of about 3 cm of the IVS. A 
SW with a center frequency of, for example, 50 Hz (Santos et al. 2019) and a propagation 
speed of 3.5 m/s, has a wavelength of 7.0 cm. This means that only a fraction of this 
wavelength can be tracked, which causes measurement inaccuracy, increasing with 
propagation speed.
In a uniform shear wave phantom with ARF-push induced shear waves, Strachinaru et al. 
(2017a) obtained similar propagation speeds with a research scanner as with the clinical 
Philips system. However, for the AVC measurements, we obtained statistically different 
propagation speeds with the Philips system compared to the Zonare system. As the 
measurements with the different systems were performed within half an hour per ses-
sion, the differences are expected to be mainly due to the differences in data processing 
for the different systems. First of all, for the Zonare measurements, a Radon transform 
was used to track the maximum negative particle velocities, while for the Philips mea-
surements, the onset of the wave, as visible from positive to negative tissue velocities, 
was tracked. This means that slightly different aspects of the SW pattern were tracked. 
We previously found in measurements in an animal model different propagation speeds 
as well when tracking different rims of the SWs (Keijzer et al. 2018). Second, while a 
frame rate of 1000 Hz was used for the Zonare, frame rates varied between 490 – 570 Hz 
for the Philips system and therefore the time resolution differed by a factor of two. This 
is expected to induce more uncertainties and thus more variability (Strachinaru et al. 
2017), as observed in our study, see Figure 5 and Figure 6. Third, the SWs were tracked 
automatically with the Radon transform for the Zonare system, while for the Philips 
system visual feedback obtained from the M-panel, the tissue velocity curve and the 
TDI movie was used to determine the propagation speeds. Therefore, when comparing 
different studies, these methodological aspects described should also be taken into 
account. Furthermore, the effect of using different systems and methods should be 
studied also for pathological hearts in more detail.
Advantage of using the Radon transform for the Zonare system is that data analysis can 
be more automated. To minimize the effect of noise, as described in the method section, 
we applied a lowpass filter to the IQ data in slowtime. Furthermore, a Gaussian spatial 
smoothing filter was applied to the autocorrelation frames. In addition, for every mea-
surement 10 M-lines were drawn over the IVS. Moreover, we interpolated the M-panels 
to a panel with an equal number of pixels in space and time. We also normalized the 
Radon domain by dividing by the Radon transform of a panel with an equal number of 
pixels with only unit values, to avoid an apparent bias (Vos et al. 2017). To further reduce 
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the effect of noise, the performance of using a least-square or high resolution Radon 
transform (Thorson and Claerbout 1985) could be investigated in the future.
The potential hemodynamic variation due to psychological stress related to the exami-
nation was estimated by comparing the first and last rest measurement within a session. 
No significant differences were found. This indicates that when patients are nervous at 
the beginning of a scanning session, this does not strongly affect these measurements, 
which is beneficial for the application of clinical diagnosis. Nonetheless, it should be 
noted that the number of measurements in this study was limited and thus not enough 
statistical power might be present to detect small differences. Therefore to investigate 
the effect of larger variations in hemodynamics, a handgrip test was performed during 
the SWS measurements. This test is not only relevant for the different levels of physi-
ological stress patients may experience, but also since diastolic dysfunction patients 
might show normal hemodynamic characteristics in rest, but have abnormal LV dia-
stolic pressures during exercise (Nagueh et al. 2016). Although heartrate did increase 
significantly during the handgrip test, the propagation speeds obtained during rest and 
the handgrip test were not found to be statistically different. It should be noted that 
for AVC we found p-values only slightly above p=0.05 (p=0.073 and p=0.079 for Zonare 
and Philips respectively). Possibly, the statistical power could be too limited to measure 
significant differences. For the AVC, we did find a mean increase in propagation speed 
during stress of 0.33 m/s and 0.39 m/s with the Zonare and Philips system respectively 
(Figure 5 and 8). Nonetheless, the differences between the measurements in rest and 
during the handgrip test are in the same range as the inter-scan variabilities (Figure 5 
and 8). This suggests that no extra variabilities are induced because of the handgrip test. 
However, only low levels of stress causing small hemodynamic changes are induced by 
handgrip tests. While higher levels of stress could be induced by using an exercise test, 
performing HFR acquisitions would be more challenging. Whether the measurement of 
the natural SWs induced by AVC and MVC is completely independent of loading condi-
tions should be further investigated in a study with higher statistical power.
Several studies have reported on the propagation speed of SWs in healthy volunteers, as 
summarized in Table 3. Some studies used a long-axis parasternal view, while Brekke et 
al. (2014) used a 4-chamber apical view. However, the exact effect of the imaging view on 
the measured propagation speed is currently unclear. The propagation speeds obtained 
in this study for the SWs after AVC are in the same range as the values measured in other 
human studies. Some studies used ARF to induce SWs during diastole in healthy volun-
teers. However, these values cannot be directly compared with the values obtained after 
closure of the valves, since the timing of the measurements is different. MVC and AVC 
occur around the onset of contraction and relaxation respectively (Remme et al. 2008). 
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Previous studies showed stiffness variation over the cardiac cycle in animals (Couade 
et al. 2011; Pernot et al. 2011; Vejdani-jahromi et al. 2015) and human (Hollender et al. 
2017; Tzschätzsch et al. 2012). Couade et al. (2011) reported on an increase in shear 
modulus from about 5 kPa to 15 kPa in the first 50 ms after the R peak in sheep, which 
corresponds to an increase in propagation speed of about 70%. With the Zonare system, 
we found in general higher values after MVC than ARF-based studies at diastole.
Table 3 Overview of human shear wave elastography measurements described in literature. The following 
abbreviations are used in the table: HCM: hypertrophic cardiomyopathy, PLAX: parasternal long-axis view, 
PSAX: parasternal short-axis view, AP4C: apical 4-chamber view, LVFW: left ventricular free wall, IVS: inter-
ventricular septum.
Natural SWS
Study View Subject MVC AVC
Kanai, (2005) PLAX, IVS Healthy volunteer - 1 – 7 m/s (10-90 Hz)
Brekke et al., (2014) AP4C, IVS Healthy volunteers - 5.41 ± 1.28 m/s
Santos et al., (2018) PLAX, IVS Healthy volunteers 3.2 ± 0.6 m/s
(2.1 – 4.4 m/s)
3.5 ± 0.6 m/s
(2.2 – 4.5 m/s)
Petrescu et al., (2019) PLAX, IVS Healthy volunteers 3.54 ± 0.93 m/s 3.75 ± 0.76 m/s
Cardiac amyloidosis 6.33 ± 1.63 m/s 5.63 ± 1/13 m/s
Strachinaru et al., 
(2019)
PLAX, IVS Healthy volunteers 4.65 ± 0.77 m/s
(3.25 – 6.50 m/s)
3.61 ± 0.46 m/s
(3.10 – 4.66 m/s)
HCM patients 6.88 ± 1.22 m/s
(5.45 – 8.91 m/s)
5.13 ± 0.68 m/s
(3.75 – 6.94 m/s)
Keijzer et al., current 
study
PlAX, IVS Healthy volunteers zonare 3.4 ± 1.0 m/s
(2.06 – 4.72 m/s)
zonare 3.8 ± 0.4 m/s
(3.23 – 4.25 m/s)
- Philips 3.2 ± 0.9
(1.82 – 4.76 m/s)
ARF based SWS
Study View Subject End-diastole End-systole
Song et al.,(2016) LAPV and PSAX, 
LVFW and IVS
Healthy volunteers 1.29 – 1.96 m/s -
Villemain et al., (2018) PLAX and PSAX, 
IVS
Healthy volunteers 2.1 ± 1.30* m/s -
HCM Patients 3.56 ± 1.71*m/s -
* Speed values c obtained by converting elasticity values E, using E=ρc2 with a tissue density ρ of 1000 kg/m3.
Several authors suggested that the difference and ratio of the propagation speeds ob-
tained after AVC and MVC are potentially more clinically relevant due to hemodynamics 
(Santos et al. 2019; Vos et al. 2017). We found a median difference of 0.60 m/s (IQR: -0.31 
– 1.25 m/s) and a mean ratio of 1.21 (IQR: 0.93 – 1.46) with the Zonare system. However, 
these values have relatively high variability, likely caused by the combined variability of 
both the AVC and MVC measurements, which may reduce relevance for clinical diagnosis. 
Nonetheless, Santos et al. (2018) found a mean difference of 0.4 ± 0.6 m/s and mean ratio 
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of 1.1 ± 0.2, which is close to the values we obtained. Also Petrescu et al. (2019) found 
higher mean propagation speeds for AVC than for MVC (3.48 ± 0.70 m/s vs 3.07 ± 0.51 
m/s) for healthy volunteers aged 20-39 years. However, for older age groups, no statisti-
cal difference was found between the propagation speeds after AVC and MVC (Petrescu 
et al. 2019). In contrast, Strachinaru et al. (2019) found higher propagation speeds for 
MVC than for AVC (4.68 ± 0.66 m/s vs 3.51 ± 0.38 m/s) in healthy volunteers. What exact 
clinically relevant information can be obtained from natural SWS measurements should 
be further investigated.
Both systems have their own advantages and disadvantages to be used for clinical 
diagnosis with SWS. Translation of using the clinical Philips system and its clinical data 
analysis package to daily clinical practice takes less time, which is a major advantage. 
However, the Zonare system saves IQ data instead of DICOM data, giving the possibility 
to apply different tracking and filter methods and to automate data analysis. Further-
more, with the Zonare system a two times higher frame rate is obtained, theoretically 
corresponding to lower measurement variabilities. The higher feasibility of measuring 
the SWs after MVC and AVC for the Zonare system is another important advantage. In 
addition, the inter-volunteer range was found to be smaller or similar, depending on 
the observer, for the Zonare compared to the Philips system. However, ECG and PCG 
could not yet be measured with the Zonare system in HFR mode. This practically means 
that the moment of valve closure had to be determined visually and that measurements 
could not be linked to a heartrate, as only one heartbeat was recorded per movie. 
However, we expect that ECG and PCG could be implemented in the HFR mode of the 
Zonare system in the future. Image quality was higher with the Philips system, and TDI 
data was directly shown on the Philips system. This made it easier to perform a direct 
quality check of the recording than with the Zonare system. However, when performing 
the measurements with the Philips system, separate recordings should be made for 
the AVC and MVC measurements as the TDI velocity scale needs optimization for either 
measurement. Strachinaru et al. (2019) showed much higher feasibilities for the MVC 
measurements (89% of 45 healthy volunteers) by using the same system but by per-
forming separate recordings for measuring the SWs after AVC and MVC. For the Zonare 
system, AVC and MVC measurements can be performed simultaneously. As such, in this 
stage of developments, both systems can be used as a research bridge to further clinical 
translation of the technique.
For clinical diagnostic application, it is important to be able to show significant differ-
ences between healthy volunteers and a patient at risk with a certain confidence. Our 
study suggests that measurement variabilities are dominated by measurement inaccu-
racies. Therefore, by averaging over multiple heartbeats, the standard error is expected 
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to be minimized. The variabilities presented in this study can be used to estimate the 
minimum amount of measurements needed for clinical diagnosis, once the minimal dif-
ference in propagation speed between a patient at risk and a healthy subject are suitably 
investigated. Considering that data processing is done offline and that measurements 
can be performed subsequently, we estimate that recording up to 10 heart beats for 
averaging is feasible with respect to time and effort.
The ultimate goal is to measure the increased stiffness of the myocardium. However, in 
this study, we only reported on linear propagation speeds. Since the typical wavelength 
of the SWs measured (about 7 cm) is large compared to the thickness of the IVS (about 
1 cm), guided waves instead of bulk shear waves are expected. Guided waves show dis-
persion even for purely elastic media, and, thus, measured propagation speeds cannot 
be directly converted to shear moduli. However, the resolution in 2-D Fourier domain 
was restricted due to the limited visible propagation length of the SWs, to measure 
dispersive effects. Xu et al. (2018) proposed a dispersive Radon transform. However, 
prior knowledge on the theoretical dispersion curves of the induced modes is needed. 
Since the IVS is a complex structure with respect to geometry and fiber orientation, we 
expect that the dispersion curves of Lamb waves in plate structures are too simplistic. As 
such, the relation between geometry of the myocardium, propagation speed and early 
diagnosis of cardiac dysfunction should be further investigated.
COnClUSIOnS
This study investigated the reproducibility of the measurement of propagation speeds 
of shear waves naturally induced by aortic and mitral valve closure (AVC and MVC) in 
healthy volunteers. Propagation speeds of 3.23 – 4.25 m/s (AVC) and 2.06 – 4.72 m/s 
(MVC) were obtained. Inter-scan variabilities were slightly higher than intra-scan vari-
abilities. For the AVC measurements, no different propagation speeds were obtained 
after test-retest (p=0.13). However, significantly different values were obtained with a 
second clinical system (1.82 – 4.76 m/s for AVC), potentially caused by differences in 
measurement methods. For this second system, inter-observer variability was tested 
and no statistical differences were found. Based on the results of this study, measure-
ment inaccuracies are expected to dominate measurement variations among healthy 
volunteers. Thus, by averaging over multiple heartbeats precision for the application of 
clinical diagnosis can potentially be improved.
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ABSTRACT
We apply a high frame rate(over 500 Hz) tissue Doppler method to measure the propa-
gation velocity of naturally-occurring shear waves(SW) generated by aortic and mitral 
valves closure. The aim of this work is to demonstrate clinical relevance. We included 
45 healthy volunteers, and 43 patients with hypertrophic cardiomyopathy(HCM). The 
mitral SW(4.68±0.66 m/s) was consistently faster than the aortic(3.51±0.38 m/s) in all 
volunteers (p<0.0001). In HCM patients SW velocity correlated with E/e’ ratio (r=0.346, 
p=0.04 for aortic SW and r=0.667, p=0.04 for mitral). A subgroup of 20 volunteers were 
matched for age and gender to 20 HCM patients. In HCM the mean velocity of 5.1±0.7 m/s 
for the aortic SW(3.61±0.46 m/s in matched volunteers, p<0.0001) and 6.88±1.12 m/s for 
the mitral SW(4.65±0.77 m/s in matched volunteers, p<0.0001). A threshold of 4 m/s for 
the aortic SW correctly classified pathological myocardium with a sensitivity of 95% and 
specificity of 90%. Naturally occurring SW can be used to assess differences between 
normal and pathological myocardium.
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InTRODUCTIOn
The prevalence of heart failure is approximately 1–2% of the adult population in devel-
oped countries, rising to ≥10% among people >70 years of age (Ponikowski et al 2016). 
Heart failure with preserved ejection fraction represents around 50%, but its diagnosis 
remains challenging. Demonstration of cardiac functional and structural alterations is 
key to the diagnosis. However, no validated non-invasive gold standard exists for mea-
suring the precise degree of myocardial stiffness (Nagueh et al 2016).
Stiffness can be estimated in vivo by measuring the propagation velocity of externally 
induced shear waves travelling through a tissue (Shiina et al 2015), the general principle 
being that shear waves travel faster in stiffer materials. This shear wave elastography 
can be performed by magnetic resonance or ultrasound imaging. The main present-day 
applications are liver fibrosis and breast, thyroid, prostate, kidney and lymph node im-
aging  (Shiina et al 2015; Parker et al 2011). Several research groups have used external 
sources to induce shear waves in the myocardium (Bouchard et al 2009; Pernot et al 
2011; Hollender et al 2012; Song et al 2013; Urban et al 2013; Vejdani-Jahromi et al 2016), 
demonstrating that diastolic myocardial stiffness can be determined using ultrasonic 
shear wave imaging (Villemain et al 2017,2018). It has been found that shear-like waves 
also naturally occur in the myocardium after valve closure (Kanai 2009; Brekke et al 
2014), caused by the impulse of the snapping valve on the mitral and aortic annuli which 
propagates within the cardiac wall. We have recently shown that these waves can be 
measured with an ultrasound system in regular clinical mode by using high-frame-rate 
Tissue Doppler Imaging (TDI) (Strachinaru et al 2017).
In this work, we study naturally-occurring shear waves in normal volunteers and hyper-
trophic cardiomyopathy (HCM) patients, as a pathological model of increased muscle 
stiffness and diastolic dysfunction (Villemain et al 2017, 2018; Elliott et al 2014; Lu et al 
2018; Finocchiaro et al 2018). The aim was to demonstrate the feasibility in a clinical set-
ting and investigate the potential application of the method for discriminating normal 
from pathological myocardium.
METHODS
Study population
This prospective study was conducted in 2016-2017 according to the principles of the Dec-
laration of Helsinki and approved by the Institutional Medical Ethical Committee (MEC-
2014-611, MEC-2017-209). Written informed consent was obtained from every participant.
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-Healthy volunteers aged 18 to 62 years. Subjects were excluded if one or more of the fol-
lowing criteria were present: a history of cardiovascular disease, systemic disease, the 
finding of cardiac abnormalities during the examination (including QRS duration over 
100ms), cardiovascular risk factors including hypertension (cutoff value 140/90 mmHg), 
diabetes mellitus or hypercholesterolemia, having breast implants or being pregnant. 
Professional athletes or morbidly obese (BMI >40kg/m2) were excluded.
-Hypertrophic cardiomyopathy patients recruited from the HCM outpatient clinic. Sub-
jects were included if they had a definitive diagnosis of hypertrophic cardiomyopathy 
(Elliott et al 2014), regardless of the localization of the most hypertrophic segments (for 
example, apical forms were not excluded). Exclusion criteria were: associated known 
coronary artery disease, more than mild valve disease (systolic anterior movement of 
the mitral valve was not considered as exclusion criterion), prior septal reduction (either 
surgical or interventional).
Echocardiography
All echocardiographic studies were performed by one experienced sonographer (MS). 
Normal complete echocardiographic studies were performed, including 2D, Doppler 
and pulsed-wave TDI of the mitral annulus. The peak velocity of the early diastolic mitral 
inflow was measured (E wave), as well as the peak early diastolic tissue velocity of the 
medial mitral annulus in apical four-chambers view (e’ wave). Their ratio (E/e’) was then 
calculated as an index of the early diastolic properties of the left ventricle. Tissue veloci-
ties of the LV myocardium were sampled in Color Tissue Doppler (color TDI) in standard 
parasternal long axis view (PLAX) using a Philips iE33 system (Philips Medical, Best, The 
Netherlands) equipped with a S5-1 transducer. As previously described (Strachinaru et 
al 2017), we used a clinical color TDI application with a frame rate over 500 Hz, acquir-
ing five separate recordings for each subject, timed to the ECG in order to obtain two 
heart beats per recording. The probe was lifted off the chest between recordings and 
repositioned in order to optimize the image. Typically, the TDI sector had an opening 
angle of 40°, which at a depth of 6 cm leads to a 4 cm sector width. The 2-D line density 
was set to minimum, leading to TDI frame rates over 500 Hz (range 500 to 590 Hz). The 
TDI movies were stored in DICOM format for offline analysis.
The DICOM TDI loops were processed using Qlab 9 (Philips Medical, Best, The Nether-
lands), see Figure 1 and Movie 1. A shear wave in the color TDI data is detected on the 
septal wall as a rapid up-and-down tissue displacement, visible in the form of a color 
shift (red to blue or blue to red depending on the direction). This pattern initiates at the 
exact visible moment of valve closure which also corresponds to the onset of the heart 
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sounds in the phonocardiography signal, and then propagates over the septal wall away 
from the valve towards the apex.
figure 1. Detailed view (modified to indicate the main elements) of the data obtained in the study subjects 
by using offline processing in Philips Qlab. A: classical parasternal long axis and the focused TDI window 
over the interventricular septum. The M-Mode line is traced mid-wall, pointing towards the shear wave 
source; B: virtual M-mode map of a full heart cycle (reconstructed offline), at 513Hz, demonstrating the 
shear waves after mitral and aortic valve closure. The onset of the waves is marked with dotted lines; C: 
mean tissue velocity curve as a function of time (averaged over the M-mode line, this velocity should not 
be mistaken with the shear wave propagation velocity), synchronous to the ECG (green) and PCG (yellow). 
The onset of both shear waves is synchronous to the onset of the respective heart sounds (S1, S2). By click-
ing on the base and the top of the wave front’s slope in the color M-mode map (small circles), the program 
highlights the corresponding points on the mean velocity time curve. The time interval in which the wave 
occurs is marked with the solid white lines (arrow); D: results panel, showing the time interval.
A curved virtual M-mode line was traced along the center of the LV wall (Figure 1A). Its 
length and direction were pre-defined by the user. No axial range gate was used. The 
shear wave source is expected to be at the valvular annulus, as demonstrated in Movie 2. 
Previous literature also mentions that the waves start at the annulus and progresses to 
the apex (Kanai 2009; Brekke et al 2014). For consistency, the arrow of the M-mode line 
always pointed towards the shear wave source, perpendicular to the wave front. The 
software provides a virtual M-Mode map (Figure 1B), allowing us to manually trace the 
leading slope of the propagating wave, as previously described (Strachinaru et al 2017).
The propagation velocity of the wave front was estimated through
Vs = D/T, (1)
where D is the (user-defined) length of the M-mode line and T is the time the wave trav-
els along the M-mode line. The propagation velocity was averaged over 3 heartbeats for 
every subject. The 3 cycles were freely selected by each observer from the 10 available 
cycles per subject per exam as the heartbeats where the best visualization of the shear 
waves could be obtained.
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The very short isovolumic times are complex to analyze (Goetz et al 2005; Golde and 
Burstin 1970). In order to identify the exact times of valve closure and discriminate shear 
waves from other events, the acquisitions included a synchronous phonocardiography 
signal (PCG), by using a Fukuda Denshi MA-300HDS(V) phonocardiography microphone. 
Also, the timing of valve closure from the underlying 2D data was confirmed by direct 
visual correlation and anatomic M-mode, using a general post-processing platform 
(Tomtec Imaging System 4.6, Unterschleissheim, Germany).
Statistical analysis
Distribution of data was checked by using histograms and Shapiro-Wilk tests. Continu-
ous variables were represented as mean±standard deviation (SD). Categorical data are 
presented as absolute number and percentages. For comparison of normally distributed 
continuous variables we used the dependent or independent means t-test when appro-
priate. In case of a skewed distribution of continuous variables, the Mann-Whitney-U 
test was applied. For comparison of frequencies the Chi-square test or Fisher’s exact 
test was used. Correlations were computed using Pearson’s method. Matching of the 
patients and control groups was done after inclusion, using a propensity score method, 
with 1:1 nearest neighbor matching according to age and gender.
The relationship between individual variables was estimated using univariate linear re-
gression. Parameters found to be significant or considered relevant based on theoretical 
assumptions were entered into a multivariate model. Receiver operating characteristic 
(ROC) analysis was applied in order to evaluate the discriminating power of the method.
Intra-observer variability was evaluated on 11 randomly-chosen subjects, on the initial 
recordings with a new measurement set performed by M.S. two months later, blinded 
to the first result. Inter-observer variability was estimated on the same recordings, be-
tween the result of M.S. and the results obtained by a first-time user, with limited prior 
knowledge of the software application (L.G.), also in a blinded manner. Inter-acquisition 
variability was evaluated on a different randomly-chosen group of 13 study subjects, 
between the initial recordings and a new ultrasound recording set three months later, 
blinded to the first result. In all variability measurements the velocity was averaged over 
3 heartbeats for every subject, the reader being allowed to select the best heart cycle 
from a recording for each measurement. Variability was estimated by using the Bland-
Altman method (Bland and Altman 1986).
Every statistical analysis was performed using the Statistical Package for Social Sciences 
version 21 (IBM SPSS Statistics for Windows, Armonk, New York, USA). Testing was done 
two-sided and considered significant if the p value was smaller than 0.05.
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RESUlTS
Shear wave behaviour in healthy volunteers
Forty-five healthy volunteers, 64% males, mean age 34±13 underwent a high frame rate 
ultrasound study (mean TDI frame rate=516±13Hz, range 500 to 590 Hz). Shear waves 
were visible and quantifiable in the interventricular septum in parasternal long axis 
(PLAX) view (Figure 1, Movie 1) after mitral valve closure in 40 volunteers (89%) and after 
aortic valve closure in 42 (93%). These waves were synchronous to onset of the heart 
sounds on the PCG and could clearly be linked to the valvular events (Movie 2, Movie 3).
In PLAX the mean velocity of the mitral valve shear wave was 4.68±0.66 m/s, range 3.25 to 
6.50 m/s, with a maximal horizontal length of the TDI region of interest of 3 to 3.5 cm. The 
mean aortic shear wave velocity was 3.51±0.38 m/s, range 3.00 to 4.66 m/s. The mitral 
shear wave was consistently faster than the aortic in all individual subjects (p<0.0001).
Male and female volunteers had mitral shear wave velocity values of 4.65±0.62 m/s and 
4.72±0.76 m/s (p=0.73) respectively. The aortic shear wave velocity was 3.43±0.32 m/s 
in males and 3.67±0.45 m/s (p=0.05) in females. There was no correlation between the 
age of the subjects and the aortic shear wave velocity (R2=0.005, p=0.67) or the mitral 
shear wave (R2=0.006, p=0.64). Also, no correlation existed with systolic blood pressure 
(R2=0.002, p=0.93 for the mitral shear wave and R2= 0.008, p=0.59 for the aortic shear 
wave velocity), diastolic blood pressure (R2=0.002, p=0.79 for the mitral shear wave and 
R2=0.02, p=0.41 for the aortic), e’ (R2=0.11, p=0.27 for the aortic shear wave and R2=0.04, 
p=0.51 for the mitral) and E/e’ ratio (R2=0.14, p=0.21 for the aortic and R2=0.01, p=0.9 for 
the mitral).
Hypertrophic cardiomyopathy patients
Forty-three HCM patients were also screened and investigated with high frame rate TDI 
(frame rate of 519±18 Hz, range 500 to 558 Hz). Their mean age was 51±12, 70% males. 
Shear waves were visible and quantifiable in the interventricular septum in parasternal 
long axis (PLAX) view (Figure 2) after mitral valve closure in 24 patients (56%) and after 
aortic valve closure in 38 (88%).
The mitral shear wave had a mean velocity of 6.7±1.3 m/s. No correlation was found be-
tween the mitral shear wave velocity and age (R2=0.04, p=0.53), systolic blood pressure 
(R2=0.04, p=0.57), diastolic blood pressure (R2=0.01, p=0.89) and e’ (R2=0.09, p=0.37). 
The aortic shear wave mean velocity was 5.2±0.8 m/s. No correlation was found for the 
aortic shear wave with age (R2=0.02, p= 0.45), systolic blood pressure (R2=0.03, p=0.32), 
diastolic blood pressure (R2=0.01, p=0.48) and e’ (R2=0.07, p=0.12).
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The E/e’ ratio was significantly correlated with the aortic shear wave velocity (r=0.346, R2 
=0.119, p=0.04) and mitral shear wave velocity (r=0.667, R2=0.444, p=0.04).
figure 2. Shear wave comparison in a normal volunteer and a HCM patient. A: A M-mode line was traced in 
the middle of the IVS, resulting in a color M-mode map. Heart sounds are marked with S1 and S2. The slope 
of the mitral shear wave (synchronous to S1) and of the aortic shear wave (synchronous to S2) are marked 
with dotted lines. B: the same diagram, in the case of a HCM patient. In order to compare the slopes of the 
respective shear waves, the width of the two M-mode maps was adjusted until the respective heart sounds 
were perfectly aligned (as if the two subjects had the same heart rate).
factors influencing the shear wave velocity in the two study groups 
(unmatched)
Given the very good feasibility of the aortic shear wave detection in both groups, the 
clinical and echocardiographic parameters were compared to the aortic shear wave 
velocity by univariate and multivariate regression in each separate group. In normal 
volunteers (Table 1) male gender was the only significant parameter influencing the 
aortic shear wave velocity, both in univariate and multivariate regression.
In HCM patients, male gender and E/e’ ratio were found to significantly influence the 
aortic shear wave velocity in univariate analysis. In the multivariate model, the only 
parameter significantly influencing the aortic shear wave velocity was the E/e’ ratio.
Matching for comparative analysis
Matching the two groups for age and gender resulted in a group of 20 normal volunteers 
and 20 HCM patients. The matched subjects’ baseline characteristics and echocardio-
graphic results are shown in Table 2.
There were significant differences in BMI, diastolic blood pressure, septal thickness, 
e’ and E/e’ ratio between the baseline features of these groups. The velocity of the 
aortic shear wave (Figure 2, Figure 3) was significantly higher in the HCM group (mean 
value=5.13±0.68 m/s, range 3.75 to 6.94 m/s) as compared to the normal (3.61±0.45 
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m/s, range 3.10 to 4.66 m/s, p<0.0001). Mitral shear wave velocity was also significantly 
higher in HCM (6.88±1.12 m/s, range 5.45 to 8.91 m/s) than in the normal group (Figure 
2, Figure 3), (4.65±0.77, range 3.25 to 6.50 m/s, p<0.0001).
Table 1. Parameters influencing the aortic shear wave velocity in normal volunteers and HCM patiens, in 
univariate and multivariate regression analysis
normal Volunteers
n=45
HCM patients
n=43
Univariate Multivariate Univariate Multivariate
B P B P B P B P
Male gender -0.240 0.05 -0.524 0.01 0.538 0.05 0.509 0.06
Age 0.002 0.67 0.008 0.45
BMI -0.026 0.16 -0.023 0.38
Systolic blood pressure 0.003 0.59 -0.007 0.32
Diastolic blood pressure 0.008 0.41 -0.008 0.48
Septal thickness 0.012 0.77 0.110 0.12 0.05 0.08 0.026 0.4
e’ -0.044 0.27 -0.108 0.12
E/e’ 0.075 0.21 0.009 0.87 0.42 0.04 0.039 0.045
Significant p values (<0.05) are highlighted in bold
BMI=:Body mass index; HCM: Hypertrophic cardiomyopathy
figure 3. Velocity values for the aortic shear wave (A) and mitral shear wave (B) in normal volunteers and 
HCM patients. The shear waves are significantly faster in HCM, with no significant overlap of the velocity 
ranges.
ROC analysis for detecting the pathological myocardium (HCM) by the aortic shear wave 
velocity showed an area under the curve of 0.98, with a sensitivity of 95% and specificity 
of 90% for a cut-off value of 4 m/s (Figure 4). The septal thickness used as reference had 
an area under the curve of 0.95. Figure 4 illustrates subjects’ classification according 
to the two thresholds (septal thickness>15mm and aortic shear wave velocity>4 m/s). 
Note that two patients had normal septal thickness and apical hypertrophy, and two 
others were diagnosed through family screening (in which maximum wall thickness 
threshold=13mm for diagnosis of HCM)15.
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Table 2. Comparison between matched normal individuals and HCM patients, ordered into demographics, 
echocardiographic parameters, and study results, respectively.
Parameter Normal volunteers
N=20
HCM patients
N=20
P
Age (yrs) 45±13 48±13 0.47
Male gender (%) 60 70 0.51
Height (m) 176±10 176±9 0.96
Weight (kg) 76±15 84±16 0.09
BMI 24±4 27±4 0.04
Systolic blood pressure (mmHg) 119±15 131±24 0.06
Diastolic blood pressure (mmHg) 71±8 80±11 0.01
Septal thickness (mm) 9±1 17±5 <0.0001
Septal e’ (cm/s) 8.3±1 5.5±2 <0.0001
Septal E/e’ 8±1 17±9 <0.0001
Frame rate parasternal (s-1) 511±27 511±20 0.98
Aortic shear wave velocity parasternal (m/s) 3.61±0.45 5.13±0.68 <0.0001
Mitral shear wave velocity parasternal (m/s) 4.65±0.77 6.88±1.12 <0.0001
Significant p values (<0.05) are highlighted in bold
figure 4. A: Study subjects classified according to the septal thickness (X axis, vertical line at the 15mm 
threshold) and aortic shear wave velocity (Y axis, horizontal line at the threshold value of 4 m/s determined 
by ROC analysis). Note that HCM patients with normal or intermediate septal thickness were correctly clas-
sified by the 4 m/s threshold; B: Receiver operating characteristic (ROC) curves for detecting normal versus 
abnormal myocardium by the septal thickness versus the aortic shear wave velocity.
Variability
For intra-observer variability (No=11 readings of parasternal aortic valve shear wave), 
the first reading displayed a mean velocity of 3.74 ± 0.59 m/s. At the second reading, the 
mean value was 3.72 ± 1.04 m/s (p=0.86). The mean difference was 0.03 ± 0.52 m/s. The 
limits of agreement(LOA) were -0.99 to +1.05 m/s (Figure 5A).
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For the inter-observer variability (Figure 5B), the mean value of the shear wave veloc-
ity obtained by the second observer was 3.51 ± 1.21 m/s (p=0.29). The mean difference 
between observers was -0.23 ± 0.69 m/s (LOA= -1.12 to +1.59 m/s).
figure 5. Variability of the shear wave velocity measurement, illustrated by Bland-Altman plots. The central 
horizontal line represents the mean difference, external lines the limits of agreement. A: intra-observer vari-
ability; B: inter-observer variability; C: test-retest (inter-acquisition) variability.
Test-retest (inter-acquisition) variability was estimated on a group of 13 volunteers (Fig-
ure 5C). The velocity of the parasternal aortic valve shear wave velocity was 3.51±0.42 
on the first recording, and the second imaging recording taken three months later had 
a velocity of 3.52±0.35 (p=0.95). The mean difference was -0.006±0.37 m/s (LOA=-0.74 to 
+0.73 m/s).
DISCUSSIOn
This prospective study shows that 1) assessment of naturally occurring shear wave 
velocities is feasible in both normal volunteers and patients, using a high frame rate TDI 
application available on a clinical echocardiography scanner in regular clinical mode; 
2) The velocity of these shear waves is significantly higher in pathological myocardium 
(HCM patients); 3) the velocity of these waves correlates with the E/e’ ratio in HCM pa-
tients.
In several studies the detection of these fast phenomena in the heart has been described 
(Pernot et al 2011; Hollender et al 2012; Song et al 2013; Urban et al 2013; Vejdani-Jahro-
mi et al 2017; Villemain et al 2017, 2018; Brekke et al 2014; Kanai et al 2000; Kanai 2005, 
2009; Couade et al 2011; Pislaru et al 2017), using experimental systems or modified 
software. We have already demonstrated that by tuning the relationship between the 
depth of the image, the 2D line density, sector width and the TDI field of view sufficient 
time resolution can be achieved, allowing visualization of the shear waves with a con-
ventional clinical scanner (Strachinaru et al 2017).
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The LV isovolumetric periods are very short (30 to 100ms). However, several mechani-
cal, electrical and hemodynamic events take place during this time (Goetz et al 2005; 
Golde and Burstin 1970; Konofagou and Provost 2012; Costet et al 2014). In subjects with 
normal atrio-ventricular and intraventricular conduction the first component of the two 
heart sounds is the valvular component: mitral (for the first heart sound) and aortic 
(for the second heart sound) respectively (Leatham 1954), and thus synchronous with 
the onset of the fast shear waves generated by the closure of the same valves (Remme 
2008). Propagation delay for the PCG tracings is negligible due to the difference in veloc-
ity (1540 m/s for sound waves versus 1 to 10 m/s for shear waves). In order to clearly 
delineate the shear waves from other phenomena, the TDI recordings were timed on 
the PCG. For both aortic and mitral shear waves, the origin and propagation could be 
documented and linked to the valvular events by using synchronized TDI, 2D, M-mode 
and PCG tracings (Movies 2-3).
The shear wave is associated with particle vibration with a main component perpen-
dicular to the direction of propagation. In the parasternal position, this main component 
is parallel to the direction of the ultrasound beam. Therefore, as already demonstrated 
(Strachinaru et al 2017), a TDI system would be most sensitive for shear waves traveling 
through the interventricular septal wall in a parasternal view, rather than in an apical 
view. A slight angulation in the parasternal position between the particle vibration and 
the ultrasound beam will reduce the apparent amplitude of the shear wave. However, 
unlike conventional TDI where the magnitude of the axial TDI velocity is measured, it 
will not affect the apparent lateral propagation velocity of the wave pattern, which is the 
primary outcome of our measurement.
On the other hand, a misalignment between the 2D imaging plane and the source of 
the waves can lead to overestimation in the propagation velocity estimation. A classical 
PLAX lies strictly perpendicular to the mitral annulus and cuts through the middle of the 
aortic annulus, reducing this risk of misalignment. Also, an angulation of the M-mode 
line with respect to the true central line of the septum might induce an intra-scan vari-
ability estimated to 5-10% (Keijzer et al 2018).
The effects of myocardial fiber structure on the wave velocity can be quite significant, 
which may result in anisotropic shear wave propagation as observed with radiation 
force-induced shear wave elastography (Villemain et al 2017, 2018; Urban et al 2016). 
Yet, the relatively low oscillation frequency (order 50 - 100 Hz) of the waves might reduce 
the effect of the fiber structure (Song et al 2016, Urban et al 2016). Furthermore, viscous 
loss will introduce dispersion (Bercoff et al 2004), and the finite wall thickness may lead 
to dispersive Lamb waves (Kanai 2005), although a previous animal study has shown 
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only a mild dispersion of the waves after aortic valve closure (Vos et al 2017). For simplic-
ity, we have chosen the mid-wall position, presumably having the highest consistency in 
placement. Further clinical studies are warranted in order to detect and characterize the 
possible variation in velocity along and across the LV wall.
Moreover, the stiffness itself, hence the shear modulus, varies in time throughout the 
cardiac cycle (Kanai 2005; Couade et al 2011), thus changing the instantaneous shear 
wave speed. Yet, we track the leading edge of the wave which propagates over relatively 
short distances and very short intervals (T < 12 ms), as imposed by the limited opening 
of the TDI field of view. Therefore, this variation could be neglected and the propagation 
assumed to be linear.
The precision of the measurement is restricted by the field of view (represented by 
M-mode length D) and frame rate. Variance in T is caused by rounding off to integer 
frame intervals. The precision can be improved by averaging multiple recordings. Also 
a larger image sector and higher frame rate (order 1000 frames/second) would reduce 
the variance in the measurements (Strachinaru et al 2017). We found a larger variance 
for the mitral (range of 3.25 m/s) than for the aortic shear wave velocity (range of 1.66 
m/s) in healthy volunteers. Several arguments could be evoked: 1) the higher velocity 
of the wave inherently produces higher variability (Strachinaru et al 2017); 2) the lower 
transvalvular gradient over the mitral valve leads to lower wave amplitudes, 3) the very 
complex mechanical and electrical events in early systole (Konofagou and Provost 2012) 
may lead to errors in shear wave quantification during this time instance; and 4) the 
relative position of the shear wave source (mitral annulus) to the anteroseptal wall 
in parasternal position may result in overestimation, as the source of the wave is not 
strictly inside the measurement plane, as mentioned before.
The propagation velocity of the aortic valve closure wave in our healthy subjects is lower 
than that found in a group of 10 human subjects by Brekke et al (2014) (5.41 ± 1.28 m/s), or 
in animal studies (Hollender et al 2012; Vos et al 2016). We speculate that the difference 
is originating from the different detection method and probe positioning: parasternal in 
our study in agreement with Kanai (2005) as opposed to apical in the study by Brekke et 
al. Interestingly, the propagation velocity of the aortic shear waves may be influenced 
by gender as demonstrated in our healthy volunteers group. The difference, although 
statistically significant, seems minor in terms of absolute numbers (3.43±0.32 m/s in 
males and 3.67±0.45 m/s, p=0.05 in females). Full characterization of the behavior of 
naturally occurring shear waves in the heart remains to be investigated in future studies.
220 Part 2
In animal model studies, the propagation of the mitral valve shear wave has been found 
to be lower than the aortic (Vos et al 2017). The opposite finding in the human heart 
cannot be explained by differences in electromechanical activation (Konofagou and 
Provost 2012; Costet et al 2014). It is however noteworthy that the animal studies were 
performed under sedation, which has a notable impact on the loading conditions of the 
left ventricle.
The physiology of the isovolumetric periods remains challenging. The instantaneous LV 
wall stiffness has several components: an active component due to muscle contraction, 
a parietal tension derived from Laplace’s law and an inert elasticity of the fully relaxed 
wall (Pernot et al 2011; Remme et al 2008). The instantaneous value of stiffness is the 
sum of these dynamic and static components. Our detection method is able to record 
naturally occurring shear waves during two moments in the cardiac cycle: one in early 
systole (mitral valve shear wave) and the other in early diastole (aortic valve shear wave). 
Although none of these moments corresponds to a truly diastolic state (full relaxation 
of the LV myocardium), the significant difference found in our study between normal 
and non-compliant myocardium (as demonstrated by the highly significant difference 
in e’), as well as the positive correlation with the E/e’ ratio suggests that the naturally 
occurring shear waves could be clinically relevant in estimating myocardial stiffness. 
However, future studies are needed to elucidate the relation between the shear wave 
propagation velocities measured during the isovolumetric periods and the actual com-
pliance of the left ventricle.
A positive correlation was found in HCM patients between the velocities of the naturally-
occurring shear waves (both mitral and aortic) and the E/e’ ratio. This observation is 
consistent with the hypothesis that naturally-occurring shear wave velocity is correlated 
to the degree of diastolic dysfunction as defined by the E/e’ ratio.
Clinical application and future directions
Pediatric and adult HCM patients have already been tested by using shear wave imaging 
(Villemain et al 2017, 2018). These investigations were performed with ultrafast special 
equipment and externally induced shear waves, and demonstrated a significantly higher 
shear wave velocity (difference of 1.5 m/s) in HCM patients with proven decreased LV 
compliance and higher degree of fibrosis. In our study there was also a very significant 
and similar difference (1.5 m/s for aortic shear wave and 2.1 m/s for the mitral) between 
shear wave velocities in normal and pathological myocardium, with minimal overlap 
and an excellent discriminating power. Subjects with normal septal thickness but apical 
hypertrophy were also correctly classified by using a 4 m/s threshold (Figure 4), as well as 
subjects with septal thickness ranging from 13 to 15 mm diagnosed through screening. 
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This suggests that the method could be used to discriminate pathological myocardium 
regardless of the septal thickness. However, the ROC analysis was performed on limited 
numbers and only on one extreme pathology. Therefore we refrain from computing and 
reporting general limits for the normal myocardium. Also, we noticed a lower feasibility 
for the mitral shear wave in HCM patients than in healthy volunteers, and therefore the 
same analysis for mitral shear wave velocity was considered less meaningful.
A diagnostic index that uses both waves would theoretically be interesting, but requires 
a systematic detection of both shear waves in the same heart cycle. This was not always 
possible in our subjects, for three reasons: first that shear waves velocities were calcu-
lated by choosing the heart cycles where the visualization of the respective wave was 
optimal, but not necessarily the cycle where both shear waves were visualized; second 
that in some subjects only one of the shear waves was quantifiable; and third, in color 
TDI the velocity scale for optimally detecting the mitral shear wave was generally differ-
ent (lower) than the one needed to detect the aortic shear wave. Also, because of the 
abnormal distribution of variables in the total group (two extremes: normal individuals 
with low shear wave velocities and HCM patients with much higher shear wave veloci-
ties), a linear correlation analysis between the two shear waves could not be performed. 
Such a correlation should be investigated over a continuum of normality and pathology.
This technique provides a possible quantitative assessment of myocardial stiffness dur-
ing the isovolumic periods. The potential clinical benefit is major: from early detection 
of diastolic abnormalities and improved characterization of heart failure with preserved 
ejection fraction to a possible new endpoint in future studies of pharmacological in-
novations (Cikes et al 2014; Voigt 2018). Further studies with a longitudinal design are 
needed in order to demonstrate the prognostic implications.
Study limitations
This is a monocentric study on a small population, so the results cannot be directly ex-
trapolated to the general population. Another important limitation is the lack of ground 
truth. Invasive stiffness measurement in volunteers remains difficult (because of practi-
cal and ethical reasons), and no validated non-invasive imaging modality is available 
for the study of cardiac stiffness in vivo (Lancelotti et al 2017). Prior clinical studies have 
however linked the significant difference in shear wave velocities between HCM patients 
and normal volunteers to a difference in LV compliance and stiffness (Villemain et al 
2017, 2018). Other confounding factors could also influence this correlation (blood pres-
sure, filling conditions). Before a direct quantification of stiffness can be done, these 
confounding factors need to be investigated. The added value of the naturally-occurring 
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shear waves’ velocity as an independent diagnostic parameter remains to be shown in a 
larger population and a wider array of pathology.
A wave with a velocity of 5 m/s travels over 3.5 cm in 7 ms. At 500 Hz the time resolu-
tion is 2 ms, so such a fast wave would be captured in 3 to 5 separate frames. This time 
resolution can be insufficient when trying to quantify velocities over 5 m/s over very 
short distances. However, the inter- and intra-observer agreement were good, with dif-
ferences of the same magnitude as the inter-measures variability, as reflected by the 
standard deviation. This variability is also significantly lower than the difference found 
between normal and pathological LV. We foresee that the advancement in technology, 
with even higher frame rates becoming available, and/or changes in data processing will 
allow a reduction in measurement error.
Manual tracking as allowed by the manufacturer-designed software is time consuming 
and prone to errors, demonstrated by the larger inter-observer variability. Therefore, 
new research should focus on a robust method of automated velocity tracking from the 
DICOM frames.
The lack of correlation with age, blood pressure and E/e’ in normal volunteers should be 
interpreted with caution. The absence of age extremes (under 18 and over 65), and the 
overall normal blood pressure lead to a tight distribution of data around a normal value, 
limiting the yield of such analyses.
COnClUSIOn
Naturally occurring shear waves in the in vivo human heart can be imaged using a stan-
dard clinical TDI application. The study demonstrates that quantification of these shear 
waves is feasible and can be used to assess differences between normal and pathologi-
cal myocardium, opening the way to a new method of estimating myocardial stiffness.
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ABSTRACT
In cardiac high-frame-rate color tissue Doppler imaging (TDI), a wave-like pattern travels 
over the interventricular septum (IVS) after atrial contraction. The propagation velocity 
of this myocardial stretch postatrial contraction (MSPa) was proposed as a measure of 
left ventricular stiffness. The aim of our study was to investigate the MSPa in patients 
with hypertrophic cardiomyopathy (HCM) compared with healthy volunteers. Forty-
two healthy volunteers and 33 HCM patients underwent high-frame-rate (>500 Hz) TDI 
apical echocardiography. MSPa was visible in TDI, M-mode and speckle tracking. When 
assuming a wave propagating with constant velocity, MSPa in healthy volunteers (1.6 ± 
0.3 m/s) did not differ from that in HCM patients (1.8 ± 0.8 m/s, p = 0.14). Yet, in 42% of 
patients with HCM, the MSPa had a non-constant velocity over the wall: in the basal IVS, 
the velocity was lower (1.4 ± 0.5 m/s), and in the mid-IVS, much higher (6.1 ± 3.4 m/s, p < 
0.0001), and this effect was related to the septal thickness. The reason is hypothesized to 
be the reaching of maximal longitudinal myocardial distension in HCM patients.
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InTRODUCTIOn
The possibility to image the heart at very high frame rates has opened a new window for 
our understanding of the cardiac physiology and pathology (Cikes et al 2014, Voigt et al 
2018). High frame rate imaging allows minute tracking of many wave-like phenomena 
that are either naturally present during the cardiac cycle due to valve closure (Brekke 
et al 2014, Kanai 2009, Strachinaru et al 2017, Vos et al 2017), atrial contraction (Voigt 
et al 2002, Pislaru et al 2014, Pislaru et al 2017), or induced by external sources (Per-
not et al 2011, Song et al 2016, Vejdani-Jahromi et al 2017, Villemain et al 2017). The 
naturally-occurring shear waves secondary to the closure of the valves (Brekke et al 
2014, Strachinaru et al 2017) appear during the time intervals in which the muscle is 
in the process of contraction (mitral valve closure) or relaxation (aortic valve closure), 
challenging the physiological interpretation of the data. Such complexity is absent in 
late diastole, where the left ventricle (LV) is supposed to be in a quasi-relaxed state, al-
lowing estimation of the true intrinsic elasticity of the wall (Voigt et al 2002, Pislaru et 
al 2014, Pislaru et al 2017). A strain rate wave-like pattern visible in the LV myocardium 
after atrial contraction was reported by Voigt et al (2002) who estimated its propagation 
velocity between 2 and 4.6 m/s in the interventricular septum (IVS) of normal individuals 
at a frame rate of 178 Hz. They demonstrated the value to be preload-dependent. Later, 
Pislaru et al investigated the same Tissue Doppler Imaging (TDI) velocity and strain rate 
pattern with higher frame rates (350-460 Hz) and computed the values at 1.4±0.2 m/s 
in normal individuals and 2.2±0.7 m/s in severe aortic stenosis patients (Pislaru et al 
2014, Pislaru et al 2017). Yet, the exact nature and behavior of this tissue velocity-based 
pattern remain unclear. These earlier studies hypothesized that the fast traction on the 
mitral annulus by the atrial contraction generates a wave into the left ventricle, which 
travels from base to apex with a constant velocity which is related to the underlying tis-
sue stiffness. It is also possible that this wave has a radial component (Pislaru et al 2017).
The aim of this study was to investigate the nature of the wave-like pattern following 
atrial contraction by integrating multiple high frame rate ultrasound modalities. In order 
to further test the above hypothesis we studied both normal and hypertrophic hearts, 
the latter being supposedly stiffer than normal hearts (Elliott et al 2014, Mirsky and 
Parmley 1973, Villemain et al 2017, 2018).
METHODS
In apical TDI videos of the interventricular septal wall, wave patterns after atrial contrac-
tion are visible, as further described in the next subsection. The pattern has a propaga-
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tion velocity on the order of several meters per second (Pislaru et al. 2014, 2017; Voigt et 
al. 2002), and general theory predicts that waves travel faster in stiffer material (Giorgi 
1993). We denote this pattern as myocardial stretch propagation post-atrial contraction 
(MSPa), in line with a similar definition by Pislaru et al. We started this study with the 
hypothesis of a wave propagating with constant velocity over the first 4 to 5 cm of the 
interventricular septum, as previously described in normal and pathologic hearts after 
atrial contraction (Pislaru et al. 2014, 2017; Voigt et al. 2002).
Study population
This prospective study was conducted in 2016-2017 according to the principles of the 
Declaration of Helsinki and approved by the Institutional Medical Ethical Committee 
(MEC-2014-611, MEC-2017-209). Written informed consent was obtained from every par-
ticipant. The same patient pool was used for selecting the study population in a differ-
ent work investigating naturally occurring shear waves after valve closure (Strachinaru 
et al. 2019).
Healthy volunteers aged 1862 y (N = 42). Patients were excluded if they had a history of 
cardiovascular disease or systemic disease, a finding of cardiac abnormalities during 
the examination (including QRS duration >100 ms), cardiovascular risk factors including 
hypertension (cutoff value: 140/90 mm Hg), diabetes mellitus or hypercholesterolemia, 
breast implants or were pregnant. Professional athletes or morbidly obese individuals 
(body mass index >40 kg/m2) were also excluded.
Hypertrophic cardiomyopathy (HCM) patients aged 20 to 73 y, recruited from the HCM 
outpatient clinic (N = 33). Patients were included if they had a definitive diagnosis of 
hypertrophic cardiomyopathy (Elliott et al. 2014), with pathologic septal hypertrophy 
(end-diastolic thickness >15 mm or >13 mm if diagnosed through family screening) and 
normal systolic function (ejection fraction >55%). Exclusion criteria were associated 
coronary artery disease, more than mild valve disease (systolic anterior movement was 
not considered an exclusion criterion), prior septal reduction (either surgical or inter-
ventional) and atrial fibrillation.
Echocardiography
All echocardiographic studies were performed by one experienced sonographer (M.S.). 
Normal complete echocardiographic studies were performed, including 2-D, Doppler 
and pulsed-wave TDI of the mitral annulus. The peak velocity of the early diastolic mi-
tral inflow was measured (E wave), as was the peak early diastolic tissue velocity of the 
medial mitral annulus in the apical four-chamber view (e’ wave). Their ratio (E/e’) was 
then calculated as an index of the early diastolic properties of the LV. We also quantified 
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the motion of the atrioventricular annulus with atrial contraction by measuring peak TDI 
velocity (a’ wave) and a’ acceleration in pulsed wave tissue Doppler images of the me-
dial mitral annulus in the apical four-chamber view. As a’ acceleration is not a standard 
clinical measurement, we detailed it in Figure 1.
figure 1. Clinical pulse-wave tissue Doppler imaging recordings of the medial mitral annulus in the apical 
four-chamber view, with demonstration of the a’ velocity and acceleration slope calculation. (a) Normal 
healthy volunteer. (b) Patient with hypertrophic cardiomyopathy. Note that the velocity scales for the two 
recordings differ.
Normal complete echocardiographic studies were performed as a reference. Grayscale 
loops were also acquired at the highest frame rate achievable (frame rates of 200-250 
Hz) from the IVS in the parasternal and apical four-chamber views.
Tissue velocities of the LV myocardium were sampled in color TDI in standard paraster-
nal and apical four- chamber views using a Philips iE33 system (Philips Medical, Best, 
The Netherlands) equipped with an S5-1 transducer (three separate recordings for each 
view, two heartbeats per clip). As previously described (Strachinaru et al. 2017), by care-
fully tuning the relationship between the depth of the image, the 2-D line density and 
the TDI field of view, frame rates >500 Hz were achieved in regular clinical TDI mode. 
The color tissue velocity scale was set up for optimal visualization of the stretch, leading 
to scale limits between 1.5 and 3.5 cm/s, corresponding to the amplitude of the wave 
pattern in TDI, which is not to be confused with its propagation velocity, which is orders 
of magnitude higher.
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Figure 2 illustrates the alignment of the probe with respect to the propagation of the 
wave on the septal wall in the apical four-chamber view. TDI is extremely sensitive to 
tissue motion in the axial direction of the probe, indicated by the yellow arrows, but not 
sensitive to lateral motion. We use this directional sensitivity to determine the dominant 
tissue motion by TDI. Additionally, we analyze grayscale clips with a speckle tracking 
algorithm. Speckle tracking detects motion in all directions, albeit with generally lower 
frame rate, sensitivity and accuracy than TDI.
By combining the information from all modalities, we illustrate the predominant tissue 
motion after atrial contraction.
The Digital Imaging and Communications in Medicine TDI loops were processed using 
Qlab 9 (Philips Medical, Best, The Netherlands). As illustrated in Figure 3a and b, the 
software is used to trace an anatomic M-mode line in the TDI clips. The M-mode line was 
traced midwall, starting apically and ending at the beginning of the muscular septum, 
pointing toward the possible wave source (the atrioventricular annulus). The software 
generates a map of color-coded TDI velocities over time and space, that is, along the M-
mode line (Fig. 3c). After atrial contraction, a pattern can be seen, of which the slope of 
the initial front determines the velocity of the MSPa. The slope is computed by manually 
fitting a line (Fig. 3c, white dotted line) to the isovelocity front of the wave. To reduce 
the variability resulting from manual tracking, as previously described for naturally 
occurring shear waves (Strachinaru et al. 2017, 2019), we compared this slope with the 
line between the entrance and exit points (frames) of the wave into the M-mode map 
(Fig. 3c, black dotted line). The entrance and exit points were also adjusted by frame-
to-frame analysis. The velocity V of the MSPa is calculated, from the time T, which is the 
interval between the time stamps of the entrance and exit frames in the map, and the 
pre-defined M-mode length L, as V = L/T in units of meters per second.
The length L ranged from 4 to 6 cm (4.9 ± 0.4 cm), starting from the onset of the muscular 
IVS (Fig. 3b). Propagation velocity was averaged over at least 3 heartbeats for every 
subject, randomly chosen from the three recorded clips.
Speckle tracking of the high-frame-rate 2-D data, represented as velocity vector imag-
ing, was used in Qlab 9 to qualitatively determine the direction and propagation of local 
motion/deformation of the IVS after the atrial contraction. Anatomic M-mode tracings 
were also obtained from the same grayscale data along the IVS using a general post-
processing platform (Tomtec Imaging System 4.6, Unterschleissheim, Germany). They 
were also employed for qualitative comparison with the data from the TDI recordings.
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figure 2. Tissue motion as visible in the left  ventricular walls aft er the atrial contraction, in the apical four-
chamber view. Atrial contraction pulls on the mitral annulus (red arrows); this induces a local stretch (small 
yellow arrows) which propagates along the walls (white arrows) in the form of a tissue Doppler imaging 
pattern (red line). Note that the direction of the ultrasound in the apical view (blue lines) is in line with both 
the stretch and the direction of propagation.
figure 3. Data obtained in the study patients using off line processing (modified to include one entire 
heartbeat). (a) Classical echocardiographic apical image and the focus region for high-frame-rate imaging. 
(b) High-frame-rate tissue Doppler imaging window over the interventricular septum. The M-mode line is 
traced midwall, ending at the beginning of the muscular septum, pointing toward the possible wave source. 
(c) Tissue Doppler imaging spacetime map at 541 Hz, collected over the M-mode line of (b), of a full heart 
cycle (reconstructed off line). This map illustrates the wave-like velocity pattern aft er atrial contraction (P 
wave on the echocardiogram). The slope of the MSPa is traced along the isovelocity front (white dotted line) 
and compared with the line between the entrance and exit points (yellow circles, black dotted line) of the 
MSPa along the M-mode line. ECG = echocardiogram; MSPa = myocardial stretch post-atrial contraction.
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Statistical analysis
Distribution of data was checked by using histograms and ShapiroWilk tests. Continu-
ous variables were represented as the mean ± standard deviation. Categorical data are 
presented as absolute number and percentage. For comparison of normally distributed 
continuous variables, we used the dependent or independent means t-test when ap-
propriate. In case of a skewed distribution of continuous variables, the MannWhitney 
U-test was applied. For comparison of frequencies, the x2-test or Fisher’s exact test was 
used. Correlations were estimated using Pearson’s correlation coefficient. The relation-
ship between variables was investigated using univariate and multivariate regression 
models.
Each statistical analysis was performed using the Statistical Package for Social Sciences, 
Version 21 (IBM SPSS Statistics for Windows, Armonk, NY, USA). Testing was done two-
sided and considered significant if the p value was <0.05.
RESUlTS
High-frame-rate tissue Doppler
The group characteristics and results are outlined in Table 1. There were significant dif-
ferences in age, systolic blood pressure, septal thickness, e’, a’, a’ acceleration and E/e’.
In the apical view, wave-like tissue velocity patterns were visible in all patients upon 
atrial contraction. In the parasternal longitudinal view of the LV, the grayscale traction 
movement of the IVS with atrial contraction was visible in all patients (Supplementary 
Video S1, online only), but high-frame-rate TDI could not visualize a wave phenomenon. 
This indicates that the dominant direction of tissue motion was along the septum, in line 
with the traction of the atria on the LV wall through the atrioventricular annulus.
In normal individuals and some HCM patients (Fig. 4a) the straight line corresponding to 
the entryexit points of the MSPa into the M-mode line was superimposed on the first iso-
velocity trace (as described under Methods), revealing a globally constant propagation 
velocity. The same constant velocity is visible on the high-frame-rate virtual M-mode of 
the underlying 2D data (Fig. 4b). Yet, we noticed in a substantial group of HCM patients 
(n = 14) that the MSPa isovelocity front had a non-constant propagation as evidenced by 
a deviation of more than two frames’ time (34 ms) at any point along the first isovelocity 
tracing from the straight entry-exit line used for reference (Fig. 5): a first mild slope in the 
basal IVS, followed by a very steep slope in the mid-IVS (Fig. 5a). By use of M-mode trac-
ings from the underlying 2-D data, the same behavior was confirmed (Figs. 5b and 7). 
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In the case of such non-constant propagation velocity, quantification was done in two 
ways. The average slope was quantified by computing the slope of the entryexit points 
line as described under Methods (see Fig. 5a for an example), thus ignoring the devia-
tion of the slope from a straight line. Alternatively, we manually traced the slowest and 
fastest first isovelocity slopes visible in the TDI panels (Fig. 5a, 1 and 2), and separately 
reported the slowest and highest apparent propagation velocities.
When analyzing the measured slope under the assumption of a linear propagation ve-
locity (Fig. 6), the average velocity of the MSPa did not differ between normal volunteers 
(1.6 ± 0.3 m/s, range = 1.1-2.1 m/s) and the HCM patients (1.8 ± 0.8, range = 0.9-3.8 m/s, p 
= 0.14). However, the maximum slope in the HCM patients presenting the non-constant 
TDI slope was 6.1 ± 3.4 m/s (range 2.3-12.5 m/s), which was significantly different from 
that of the normal volunteers (p <0.0001). The slow slope in these patients was 1.4 ± 0.5 
m/s (range = 0.8-2.5 m/s, p = 0.2) versus normal volunteers.
Subgroup analysis (Table 1, Fig. 6) among the patients with or without constant propa-
gation velocity of the MSPa revealed a significant difference in septal thickness between 
the two groups (19 ± 4 mm in the non-constant propagation group and 16 ± 3 mm in the 
linear group, p = 0.02). Also, the linearized MSPa velocity in the non-constant velocity 
group was significantly higher than that in normal volunteers (2.6 ± 0.8 m/s vs. 1.6 ± 0.3 
m/s, p < 0.0001).
The only parameter predicting the presence of a non-constant propagation veloc-
ity (Table 2) in a univariate and multivariate logistic regression analysis was the septal 
thickness (p = 0.03 univariate and p = 0.001 multivariate).
In the total group of 33 HCM patients, the linearized MSPa velocity did not correlate with 
age (p = 0.24), systolic or diastolic blood pressure (p = 0.75 and 0.96, respectively), septal 
thickness (p = 0.11), e’ (p = 0.39) or E/e’ (p = 0.47).
The a’ velocity and acceleration were significantly higher in the normal volunteers, sug-
gesting either a stronger atrial traction on the mitral annulus or a stiffer IVS.
2-D tissue tracking and M-mode
The grayscale clips were analyzed with speckle tracking and anatomic M-mode, and for 
normal volunteers, local velocity vectors revealed a traction movement on the mitral 
annulus, followed by a local downward-only stretch, progressing from base to apex, 
later followed by a global outward movement of the whole IVS (atrial “volume kick”). As 
exemplified in Supplementary Video S2 (online only) and Figure 7a, in HCM patients with 
256 Part 2
a constant velocity of the initial front, the same progressive base-to-apex downward 
stretch could be seen. In patients having a non-constant velocity, we noticed aft er the 
mitral annulus traction an initial basal-only slow downward stretch, followed by a global 
rigid downward motion of the entire IVS and later a short outward movement (Supple-
mentary Videos S3 and S4). This is consistent with the behavior of the MSPa in TDI and 
M-mode panels (Fig. 7b).
figure 4. Zoomed-in view of the end-diastolic phase aft er atrial contraction (P wave). (a) Tissue Doppler 
imaging velocity pattern starting from the basal interventricular septum. In normal volunteers and some 
hypertrophic cardiomyopathy patients, the isovelocity front line (white dotted line) was superimposed on 
the black dotted line traced between the entry and exit points of the myocardial stretch post-atrial contrac-
tion (yellow circles) into the M-mode map, revealing a constant slope. (b) Synchronous anatomic M-mode 
of the underlying 2-D information along the same M-mode line. A progressive base-to-apex downward line 
shift  is visible, following the same contour.
DISCUSSIOn
The main findings of this prospective study are as follows: (i) No significant diff erence 
could be found in the linearized propagation velocity of the wave-like pattern occurring 
in TDI post-atrial contraction between normal volunteers and HCM patients. (ii) Clinical 
and classic echocardiographic parameters did not correlate with the linearized propaga-
tion velocity of this pattern. (iii) In about half of the HCM patients, the wave front seemed 
to propagate with non-constant velocity, and this eff ect was related to disease severity 
as reflected by the end-diastolic septal thickness.
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Previous studies have described the wave-like phenomena appearing in color TDI after 
atrial contraction (Pislaru et al. 2014, 2017; Voigt et al. 2002). By using a multimodality 
(speckle tracking, M-mode, TDI) approach, we found that the dominant direction of local 
tissue motion within the wave pattern was longitudinal to the wave propagation direc-
tion, as illustrated by the absence of the wave pattern in a parasternal TDI recording. 
When this study was compared with Voigt et al. (2002), there was a significant difference 
in the reported propagation velocity range, which could be due to errors in manually 
measuring very fast phenomena with relatively low time resolution in that study. In 
our study, the velocity range in normal individuals was similar to those found in earlier 
studies that used similarly high frame rates (Pislaru et al. 2014, 2017), but we could not 
find a statistically significant difference in linearized velocities between normal and 
pathologic myocardium, despite the numerous differences (age, body mass index and 
echocardiographic parameters) between the two study groups. This was an unexpected 
finding as HCM ventricles were considered a pathologic model of increased muscle stiff-
ness and diastolic dysfunction (Elliott et al. 2014; Mirsky and Parmley 1973; Villemain et 
al. 2018a, b). Also, the linearized propagation velocity of this wave-like pattern was not 
correlated with differences in blood pressure, septal thickness or echographic signs of 
diastolic dysfunction.
figure 5. In more than 40% of the patients with hypertrophic cardiomyopathy, a non-constant shape of the 
initial front could be seen. (a) Tissue Doppler imaging velocity pattern. The straight line between the entry 
and exit points of the MSPa into the M-mode map (black dotted line) emphasizes the deviation of the first 
isovelocity front (white lines) from a constant propagation velocity. The first milder slope is marked ‘1’ and 
the second steeper slope is marked ‘2’. (b) Anatomic Mmode of the underlying 2-D information along the 
same M-mode line, revealing the same variation in propagation velocity.
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These findings differ from the results of previous studies (Pislaru et al. 2014, 2017). This 
triggered the in-depth analysis of TDI and 2-D data in search of an explanation.
We noticed the non-constant propagation of the front of the IVS deformation pattern 
post-atrial contraction, present in 42% of the HCM group, and this finding was statisti-
cally related to the septal thickness. Its appearance in the TDI map consists of a first mild 
slope (1.4 ± 0.5 m/s) in the basal part of the IVS followed by a very steep or almost vertical 
slope (Figs. 5 and 7) toward the apex, with an average velocity of 6.1 ± 3.4 m/s, which is 
much higher than the velocities measured in the group of healthy volunteers. Strikingly, 
the linearized MSPa velocity did not significantly differ between the two groups. On the 
other hand, it was significantly different when comparing only the non-constant velocity 
subgroup and normal volunteers (2.6 ± 0.8 m/s vs. 1.6 ± 0.3 m/s, p < 0.0001). This would 
suggest that only those patients with non-constant velocity propagation of the MSPa 
had higher myocardial stiffness than normal individuals. However, the two HCM groups 
were statistically similar, except for the septal thickness (19 ± 4 vs. 16 ± 3 mm, p = 0.02).
With respect to this very steep slope, although HCM is associated with higher myocardial 
stiffness, such high propagation velocities have not been measured with an alternative 
stiffness measurement that uses induced shear waves by (Villemain et al. 2018a,b). They 
measured an average velocity of 3.5 m/s in the diastolic phase for HCM patients, which 
is a factor of 2 less than our average values in the steep slope. One explanation might 
be related to the physics of such traveling waves. The pulling action of the atria on the 
ventricle induces a wave in which the particle motion is mainly in the direction of its 
propagation (i.e., along the wall), as also observed by the absence of a TDI wave pat-
tern in the parasternal view. Such waves might behave as symmetric Lamb waves, as 
opposed to asymmetric Lamb waves or bulk shear waves which are generated with the 
technique applied by (Villemain et al. 2018a,b). The symmetric zero-order Lamb waves 
have a higher propagation velocity than bulk shear waves, up to a factor between 1.7 
and 2 for a frequency range of nearly 040 Hz, as estimated by a wall thickness of 1 cm 
and propagation speed of 2 m/s (Brum 2019). Hence, the MSPa, purely because of its 
dominant longitudinal tissue motion direction, would expectedly lead to propagation 
velocities higher than those found by Villemain et al., but it is very unlikely that they 
would reach well over 10 m/s.
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figure 6. Linearized propagation velocity of the MSPa in the study population of normal volunteers and 
HCM patients. (a) Comparison between normal volunteers and the whole HCM group. Although the velocity 
range is larger in HCM, the diff erence remains statistically non-significant. (b) By splitting the HCM accord-
ing to the constant or non-constant velocity of the MSPa, we obtain two subgroups. The subgroup with 
constant-velocity MSPa has a slightly lower linearized MSPa than normal volunteers (1.4 ± 0.4 m/s, p = 0.03), 
whereas the non-constant velocity group has a significantly higher linearized propagation velocity (2.6 ± 0.8 
m/s, p < 0.0001). HCM = hypertrophic cardiomyopathy; MSPa = myocardial stretch post-atrial contraction.
Table 2. Logistic regression analysis of the parameters predicting an non-constant propagation of the MSPa 
in HCM patients (N=33).
Parameter Univariate analysis Multivariate analysis
95% CI p 95% CI P
Age 0.93-1.03 0.41 0.88-1.03 0.22
Gender 0.05-1.66 0.16 0.20-11.39 0.68
BMI 0.94-1.24 0.31
Systolic blood pressure 0.98-1.08 0.21 1.01-1.20 0.02
Septal thickness 1.03-1.61 0.03 1.19-2.01 0.001
e’ 0.73-1.48 0.84
E/e’ 0.91-1.11 0.97
BMI: body mass index; CI: confidence intervals
Significant p values are highlighted in bold.
(Villemain et al. 2018a,b) mentioned that the stiff ness was measured in diastole, but it is 
unclear whether the measurement was timed before, during or aft er the atrial contrac-
tion. This timing may be critical, as experimental studies of the ex vivo myocardium 
have found an exponential relation between stress and strain (Holzapfel and Ogden 
2009; Mirsky and Parmley 1973; Villari et al. 1993; Weber 1989). Atrial contraction in 
end-diastole leads to a rapid increase in LV strain, which might thus result in a rapid 
increase in momentary stiff ness in the case of HCM, especially when the myocardium is 
close to its maximum distensibility. On slow-motion 2-D videos (Supplementary Videos 
S1S4 at 220250 Hz), the progression of the local tissue stretch aft er atrial contraction 
can be directly seen, as can its relation to the global displacement of the left  ventricular 
wall. In normal volunteers (Fig. 3), the LV wall never reaches the maximal possible tissue 
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distension permitted by the stiffer collagen network (Elliott et al. 2014; Weber 1989), 
allowing a progressive linear tissue stretch from base to apex. In the HCM patients in 
whom the slope was linear, some tissue distensibility may be preserved, and the LV 
stretch behaves similarly to that of normal individuals (Figs. 4 and 7a; Supplementary 
Video S2). In the more severe HCM patients, as the IVS becomes thicker and more rigid, 
the atrial contraction could induce a limited slow basal stretch, followed by a very steep 
movement of the entire LV wall as the hypertrophic ventricle reaches maximal longitu-
dinal distension allowed by the collagen network (Figs. 5 and 7b; Supplementary Videos 
S3 and S4). In other words, the non-constant propagation would be caused by the shift 
from the myocardial stiffness to the stiffness of the limiting and more rigid collagen net-
work surrounding the myocardial fibers. Depending on the degree of tissue distension 
existing before the atrial contraction, this shift may occur sooner or later, explaining the 
pattern in Figures 5 and 6, as well as the rigid wall motion seen in Supplementary Videos 
S3 and S4. Loading conditions will affect the strain of the myocardium and thus could 
drastically alter the propagation velocity of the MSPa (Voigt et al. 2002).
With respect to the initial mild slope, we discuss two possible explanations. First, the 
local stiffness of the basal septum could be lower than that of other parts of the septum, 
and similar to healthy tissue. Yet, this is less likely in HCM, where muscle stiffening is 
expected to be diffuse. Second, if the tissue is indeed reaching a maximum distension 
during the atrial kick, then it would still be in an elastic state at the onset of the atrial 
kick, with its associated baseline stiffness values. Table 1 outlines a non-significant dif-
ference in the linearized propagation velocity of MSPa in the entire HCM group compared 
with healthy volunteers.
On the other hand, if the HCM group is split on the presence of the nonconstant propaga-
tion velocity, the difference between the two HCM subgroups is significant (2.6 ± 0.8 m/s 
vs. 1.4 ± 0.4 m/s, p < 0.0001), as is that between the nonconstant propagation and the 
healthy volunteer group (2.6 ± 0.8 m/s vs. 1. 6 ± 0.3 m/s, p < 0.0001) . We also noted that 
HCM patients had a significantly lower a0 velocity in pulsed TDI, as well as a lower a0 
acceleration slope. This finding could be interpreted as a lower and slower traction on 
the basal septum, potentially resulting in a slower basal stretch through viscous effects. 
This slower basal stretch remains directly visible in grayscale motion (Supplementary 
Video S4).
As for the possible transversal component, we expected this to be visible in the para-
sternal window in TDI (particle vibration in line with the Doppler), as already found for 
naturally occurring shear waves (Strachinaru et al. 2017). But in our patients, no wavelike 
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pattern could be seen in parasternal TDI aft er atrial contraction. From this observation 
we conclude that the dominant motion is a longitudinal stretch along the septal wall.
In 2-D imaging, the longitudinal stretch (MSPa) is shortly followed by an outward dis-
placement of the whole LV wall, explained by the pressure rise in the ventricle aft er atrial 
contraction, which is called the volume stretch (atrial “volume kick”) and visualized by 
velocity vector imaging (Supplementary Videos S2 and S3).As it occurs later in time, that 
phenomenon is separate from the MSPa, which we consider in this study, and therefore 
out of the scope of the present study.
figure 7. Magnified zoomed-in view of anatomic M-mode tracings along the interventricular septum, at 
250 Hz, over 5 cm, just aft er the start of the echocardiogram P wave and before the onset of the next QRS 
complex. The annulus is marked with a red arrow. (a) HCM patient with a linear MSPa velocity slope. The 
downward tissue shift  as seen propagating along the M-mode line also follows a straight line (dotted line). 
(b) HCM patient exhibiting non-constant velocity of the MSPa. The first tissue downward motion has an ini-
tial milder slope, followed by a very steep one along the M-mode line. HCM = hypertrophic cardiomyopathy; 
MSPa = myocardial stretch post-atrial contraction.
limitations
High-frame-rate imaging represents a compromise between spatial and temporal 
resolution. The error in velocity estimation for very fast phenomena is larger with higher 
propagation velocity, lower frame rate and shorter traveling distance. A wave traveling 
Chapter 12 263
Myocardial stretch post atrial contraction in healthy volunteers and hypertrophic cardiomyopathy patients
at 2 m/s needs 25 ms to travel over a 5-cm length. At 5 m/s this time is reduced to 10 ms, 
and at 10 m/s, to 5 ms. At a frame rate of 540 Hz, the time resolution is a little less than 2 
ms, which is suff icient to detect the general behavior of the MSPa in normal individuals, 
but the error may be significant for velocities >10 m/s (see error analysis in Strachinaru 
et al. 2017, Appendix 1). Higher frame rates and averaging over multiple measurements 
would increase the accuracy of the propagation velocity measurements, which may be 
needed for actual clinical application.
The significance of our findings is limited by the number of patients. However, the non-
constant propagation velocity was present in about half the patients even in this small 
group of HCM patients. Age matching was initially proposed for checking group vari-
ances, but was no longer considered, given the absence of statistically significant dif-
ference for the linearized MSPa between the study groups, despite their heterogeneity.
Tissue Doppler imaging velocities are known to be subject to angle dependency and 
cannot diff erentiate local deformation from global displacement (Dandel et al. 2009). 
Angle dependency was a minor issue in the TDI signal of the IVS in apical view because 
the motion was parallel to the ultrasound beam (Fig. 2). The absence of diff erentiation 
between local and global displacement was overcome by also studying tissue motion 
over the anatomic M-mode and by 2-D image analysis. Those measurements confirmed 
the findings from the TDI analysis.
As in previous studies, tracking of the MSPa was performed manually, which may increase 
the variability in velocity estimation, but to reduce this variability we traced a straight 
reference line between the entry and exit points of the MSPa into the M-mode map in all 
patients and adjusted it by frame-to-frame analysis as described under Methods. This 
line acted also as reference for the possible deviation of the MSPa from linearity.
Clinical implications and future directions
Analyzing the MSPa provides deeper insight into the diastolic function of the LV, as our 
findings suggest that the LV wall of HCM patients in diastole rapidly reaches a point 
where further longitudinal straining is constricted by the stiff er collagen network.
Because the MSPa does not exhibit the typical properties of an oscillatory shear wave, 
direct calculation of elasticity stiff ness from its propagation velocity should be done 
with caution. Most likely, the propagation of the isovelocity front depends on the 
stressstrain relationship of the tissue, the actual strain during the atrial contraction, ad-
ditional stresses caused by the LV loading conditions, and wall thickness, structure and 
geometry (Holzapfel and Ogden 2009; Villari et al. 1993; Voigt et al. 2002; Weber 1989). 
264 Part 2
Therefore, calculating stiffness values from TDI measurements assuming a linear propa-
gation velocity, as has been done in earlier studies, may be an oversimplification and 
may miss clinically relevant deviations from this assumption. However, the presence of 
a non-linear MSPa seems to indicate more advanced disease in HCM, with a significantly 
thicker septum and presumably more fibrosis. Further research may be directed to us-
ing this as a qualitative sign of disease severity without the need to directly compute 
stiffness values.
COnClUSIOnS
The onset of the left ventricular end-diastolic myocardial stretch after atrial contraction 
exhibits a constant and quantifiable propagation velocity in normal individuals, but a 
non-constant velocity in about half of the HCM patients in the study. This deviation of 
the TDI velocity pattern can be explained by a non-linear relation between strain and 
stress and the inhomogeneous structure of the LV wall, even more apparent in thickened 
hypertrophic myocardium. This would imply clinical relevance, but actual quantifica-
tion of tissue elasticity should be performed with care.
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Left ventricular (LV) flow patterns have been studied as potential early stage markers of 
cardiac dysfunction (1). A relatively new method of measuring LV flow patterns, named 
echo-particle image velocimetry (echoPIV), tracks the motion of ultrasound contrast 
agent (UCA) microbubbles in the blood using echocardiography. However, the low frame 
rates (50-70 Hz) permitted by the current generation of clinical ultrasound scanners 
causes velocity magnitudes during filling and ejection to be severely underestimated. 
This is due to the relatively large displacement of the bubbles between frames. The 
recent feasibility of high frame rate (HFR) echocardiography, using diverging-wave 
transmission schemes, has allowed for frame rates of up to 100 times faster than 
conventional imaging methods (2). The image quality improvements when using HFR 
contrast enhanced ultrasound (CEUS) over standard CEUS have recently been described 
in (3). Still, measurement of the high energy and high velocity trans-mitral jet has yet to 
be demonstrated in humans. We have shown previously, in an in vitro LV phantom study, 
that HFR echoPIV can accurately measure the high energy diastolic flow patterns (4). In 
this work we demonstrate that this holds true in a patient with heart failure.
A patient with dilated cardiomyopathy, admitted for right decompensation cordis (form-
ing part of a study approved by the medical ethics committee of the Erasmus Medical 
Center), was scanned using both a clinical scanner (EPIQ 7, Philips Healthcare, Best, 
the Netherlands), and an open research scanner (Verasonics Vantage 256, Verasonics, 
Kirkland, WA) with a P4-1 probe (ATL). Pulsed-wave (PW) Doppler measurements were 
obtained, using the clinical scanner, in the region of the mitral valve. UCA (SonoVue®, 
Bracco Imaging SpA, Milan, Italy) was then continuously infused at 0.6 ml/min (VueJect 
BR-INF 100, Bracco Imaging) and arrival in the LV verified with the clinical scanner. The 
research scanner was then used to obtain HFR CEUS acquisitions using a 2-angle (-7°, 
7°) diverging wave sequence with pulse inversion at a pulse repetition frequency of 
4900 Hz, resulting in an imaging frame rate of 1225 Hz. EchoPIV analysis was performed 
in the polar domain, using custom PIV software that used correlation compounding 
on ensembles of 5 frames for each angled acquisition separately (total of 10 frames of 
averaging ≈ 4 ms) (4). The final vector-grid resolution was 1.25° by 1.25 mm. HFR echoPIV 
magnitudes were validated by comparing the mean temporal velocity profile to the PW 
Doppler spectrum captured in the same locations.
The velocities measured with HFR echoPIV agreed well with the PW Doppler spectrum 
(Figure 1.a), with peak velocities up to 80 cm/s accurately measured in this patient. This 
is the first demonstration of echoPIV estimating the high velocity trans-mitral jet; where 
previously the use of conventional echocardiography resulted in severe underestima-
tion of the velocity magnitude. The high temporal resolution also permits study of the 
flow patterns in greater detail. Such as the large, central clockwise vortex that could be 
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observed developing off of the trans-mitral jet before migrating apically (Figure 1: b-d: 
*). Smaller, more transient vortices could also be observed, for example the counter-
clockwise vortex between the jet and the free-wall (Figure 1b: #).
HFR echoPIV has been demonstrated in a heart failure patient and we have shown that 
it is feasible to measure the high velocity diastolic flow patterns in 2D, previously unob-
tainable through conventional ultrasound imaging.
figure 1. a) Mean echoPIV velocity (red) overlaid on Pulsed-wave Doppler spectrogram obtained in mi-
tral valve region. b-d) Velocity map visualisations during diastolic filling (temporal locations marked in a), 
showing the high velocity trans-mitral jet entering the ventricle (b) and central clockwise vortex that starts 
basally and migrates apically (c-d). See Supplementary Media for video of sequence. MV = Mitral valve, AoT 
= Aortic outflow tract. *Large, persistent clockwise vortex that pinches-off the jet and migrates apically. # 
Small, transient counter-clockwise vortex constrained by free-wall.
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Echocardiography has been searching for a long time for a reliable, simple and direct 
way to characterize the myocardial function and the diastolic properties of the heart1-3. 
But without being able to ’’look’’ inside the muscle, everything was based on shape 
change, global and local deformation, blood flow, and indirect estimation of pressure 
gradients.
1. ClASSICAl APPROACHES
The first part of this thesis explores the limitations of the classical approach to diastology.
The American Society of Echocardiography and European Association of Echocardiogra-
phy (ASE/EAE) have published algorithms for the grading of diastolic function by echo-
cardiography2. In an effort to increase the yield of clinical diastolic function assessment, 
we directly compared the feasibility and results of two slightly different diagnostic 
algorithms for diastolic function based on classical echocardiographic parameters. 
The ASE/EAE and Thorax Centrum (TXC) algorithms could not precisely classify 48 % of 
patients and 10 % respectively3. The authors of the multi-center Euro-Filling study found 
only 17% of undetermined cases by the latest recommended algorithm of the ASE/EAE4. 
Although the TXC algorithm performed better in our patient group, a clinical validation 
study including outcome and ideally reference gold standard (invasive measurement of 
left ventricular (LV) pressures) is still necessary. This means that in daily clinical practice 
it may be difficult to grade diastolic dysfunction with any scheme based on classical 
echocardiographic parameters, and many relevant patients may fall into the grey area 
of uncertainty.
One objective parameter of increased LV filling pressures is the echocardiographic ratio 
of the transmitral E-wave velocity and early diastolic velocity of the myocardium, the so-
called E/e’ ratio. In the Euro-Filling study only modest correlations were seen between 
E/e’ and invasive pressure measurements4. It is not clear whether this poor correlation 
would also be translated into a poor correlation with other signs, symptoms or biomark-
ers of heart failure.
In a group of elderly patients with severe symptomatic aortic stenosis we studied the 
possible relationship between the E/e’ ratio and biomarkers of elevated intracardiac 
pressure. We found a significant but moderate correlation between the E/e’ ratio and 
NT-proBNP5. The correlation was best for the septal point E/e’ (r = 0.584, r2 = 0.34, P 
<0.0001); the lateral (r = 0.377, r2 = 0.14, P <0.0001) and the average E/e’ (r = 0.487, r2 = 0.24, 
P <0.0001) having slightly lower levels of correlation. This level of correlation with NT-
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proBNP is slightly better than found in the Euro-Filling study against invasive pressure 
measurements4 . It is noteworthy that both in our study and the Eurofilling study a slight 
superiority in measuring the septal point as compared to the lateral or even the average 
E/e’ was seen. 
In the same group of elderly patients with severe aortic stenosis, the independent pre-
dictors for baseline pulmonary artery pressure (PAP) were the body mass index (ß=0.21, 
p=0.006), COPD GOLD class (ß=0.20; p=0.009), the E/e’ ratio (ß=0.20; p=0.02) and the 
degree of aortic regurgitation (ß=0.20; p=0.01). After receiving a TAVI prosthesis, there 
was significantly less (51% vs 29%, p<0.0001) pulmonary hypertension, defined as a 
tricuspid regurgitation velocity ≥ 2.8m/s. The baseline variables related to an improve-
ment in PAP were the tricuspid regurgitation velocity (p=0.0001) and the E/e’ (p=0.005). 
From the parameters potentially modified with TAVI, the only independent predictor 
of PAP variation was the change in the E/e’ ratio (ß=0.23; p=0.005). This suggests that 
PAP evaluation by echocardiography needs to be a part of the prognostic estimation of 
potential TAVI candidates, along with the filling pressures of the left ventricle, the two 
elements being interconnected. E/e’ remains the most important echocardiographic 
parameter to be considered.
Another precise parameter used as a cornerstone in the ASE/EAE algorithm is left atrial 
(LA) size which reflects the severity and chronicity of LV dysfunction2,6. The clinical value 
of LA function has not yet been translated into recommendations, in part because of 
lack of reference ranges for normal condition6. In a monocentric prospective study on a 
healthy population with ages ranging between 20 to 72 years, we show that LA function 
assessed with volumetric and myocardial deformation methods is influenced by age 
and LV diastolic function7.
The global change in atrial volume during the cardiac cycle is simpler than that of 
the left ventricle, having mainly a longitudinal component, mostly due to the motion 
of the mitral annulus (which in turn is mostly due to left ventricular contraction and 
relaxation)8. When looking at the mitral annulus motion from the left atrial perspective, 
in end-diastole the left atrium contraction induces a supplementary volume inflow7 but 
also a rapid traction motion on the atrioventricular annulus8, that induces a supplemen-
tary increase in LV global longitudinal strain, contributing to filling and to the LV parietal 
tension in end diastole.
Classical echocardiographic parameters of systolic and diastolic function have a good 
sensitivity in symptomatic heart failure patients2,6. However, diagnosing patients 
in the clinically symptomatic stage may be too late for any intervention aiming to a 
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complete recovery of function. These parameters should also provide sufficient sensi-
tivity for relevant changes in stable patients or in the early stages of disease2,4,6. In the 
prospective Bio-SHiFT study, we analyzed 332 echocardiograms in 106 patients during 
a median follow-up of 2.3 years. The endpoint comprised HF hospitalization, LV assist 
device implantation, heart transplantation, and cardiovascular-related death. Although 
individual temporal variations of echocardiographic parameters were associated with 
cardiovascular outcome independent of NT-proBNP levels, the average of these param-
eters remained stable during the 2.3 years follow-up and did not worsen as an adverse 
event approached. It thus seems that, in such a timeframe, routine frequent monitoring 
of systolic or diastolic function with classical echocardiography parameters does not 
carry incremental prognostic information over a single measurement in a minimally 
symptomatic and relatively young patient group9, suggesting that their sensitivity may 
be insufficient for early detection of a variation in the heart function.
The conclusion arising from the clinical investigations in the first part of this thesis is 
that the present-day echocardiographic evaluation of the LV diastolic function requires 
multiple parameters and complex algorithmsthat unfortunately lack sensitivity for 
detecting subtle changes in the LV function. There is an obvious need for a change in 
paradigm, with the search for new parameters and new ways of looking at the heart with 
ultrasound10.
2. HIGH fRAME RATE ECHOGRAPHY
The second part of this thesis proposes a new way of investigating the LV properties, 
based on passive shear wave imaging and high frame rate tissue Doppler imaging. Shear 
wave imaging offers a potential way of remotely ’’touching’’ the myocardium, thus be-
ing able to quantify its stiffness10.This thesis focuses at the shear waves that naturally 
occur on the interventricular wall after closure of the aortic and mitral valves. The shear 
waves consist of minute vibrations of the wall, and are detected through Tissue Doppler 
imaging. For the first time, we show that a clinical system in regular clinical mode is able 
to trace these naturally-occurring phenomena, which clearly simplifies the ’’bench to 
bedside’’ step. However, the frame rates provided by present day clinical tissue Dop-
pler11 echocardiography were observed to be on the lower side of obtaining sufficient 
accuracy to quantify shear waves. Moreover, related to the method itself, the properties 
of the waves had not yet been related to disease states of the heart. Thus, the second 
part of the thesis aimed at a clinical translation of the passive shear wave elastography 
method to the investigation of diseased states of the heart. Given the substance of the 
new results, we discuss the topics separately.
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2.1 Shear wave elastography
We showed that passive shear wave imaging of the heart with a clinical high frame rate 
tissue Doppler application is feasible in vivo and can be used as a research tool. Based 
on physics, these shear waves propagate with a velocity that is presumed to be mono-
tonically increasing with the stiffness of the tissue12.
We observed that regular unmodified clinical systems can be set up by using only the 
normal system controls, in order to obtain color TDI frame rates above 500 Hz (500 to 710 
Hz, depending on depth, line density and opening of the field of view). In Chapter 8 we 
showed that with a clinical tissue Doppler imaging (TDI) application we can accurately 
quantify the propagation velocity of shear waves induced in vitro in tissue phantoms by 
acoustic radiation force. We also show that we can detect and quantify the naturally-
occurring shear waves in the heart with such clinical system13. This was the basis of the 
subsequent chapters.
Clinical cardiac TDI is set up to detect low velocity but high intensity signal, with a veloc-
ity scale in the order of cm/s11. What TDI “sees” from a shear wave is the local particle 
vibration induced by the wave (Figure 11), with a velocity range (1 to 7 cm/s)13,14 that 
falls into the detection range of the TDI. The wave itself propagates with velocities in the 
range of 1 to 10 m/s in soft biological tissue such as the myocardium.
Because the TDI application detects the local tissue velocity (the velocity amplitude of 
the wave, see Introduction Section 7 and 10), these shear waves can best be detected 
by TDI in the parasternal views of the left ventricle rather than the apical views, and this 
relates, as shown in the Section 7 of the Introduction, to the properties of the wave and 
the technical particularities of tissue Doppler imaging.
figure 11. Conceptual drawing (Source: per-
sonal collection) of a shear wave propagating in 
a thin plate (the interventricular septum in para-
sternal longitudinal view of the left ventricle), 
with the shear wave source to the right (block ar-
row), corresponding to the atrioventricular and 
aortic annulus in vivo. Although the direction of 
propagation is perpendicular to the ultrasound 
scan lines (dotted lines), the tissue displacement 
within the wave is in line, and this local displace-
ment is what the TDI system actually detects.
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In the parasternal position, there are at least two possible probe rotations in which 
to investigate shear wave propagation: the long and the short axis views of the LV. We 
opted for the long axis view, where the propagation direction of the shear wave gener-
ated at the mitral or aortic annulus is in the imaging plane, with minimal angulation6, as 
demonstrated in Figure 12. The risk of error due to misalignment is minimized by using 
the classical anatomical landmarks defining the parasternal longitudinal view of the left 
ventricle, which place the shear wave sources into the field of view: the aortic valve and 
aortic annulus and the mid-portion of the mitral valve and mitral annulus.
Other research groups that investigated myocardial stiffness by externally-induced 
shear waves15-17 demonstrated an anisotropic propagation of the shear waves in the long 
versus the short axis. This may be due to geometric reasons (propagation of a wave in 
a straight versus a curved plate-like material), but also anatomical (tissue anisotropy 
due to fiber orientation). However, due to the same limitations imposed by the physical 
properties of the waves and the angle dependency of the clinical TDI application, the 
passive detection of shear waves in short axis was not feasible with our method.
figure 12. Relation between the shear wave propagation and the imaging plane in the parasternal long 
axis view (Source: personal collection). A: actual echocardiographic image. The shear waves appear at the 
valvular annulus and course along the interventricular septum (IVS) to the apex (arrow). B: the imaging 
plane represented by the transparent triangle in panel A is rotated 90% counterclockwise, with the LV apex 
towards the viewer. Shear waves generated at the atrioventricular or aortic annulus are perpendicular to 
the imaging plane (represented by the central blue line).
Other research groups analyzing the naturally-occurring shear waves in the heart with 
experimental high frame rate TDI have either opted for a parasternal longitudinal 
view18,19 or an apical view20. With respect to the apical position, still being able to see the 
wave with TDI may be puzzling, given the fact that the particle vibration is perpendicular 
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to the Doppler interrogation lines. However, if the interventricular septum does not per-
fectly align in the middle of the image, which is rarely the case in the apical longitudinal 
view of the left ventricle, some angulation might exist allowing visualization of the shear 
waves (visualizing the local velocity vector that is parallel to the Doppler interrogation 
lines).
The shear wave after aortic valve closure in healthy volunteers was evaluated by all the 
TDI studies13,14,18-21. The feasibility was very good, reported to 92%18 and 93%14 respec-
tively, and the results were similar (Chapter 7). The only study describing aortic shear 
wave velocities in the apical approach reports much higher values (5.41 ± 1.28 m/s) 
in a group of only 10 healthy subjects20. The reason for this difference is unclear, and 
may have to do with measurement errors as reflected by the large standard deviation, 
insufficient statistical power due to low numbers, or on a phenomenological level, the 
presence of a longitudinal component of the wave displacing with much higher veloc-
ity22. Such waves might behave as symmetric Lamb waves, as opposed to asymmetric 
Lamb waves or bulk shear waves which are measured in the parasternal position23. The 
symmetric zero-order Lamb waves have a higher propagation velocity than bulk shear 
waves, up to a factor of 1.7 for lower frequencies24. This implies that multiple types of 
waves could be simultaneously induced by valve closure, which would require either 
caution when translating propagation speeds into tissue stiffness, or standardization 
of parasternal versus apical measurements. Until such standardization is achieved, this 
point limits the reproducibility of the method in patients. Current efforts of our research 
group are directed to further understanding the correlation between parasternal and 
apical recordings.
For the shear wave after mitral valve closure a lower feasibility was observed14,21 possibly 
explaining the difference in results between the studies (4.65 ± 0.77 m/s in Strachinaru 
et al 201914 vs 3.54 ± 0.93 m/s in Petrescu et al 201919). One of the reasons for this lower 
feasibility may be the lower transvalvular gradient over the mitral valve leading to lower 
wave amplitudes. Moreover, Petrescu et al (2019) used tissue acceleration values to 
trace the shear waves, rather than tissue velocity values like we did. These points merit 
further investigation, since the two studies find a different relation between the aortic 
and mitral shear wave velocities.
In this thesis we show that we can identify, visualize, and isolate shear waves from 
other events and measure their velocity. In order to be clinically relevant, shear wave 
imaging needs to provide new and significant information, that cannot be obtained 
through present day clinical imaging. As already presented in the Introduction, there 
is a theoretical relation between shear wave velocity and the stiffness of a material12. 
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Other research teams investigating externally-induced shear waves in the myocardium 
have even computed stiffness values based on this assumption15-17. Yet, as discussed in 
Chapter 10, 11 and 12, we believe that the dynamic nature of the instantaneous stiffness, 
as well as the inhomogeneous wall structure and the already known anisotropy15,25,26 
in the longitudinal and radial direction make direct estimation of tissue stiffness more 
complicated than in theoretical homogeneous models. For the naturally-occurring 
shear waves the dynamic component of muscle contraction or relaxation is even more 
important because of the location of these events in the isovolumetric periods where 
the stiffness varies rapidly. Despite all these potential limitations, we demonstrate in 
Chapter 10 that naturally-occurring (passive) shear waves have very different propaga-
tion velocities in hypertrophic versus normal myocardium, which is a significant finding. 
The magnitude of this difference is around 2 m/s for the mitral valve shear wave and 1.5 
m/s for the aortic shear wave (difference of the mean values found in healthy volunteers 
and hypertrophic cardiomyopathy patients)14. Similar very significant differences were 
observed by other research groups when comparing healthy volunteers with amyloi-
dosis patients (2.8 m/s difference in mitral valve shear wave and 1.9 m/s in aortic shear 
wave)19. We do not know however how the shear wave velocities evolve over time in 
an individual patient as the heart progresses from normal to the extreme pathologic 
as used here for comparison. In other words, future studies should demonstrate that 
shear wave velocities not only differ drastically in extremely ill patients as compared to 
normal individuals, but also follow a continuum of velocity values as the myocardium 
gets progressively sicker and stiffer.
In Chapter 11 we show that passive shear waves can even help differentiate intratissular 
variations in the elastic properties. The ability to detect two different levels of patho-
logical stiffness in the same patient (the abnormally stiff hypertrophic cardiomyopathy 
myocardium and the scar tissue post septal reduction therapy) partially gives a positive 
answer to the question of progression of disease mentioned above. Being able to detect 
localized variations in tissue stiffness inside the myocardium would potentially allow a 
quantitative mapping of the myocardial stiffness, that could for example be rendered in 
color-coded stiffness maps, in a similar manner to that presently used in parenchyma-
tous organs12. These maps could be obtained by multiple determinations of shear wave 
velocities across the left ventricular wall, provided that the spatial resolution of this 
method is smaller than at least the half of the minimum width of the LV wall (allowing 
at least 2 lines to be traced and separately resolved). Again, the sensitivity threshold 
should also be sufficient in order to detect significant local variations in velocity.
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2.2 The myocardial stretch post atrial contraction
Atrial contraction exerts a mechanical traction motion on the atrioventricular annulus27 
(Chapter 6). After atrial contraction a strain rate wave-like pattern visible in the LV myo-
cardium was reported by Voigt et al28 who estimated its propagation velocity between 
2 and 4.6 m/s in the interventricular septum (IVS) of normal individuals at a frame rate 
of 178 Hz. They demonstrated the value to be preload dependent. Later, Pislaru et al 
investigated the same Tissue Doppler Imaging (TDI) velocity and strain rate pattern 
with higher frame rates (250-465 Hz) and computed the values at 1.4±0.2 m/s in normal 
individuals, 2.2±0.7 m/s in severe aortic stenosis patients29,30 and 3.2 ± 1.0 m/s in amyloi-
dosis31. Yet, the exact nature and behavior of this tissue velocity-based pattern remain 
unclear. These earlier studies hypothesized that the fast traction on the mitral annulus 
by the atrial contraction generates a wave in the left ventricular wall, which travels from 
base to apex with a constant velocity which is related to the underlying tissue stiffness. 
It was also hypothesized that this wave had a radial component30.
We show in Chapter 12 that the myocardial stretch in late diastole induced by the atrial 
contraction (MSPa) does not display a linear behavior in pathological myocardium, mak-
ing it more difficult to use in directly calculating tissue stiffness from its propagation 
velocity. As mentioned earlier, this wave-like event showed initially a lot of promise, be-
ing ideally situated in late diastole, precisely after a relatively long period of equilibrium 
(diastasis), when the LV myocardium should be in its most relaxed state. We started our 
study with the intention of further understanding the behavior of this TDI pattern and 
further expanding the very interesting results obtained by previous researchers. The 
results described in Chapter 12 rise concerns regarding the very nature of this event 
(rather a progressive myocardial stretch than a wave) and its direct relation to the myo-
cardial stiffness (non-linear behavior in pathological myocardium). It is interesting to 
mention that previous studies found only linear propagation, with the highest velocity 
in severe aortic stenosis patients30 (2.2 ± 0.7 m/sec) and in amyloidosis (3.2 ± 1.0 m/s)31. 
In our group of hypertrophic cardiomyopathy patients, we found linear and non-linear 
propagation, the latter appearing in the more diseased ventricles (significantly thicker 
septum). It is possible that MSPa behaves linearly up to a certain degree of disease (in our 
study a certain degree of tissue distensibility), and non-linearly beyond. This obviously 
elicits for more research, in a larger array of pathologies, and in progressive degrees 
of disease. If the velocity of linear propagation of the MSPa cannot be reliably used for 
tissue stiffness calculation, the appearance of the non-linear propagation might be used 
as a qualitative sign of extreme tissue stiffness32 (lack of distensibility in end-diastole).
Chapter 14 285
Discussion
2.3 Intracardiac flow patterns
High frame rate imaging shows promising results in tracking and quantifying intracar-
diac diastolic flow patterns. A significant part of the parietal tension of the LV is given by 
the filling state, currently represented by preload and afterload13,32. There is a dynamic 
relation between parietal tension induced by filling and filling itself. This has until now 
been exploited to indirectly estimate the diastolic properties of the LV2. As already 
mentioned in Chapters 10, 11 and 12, in vivo tissue stiffness measured by shear wave 
imaging is expected to be influenced also by preload and afterload. Measured stiffness 
may need to be corrected for these parameters32. In Chapter 13 we estimated the intra-
cardiac flow with high frame rate imaging, by using an experimental system being able 
to reach very high frame rates (1000+ FPS) with full sector opening. We propose a new 
application of high frame rate imaging, the in vivo analysis of diastolic blood flow into 
the left ventricle. Echo-particle image velocimetry (echoPIV) is already used with regular 
clinical systems33. However, the relatively low frame rates (50-70 Hz) permitted by the 
current generation of clinical ultrasound scanners causes velocity magnitudes during 
filling and ejection to be severely underestimated. Our algorithm (Chapter 13) tracks the 
motion of ultrasound contrast agent microbubbles in the blood using very high frame 
rates, allowing to detect diastolic velocities with similar accuracy as the pulsed-wave 
Doppler34 at least up to about 1 m/s. Future high frame rate systems could incorporate 
blood flow tracking and shear wave imaging in the same analysis, allowing for combined 
and corrected indices (shear wave velocity, corrected by volume and inflow velocity 
variation derived from high frame rate imaging).
3. PHYSIOlOGICAl InTERPRETATIOn
We show in this thesis that we can quantify markers of instantaneous tissue stiffness, 
at several points during the cardiac cycle. How can we expand this data to the diastolic 
function of the left ventricle?
Naturally-occurring shear waves are present during the isovolumetric periods. The 
instantaneous LV wall stiffness has several components: an active component due to 
muscle contraction, a parietal tension derived from Laplace’s law and an inert elastic-
ity of the fully relaxed wall. The instantaneous value of stiffness is the result of these 
dynamic and static components14,21. Our detection method is able to record naturally 
occurring shear waves during these two moments in the cardiac cycle: one in early sys-
tole (induced by mitral valve closure) and the other in early diastole (induced by aortic 
valve closure). Although none of these moments corresponds to a truly diastolic state 
(full relaxation of the LV myocardium), the significant difference found in this thesis 
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between normal and non-compliant myocardium suggests that the naturally occurring 
shear waves could be clinically relevant in estimating myocardial stiffness (Chapter 
10). The stiffness and hence, the shear modulus, varies in time throughout the cardiac 
cycle15,23,25,26,35, thus changing the instantaneous shear wave velocity.
When expanding to the whole duration of the diastole, as already known from pressure-
volume loops, LV compliance also varies with each heart cycle, and with the preload 
and afterload of the ventricles, and may further be influenced by the interventricular 
interdependence induced by the closed pericardial space36,37. In these conditions, a very 
punctual measurement may not be completely representative of the diastolic function.
In order to make the step from instantaneous stiffness using just information derived 
from naturally-occurring shear waves to a more comprehensive evaluation of the 
diastolic function, we could study an echocardiographic index based on the relation of 
the shear wave velocities measured during the two isovolumetric periods (difference, 
average, ratio)18,32 (Chapter 9). However, looking at the data obtained so far (Chapter 
9 and 10), we note that the feasibility for the mitral valve shear wave is lower than for 
the aortic shear wave, both with the clinical TDI application (89% in healthy volunteers 
and 56% in HCM patients)14 and the modified high frame rate clinical system we used 
for comparison (66% in healthy volunteers)21. That means that in around 50% of the 
patients such a derived index will not be feasible with the present method. Possible 
solutions would be using only one of the two time points which has better feasibility 
(the shear wave after aortic valve closure, with a feasibility of 93% in healthy volunteers 
and 88% in HCM), or finding a technical solution to optimize the detection of the mitral 
closing shear wave. In Chapter 10 we opted for the second approach, lowering the TDI 
velocity scale in separate acquisitions in order to selectively optimize the feasibility of 
the mitral valve shear wave. This allowed for a notable difference as mentioned above 
(89% with dedicated settings vs 66% with general settings in healthy volunteers).
Another possible approach to the diastolic function through shear wave imaging would 
be a continuous or triggered multi-point determination of shear wave velocities dur-
ing the cardiac cycle, as has already been done in experimental settings25 by using 
externally-induced shear waves.
4. COMPARISOn TO OTHER TECHnIQUES
Other research teams have focused on externally-induced shear waves, and showed 
significant findings15-17,25,26. These externally-induced waves require a short burst (300 
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μs)16-17 of focused ultrasound (acoustic radiation force push) into the myocardium in 
order to induce a local excitation, that would then propagate as a shear wave in all direc-
tions. These bursts were triggered by an ECG and positioned in end-diastole, before the 
P wave. Then, using the same probe the shear waves were tracked with very high frame 
rates (around 5000 Hz), also in the parasternal position, but both in short and long axis, 
allowing for estimation of the local myocardial anisotropy15,16,26.
In spite of the different excitation source, tracking method and the important difference 
in frame rates used, the two methods compare in several aspects:
- Shear waves are generated both naturally, by valve closure, and by acoustic radiation 
force. Since shear wave tracking by successive pulses during the whole heart cycle has 
been described25, it is theoretically possible to measure instantaneous shear waves 
velocities throughout the cardiac cycle and compare the results that are simultaneous 
to the naturally-occurring shear waves. In practical terms this may prove difficult for 
several reasons. First, by using serial high energy bursts to induce shear waves the 
acoustic energy deposit is above regulations15. Second, the shear waves induced during 
the systolic period have lower amplitude25, making their detection difficult with trans-
thoracic imaging. Third, generating actual systolic and diastolic stiffness maps needs a 
high sampling rate, which is actually technically achievable. Push-detection cycles in 
the study by Pernot et al 25 were performed in 5 ms and repeated every 7.5 ms, thus 
achieving a sampling rate of 133 measurements per second ex vivo. Such high repetition 
frequency of the push-detection sequence would surely exceed current acoustic safety 
limits for human exams, thus limiting translation to clinical application. To overcome 
this safety limitation, the in vivo heart rate could be temporarily slowed down by medi-
cation, allowing a lower sampling rate to still reach the same number of samples per 
cycle, or the trigger point could be moved progressively and data from several heart 
beats be stitched onto a single artificial heart beat. These are possible modalities to 
improve sampling rate per cycle while staying below acoustic safety limits.
- Externally-induced waves have the advantage of being controlled by the user, so inde-
pendent from valve structure and mobility or transvalvular gradients. They can also be 
studied during the phases of the cardiac cycle when the stiffness of the LV is lowest and 
varies the least, being most closely related to the passive wall stiffness, i.e. in diastasis. 
Yet, generating and tracking these waves requires custom-designed ultrasound systems 
capable of inducing ultrasound push pulses and acquiring images at high frame rates. 
On the other hand, naturally-occurring shear waves are generated with each valve 
closure, without any external energy, and in the same patient their position within 
the heart cycle is expected to remain stable as long as the electrical activity remains 
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unchanged. However, their position in the cardiac cycle makes them less representa-
tive for the intrinsic properties of the myocardium during the true diastole (Chapter 9 
and 10). Also, being generated by the valves, they are dependent on valve morphology, 
mobility, as well as pressure differences across the valves. It is theoretically possible 
that in significant mitral or aortic disease (stenosis or insufficiency) or very low trans-
valvular gradient states (severe systemic hypotension, advanced heart failure with low 
output) these waves are not detectable. This supposition has yet to be proven in future 
investigations.
- Externally induced shear waves have been proven to be diagnostic for the myocardial 
stiffness in normal and pathological myocardium16,17. The studies demonstrated shear 
velocity values of 2.1 ±1.3 m/s in healthy volunteers and 3.56 ± 1.71 m/s in HCM patients 
by triggering shear waves in end diastole, just before the P wave (these velocity values v 
were obtained by converting the reported elasticity values E17, using E=ρv2 with a tissue 
density ρ of 1000 kg/m3). In this thesis we demonstrate that naturally-occurring shear 
waves can also differentiate normal from pathological myocardial tissue(Chapters 10 
and 11). The velocity values obtained were significantly higher than the ones obtained 
in the same type of population by externally-induced shear waves, corresponding to 
natural waves occurring in the myocardium during a partially contracted/relaxed state14.
- Tracking naturally occurring cardiac shear waves is already possible with present-day 
ultrasound scanners (this thesis), and a more precise quantification can be done with 
higher frame rates18,19. High frame rate imaging by using plane wave compounding in 
order to detect natural or externally induced shear waves requires new technology, that 
is only now integrating in clinical cardiac ultrasound systems38.
- An advantage of exploiting natural shear waves is that these SWs were found to have 
larger tissue velocity amplitudes13,14,18,39 (~4 cm/s) than the waves induced by an external 
acoustical force15 (~1 cm/s), likely leading to higher signal to noise ratios in TDI.
- However, the low frequency content of natural SWs18,22,23,35,39 compared to external 
sources15,25, 26,40,41 and thus the inherently larger wavelengths form a disadvantage of 
natural SWE measurements. Since the SWs can only be tracked over the limited length 
of a few centimeters of the interventricular septum (IVS), smaller fractions of the wave-
length can be tracked for SWs with low frequencies, possibly leading to more measure-
ment inaccuracy. Additionally, for 2D natural SWE measurements, the source of the SWs 
is not assured to be in plane with the field of view, as is the case for externally induced 
shear waves, and therefore out-of-plane propagation could also induce measurement 
inaccuracy39,42. As explained in section 1 of this chapter, the parasternal long axis view, 
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by using very reproducible anatomical landmarks, is a good solution in order to avoid 
this type of error.
In our opinion, the two types of waves (externally induced versus natural) are not mutu-
ally exclusive as for their diagnostic yield. We anticipate that externally-induced shear 
waves will allow a precise quantification of the most-relaxed state of the myocardium in 
diastole, closely approximating the passive wall stiffness and maybe even its dynamics 
during the cardiac cycle. They would probably be the gold standard for cardiac shear 
wave elastography10,43. Natural shear waves, being spontaneously present in almost 
every patient, would probably be used in the everyday echo lab due to their practical 
advantages (easy and fast to acquire, punctual measurement in a relatively fixed posi-
tion during the cardiac cycle), making serial follow-up of patients readily available42. 
Further studies are however needed comparing these two modalities.
5. TRAnSlATIOn InTO ClInICAl APPlICATIOn
Adequately addressing the challenges described in the Introduction would allow wide-
spread clinical research. However, the final purpose would be to identify a new clinical 
ultrasound-based method allowing to better understand the in vivo physical properties 
of the left ventricular wall. To achieve this goal several other steps need to be taken:
- In order to validate shear wave imaging as a tool for clinical use, large standardiza-
tion studies need to be performed. The recent evolution of deformation imaging from a 
research tool to a new clinical measurement of LV function44 demonstrates such an effort 
of harmonization and standardization in echocardiography.
- Initial clinical studies of shear wave velocities show very promising results, at least 
regarding the velocity range14,17,19 and clear difference between normal and pathologi-
cal tissue (Chapter 10) and different degrees of pathology (Chapter 11). Yet, in order to 
have high diagnostic yield and clinical relevance in early detection of disease, the shear 
wave velocity should be a continuum from normal to pathologic. A possible approach 
would be the creation of animal models of induced myocardial disease39, allowing to 
serially test for a progressive degree of disease in a limited number of subjects. Further, 
establishing normal reference values for clinical use needs larger populations studies, in 
various pathologies, and especially in progressive states of disease.
- Full characterization of the myocardial properties throughout diastole may be per-
formed by externally-induced shear wave imaging, by using for example a stitching 
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method, putting together measurements from several successive heart beats. This would 
potentially allow computing average velocity/stiffness values throughout diastole. An 
integrated time-velocity index may be more representative of the diastolic function than 
one punctual velocity determined in any point during diastole.
6. fUTURE PERSPECTIVES
There are several possible applications that could be developed based on the ultrasonic 
cardiac shear wave imaging:
Tissue characterization with echocardiography
Shear wave imaging offers the possibility of quantifying tissue stiffness in a specific 
region of the myocardium (Chapter 10), and even demonstrating variations in two adja-
cent segments of the wall (Chapter 11). This would potentially allow a quantitative es-
timation of the myocardial stiffness, that could for example be rendered in color-coded 
stiffness maps, in a similar manner to that presently used in parenchymatous organs12.
3D/ multiplane shear wave imaging
One could imagine refining this method until being able to look three dimensionally at 
the way shear waves propagate into the heart47, and reconstructing maps of myocardial 
stiffness in surface or in depth. A large part of this goal seems only restricted by the 
present state of technology and computing power, both of which are rapidly evolving. 
However, our experience so far with 3D imaging demonstrates that even for normal 
frame rates a reasonable resolution can only be achieved through stitching of multiple 
heart beats, by plane-by-plane reconstruction of the 3D volume. One possible solution 
is a volumetric plane wave, emitted simultaneously from all the crystals of the matrix 
probe, illuminating the whole volume in one emission, or compounding of few emis-
sions in order to improve resolution. Theoretically this would solve the problem of 3D 
frame rate and achieve similar resolution to 2D compounded plane waves.
Other possible approaches to echocardiographic shear wave imaging
Experimental studies used intracardiac probes for in vivo high frame rate strain imag-
ing48. The intracardiac probes have to be brought in invasively and it is yet uncertain if 
intracardiac shear wave imaging49 would bring any benefit as compared to the much 
better studied pressure/volume loops or simply cardiac output, pulmonary pressure 
and wedge pressure determination obtained through right heart catheterization.
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Until now, very few studies were performed with transoesophageal high frame rate 
echocardiography50. Although the gain in resolution may be significant in the near field 
(covering the atria), the study of the left ventricle in transesophageal echocardiography 
remains difficult because of its position away from the probe.
Another attractive perspective would be normalizing stiffness values in a specific myo-
cardial area to the deformation indices derived from bidimensional strain. This might be 
more representative of the local interaction between stress and strain.
As presented in the previous chapters, tissue stiffness is a continuum, and results from 
a complex interaction between active and passive forces, pressure gradients and shape/
volume variation. Most probably the stiffness itself will have to be normalized to the 
contribution of these forces, either by studying volume distension or pressure gradients, 
in a specific part of the cardiac cycle10.
7. COnClUSIOn
In the first part of this thesis we demonstrate that left ventricular function can be as-
sessed by using conventional echocardiographic imaging. Yet, the accurate estimation 
of the diastolic function of the left ventricle with echocardiography remains challenging, 
gives incomplete answers in a significant proportion of patients and has insufficient 
sensitivity for early detection of cardiac abnormalities. In an effort to overcome the gaps 
of our present day echocardiographic algorithms, we propose a new way of investigat-
ing the properties of the left ventricle, by using high frame rate shear wave imaging. 
Shear wave imaging offers a potential way of remotely “touching” the myocardium and 
measuring a marker for stiffness. We prove that cardiac shear wave imaging is feasible 
and can be used in order to answer relevant clinical questions.
We have now a new and more direct way of understanding the behavior of the cardiac 
muscle, and knowing its compliance to deformation forces10,42. How much this resis-
tance in itself may be characteristic of the function of the heart as a whole we do not 
yet know. This has still to be tested in theoretical models, in normal individuals and in 
pathological hearts, by directly comparing invasive pressure-volume loops with simul-
taneous stiffness determination through shear wave imaging. A large field of research 
opens before us, and hopefully in the coming years we will be able to gather evidence 
allowing to provide answers to this essential question.
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Heart failure is a clinical syndrome defined by the presence of typical symptoms 
(breathlessness, fatigue, ankle swelling), induced by an underlying functional cardiac 
abnormality, that results in an insufficient pump function or high intracardiac pressures 
at rest or during exertion. Despite numerous advances in the prevention, diagnosis and 
treatment of cardiac disease that lead to dysfunction, heart failure still prevails in 1-2% 
of the adult population in high income countries, and up to 10% of people over 70 years 
of age, and accounts for high rates of mortality and hospitalization.
However, recognizing the disease at this stage may be too late for possibly attempting 
a curative treatment that would restore the normal cardiac function. Before the clinical 
symptoms set on, patients do have unrecognized structural or functional abnormalities 
that prelude heart failure. Demonstrating such a structural (myocardial disease, valvular 
heart disease, etc.) or functional abnormality in the heart is thought to be essential to the 
early diagnosis and treatment. In the very early stages of the disease, such abnormality 
can be subtle or completely absent at rest, and present only during exertion, eliciting 
complicated investigations.
This thesis aims to prove that high frame rate echocardiography and cardiac shear wave 
imaging is feasible and can be used in order to detect the global or local stiffness of the 
heart walls which would be clinically relevant. This method could be used for the early 
detection of the subtle abnormalities that precede the onset of clinical heart failure. It 
is not the purpose of this thesis to propose a new technical solution, since the scientific 
effort was more directed towards the clinical and pathophysiological perspective. Tak-
ing advantage of an unforeseen technical ability of a clinical ultrasound system, we aim 
to demonstrate the importance and the clinical message of shear wave imaging in the 
heart. Hopefully this will trigger more efforts in the technical field and lead to a true 
clinical high frame rate application accessible to every cardiologist.
MAIn fInDInGS
In Part One we investigated current parameters used to estimate cardiac function with 
echocardiography. We demonstrate that the assessment of the diastolic function of the 
left ventricle with echocardiography remains challenging, gives incomplete answers in 
a significant proportion of patients and has insufficient sensitivity for early detection of 
cardiac abnormalities.
We demonstrate in Chapter 2 in a group of 200 patients that in some cases it may be 
difficult to grade diastolic dysfunction with the ASE/EAE algorithm, since there may be 
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discrepancies in the assessed parameters. The locally developed algorithm to grade LV 
diastolic dysfunction was simpler, faster and yielded a higher diagnostic outcome as 
compared to the ASE/EAE algorithm.
The general message is that present day algorithms are very complicated and insuf-
ficiently precise in estimating the diastolic function of the left ventricle, because of the 
indirect nature of the parameters used and the theoretical assumptions made in order 
to validate each step.
One of the key parameters in diastology is the E/e’ ratio. It represented a revolution in 
our understanding of the diastolic function based on more than filling patterns and flow 
indices.
Yet, Chapter 3 demonstrates that it has only a moderate correlation with biomarkers of 
elevated intracardiac pressure, the best for the septal point E/e’ (r = 0.584, P <0.0001). 
This correlation is influenced by the ejection fraction and the presence of co-morbidities 
(aortic or mitral regurgitation, annular calcifications, severe renal dysfunction, obesity 
or severe COPD).
Chapter 4 shows the major role of the diastolic dysfunction in the rise of the pulmonary 
pressure in an elderly population with severe aortic stenosis and co-morbidities, with 
an important impact on clinical decision and prognostic evaluation before and after the 
TAVI intervention.
Left atrial dilatation is predictive for complications in a multitude of cardiac diseases; 
therefore, adequate assessment is essential. Technological advances have made it pos-
sible to quantify LA function with Speckle Tracking Echocardiography (STE). In Chapter 5 
we assessed LA myocardial and volumetric function in a healthy cohort and investigated 
correlations with baseline characteristics. In this study we provided normal values for 
the three phasic functions of the LA, assessed with STE and volumetric function. Mean 
LA-strain was 39.7 ± 6.2%, LA-SRe -2.78 ± 0.62 s-1 and LA-SRa -2.56 ± 0.62 s-1 . Subjects 
were divided into 5 age decades (each 50% female). LA-strain and LA-SRe were lower in 
the oldest groups, whereas LA-SRa was higher. LA-SRa was higher in males(-2.69 ± 0.68 
s-1 vs -2.42 ± 0.52 s-1 ).
The methods used to characterize the volume change and the deformation of the left 
atrium, as demonstrated in the previous chapter, are highly dependent on technical 
factors and may be difficult to use in a clinical environment. In Chapter 6 we investi-
gated the mitral annular displacement by speckle tracking as an alternative method 
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to studying the longitudinal left atrial function. There was a very strong correlation 
between three-dimensional volumetric function and mitral annular displacement, both 
for the reservoir (r = 0.78; P < 0.0001) and contractile (r = 0.76; P < 0.0001) functions. The 
correlation with the global longitudinal strain displayed an r = 0.87, P > 0.0001 for the 
reservoir and r = 0.81, P < 0.0001 for the contractile function. Mitral annular displacement 
was a very good discriminator for normal versus abnormal participants [area under the 
curve (AUC) for reservoir = 0.872 and for contractile = 0.843; P < 0.0001], performing less 
well than three-dimensional (AUC reservoir = 0.892 and contractile = 0.915; P < 0.0001) 
or deformation (AUC = 0.921 and 0.903 respectively; P < 0.0001), but better than pulsed 
TDI contractility(AUC = 0.807; P < 0.0001).Mitral annular displacement by speckle track-
ing is a reliable and fast method to evaluate left atrial function. Given the strength of 
the correlations with strain parameters, it could be used as a surrogate measure of the 
deformation of left atrium.
In Chapter 7 we compared the prognostic value of a single ‘baseline’ echocardiographic 
estimation of systolic and diastolic function parameters with repeated echocardiogra-
phy in stable chronic heart failure patients in the prospective Bio-SHiFT study cohort. 
Single baseline or repeatedly measured echocardiographic parameters (LV ejection frac-
tion, diastolic LV diameter, systolic LV diameter, systolic left atrial diameter, E/A ratio and 
E/e’ ratio) were associated with the endpoints. However all parameters remained stable 
on average during the 2.3 years follow-up in this, largely, minimally symptomatic CHF 
cohort and none of the trajectories from the investigated parameters showed worsen-
ing prior to the occurrence of clinical events (hospitalization for heart failure, LV assist 
device implantation, heart transplantation, and cardiovascular death). Thus, regular 
echocardiographic monitoring of systolic or diastolic LV function within this time-frame 
does not seem to carry incremental prognostic information over a single baseline mea-
surement, suggesting that classical echocardiographic parameters of cardiac function 
have insufficient sensitivity for the early detection of subtle cardiac abnormalities.
In Part two we propose a new method of looking at the properties of cardiac muscle by 
using high frame rate echocardiography and shear wave imaging.
The propagation velocity of shear waves relates to tissue stiffness. In Chapter 8 we 
prove that a regular clinical cardiac ultrasound system can determine shear wave veloc-
ity with a conventional unmodified tissue Doppler imaging (TDI) application, in tissue 
phantoms and in vivo in the parasternal view. The investigation was performed on tissue 
phantoms using a research platform capable of inducing and tracking shear waves and 
a clinical cardiac system able to achieve frame rates of 400-700 Hz in TDI by tuning the 
normal system settings. The research platform scanner was used as reference. Shear 
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wave velocities measured with TDI on the clinical cardiac system were very close to 
those measured by the research platform scanner, with a mean difference of 0.18 ± 0.22 
m/s, and limits of agreement between -0.27 and +0.63 m/s, which can be considered 
reasonable for research purposes.
For the quantification of myocardial function, myocardial stiffness can potentially be 
measured non-invasively using shear wave elastography. However, using the method 
for clinical diagnosis requires high precision. In Chapter 9 we tested the reproducibility 
of measuring propagation speeds of shear waves naturally induced by aortic and mitral 
valve closure with two different clinical systems (the unmodified clinical system used 
in the previous chapter versus a modified clinical system able to reach much higher 
frame rates and full access to the raw ultrasound data). In a group of healthy volunteers, 
the inter-scan and intra-scan variabilities were found to have similar ranges. Also, the 
propagation speeds obtained on different days were reproducible. We found different 
propagation speeds between the two clinical systems. Our analysis of the differences 
found suggested that the variations measured among healthy volunteers were mainly 
caused by measurement inaccuracies. In order to achieve clinically acceptable measure-
ment precision averaging over multiple heartbeats should be used.
In Chapter 10 we apply the clinical high frame rate tissue Doppler method to measure 
the propagation velocity of naturally occurring shear waves generated by aortic and 
mitral valves closure in healthy volunteers and patients with hypertrophic cardiomy-
opathy. In HCM, the mean velocity was 5.1 ± 0.7 m/s for the aortic shear wave (3.61 ± 0.46 
m/s in matched volunteers, p < 0.0001) and 6.88 ± 1.12 m/s for the mitral shear wave(4.65 
± 0.77 m/s in matched volunteers, p < 0.0001). The very different propagation velocities 
in the two groups, practically without overlapping values, suggest that they can be used 
to assess differences between normal and pathologic myocardium. A threshold of 4 m/s 
for the aortic SW correctly classified pathologic myocardium with a sensitivity of 95% 
and specificity of 90%.
A local variation in stiffness is hypothesized to appear as a variation in the propagation 
velocity of naturally-occurring shear waves. In Chapter 11 we demonstrate that in vivo 
myocardial shear wave imaging can detect a localized variation in myocardial tissue 
properties through a variation in propagation velocity. Elasticity maps of the myocardial 
tissue could be reconstructed in the future by automatic tracking algorithms.
In cardiac high-frame-rate color tissue Doppler imaging from the apical position, a 
wave-like pattern travels over the interventricular septum after atrial contraction. The 
propagation velocity of this myocardial stretch post-atrial contraction (MSPa) was also 
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proposed as a measure of left ventricular stiffness, in a purely relaxed state. In Chapter 
12 we investigated the MSPa in patients with hypertrophic cardiomyopathy compared 
with healthy volunteers. Our results suggest that this wave-like pattern does not simply 
behave like a longitudinal wave as suggested by other authors. In about 50% of the pa-
tients it displays an acceleration in the basal to mid-septum. The reason is hypothesized 
to be the reaching of maximal longitudinal myocardial distension in HCM patients. 
Despite the initial promising results, it may not be sensitive enough for direct stiffness 
estimation through linear equations.
Left ventricular flow patterns have been studied as potential early stage markers of 
cardiac dysfunction. A relatively new method of measuring flow patterns, named echo-
particle image velocimetry (echoPIV), tracks the motion of ultrasound contrast agent 
microbubbles in the blood using echocardiography. However, the low frame rates (50-70 
Hz) permitted by the current generation of clinical ultrasound scanners causes velocity 
magnitudes during filling and ejection to be severely underestimated. This is due to the 
relatively large displacement of the bubbles between frames. The recent feasibility of 
high frame rate (HFR) echocardiography, using diverging-wave transmission schemes, 
has allowed for frame rates of up to 100 times faster than conventional imaging meth-
ods. In Chapter 13 we provide the first demonstration of echoPIV estimating the high 
velocity trans-mitral jet by using high temporal resolution in 2D, previously unobtain-
able through echoPIV with conventional frame rates.
In Chapter 14 (Discussion) we summarized the results of our research and analyzed the 
implications, the strengths and limitations of this new method, as well as future work 
needed to successfully translate it in clinical practice. We do not yet know how much the 
stiffness in itself may be characteristic of the function of the heart as a whole. Further, in 
order to have high diagnostic yield and clinical relevance in early detection of disease, 
the shear wave velocities should represent a continuum from normal to pathologic. 
This has still to be tested in theoretical models, in larger population studies in normal 
individuals and in pathological hearts.
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Hartfalen is een klinisch syndroom en is gedefinieerd door het optreden van typische 
verschijnselen als kortademigheid, moeheid, en dikke enkels. Het wordt veroorzaakt 
door een onderliggend functionele afwijking van het hart, waardoor de pompfunctie on-
voldoende is of de bloeddruk in het hart hoog is tijdens rust of inspanning. Ondanks vele 
verbeteringen in preventie, diagnose, en symptoombestrijding van hartziektes die tot 
de disfunctie kunnen leiden komt hartfalen nog altijd voor in 1 tot 2% van de volwassen 
bevolking in landen met hoge inkomsten, en komt zelfs voor in tot 10% van de mensen 
van 70 jaar of ouder. Hartfalen veroorzaakt grote kans op ziekenhuisopnames en sterfte.
Herkennen van hartfalen in de late fase van het syndroom kan echter te laat zijn voor een 
volledig herstel door behandeling gericht op het normaliseren van de hartfunctie. Reeds 
voordat de symptomen zichtbaar worden hebben patiënten al structurele of functionele 
afwijkingen voorafgaand aan het daadwerkelijke falen van het hart.
Het wordt algemeen aangenomen dat het aantonen van zulke structurele of functionele 
afwijkingen aan de hartspier, kleppen, etc. essentieel zullen zijn voor vroege herkenning 
en behandeling. In zeer vroeg stadium kunnen afwijkingen nog marginaal of zelfs afwezig 
zijn in rusttoestand, maar niet tijdens inspanning, wat vraagt om complex onderzoek.
Dit proefschrift heeft als doel om te bewijzen dat echocardiografie met hoge beeld-
frequentie en shear wave afbeeldingstechieken in het hart mogelijk zijn, en gebruikt 
kunnen worden voor het detecteren van globale en lokale stijfheid van de hartwand. De 
detectie zou klinisch relevant zijn. De methode kan mogelijk gebruikt worden voor het 
vroeg herkennen van subtiele afwijkingen die vooraf gaan aan het ontwikkelen van kli-
nisch hartfalen. Het wetenschappelijk doel van dit proefschrift was niet om een nieuwe 
technologische methode te ontwikkelen maar juist het klinische en pathofysiologische 
aspect te onderzoeken. Gebruik makend van een onverwachte technische mogelijkheid 
van een klinisch echosysteem om weefsel Doppler beelden te maken met zeer hoge 
beeldfrequentie, willen we het belang en het klinisch bericht verspreiden van de shear 
wave afbeeldingstechniek in het hart. We hopen hiermee verdere technische ontwik-
kelingen te stimuleren die uiteindelijk zullen leiden tot regulier klinisch gebruik van de 
hoge beeldfrequentie techniek in cardiologie.
BElAnGRIjKSTE BEVInDInGEn
In Deel 1 bestuderen we de huidige parameters waarmee hartfunctie wordt afgeschat 
in echocardiografie. We laten zien dat de beoordeling van de diastolische linker kamer 
functie een uitdaging blijft met echocardiografie, dat het incomplete antwoorden geeft 
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in een aanzienlijk deel van de patiëntenpopulatie en dat het onvoldoende gevoelig is 
voor vroege detectie van afwijkingen van het hart.
Hoofdstuk 2 laat in een groep van 200 patiënten zien dat in sommige gevallen het moei-
lijk is om een waardering van de diastolische dysfunctie te geven volgens het ASE/EAE 
algoritme, omdat er een discrepantie is tussen de gemeten parameters.
Retrospectief, het door ons ontwikkelde algoritme om de linker kamer diastolische 
dysfunctie te waarderen was eenvoudiger, sneller in diagnose en had een betere diag-
nostische uitkomst in vergelijking met het ASE/EAE algoritme. Het belangrijkste bericht 
is dat huidige algoritmes complex zijn en onvoldoende nauwkeurig in het afschatten van 
de linker kamer diastolische functie, vanwege de indirecte relatie tussen de gebruikte 
parameters en kamer functioneren, en de theoretische aannames in de validatie van 
elke onderliggende stap.
Eén van de cruciale parameters in diastologie is de verhouding tussen diastolische piek-
instroom bloedsnelheden en piek-snelheid van het weefsel rond de mitraal klep (E/e’ 
ratio). Dit veroorzaakte een revolutie in het begrip van diastolische functie ten opzichte 
van de eerdere methode waarbij alleen naar bloedstroomsnelheden en -patronen werd 
gekeken. Desondanks laat Hoofdstuk 3 zien dat er slechts een beperkte correlatie is 
met biomarkers die gerelateerd zijn aan verhoogde druk in de linker kamer. De hoogste 
correlatie heeft de E/e’ ratio, gemeten septaal (r= 0,384; P<0,0001) De correlatie wordt 
beïnvloed door de ejectiefractie en de aanwezigheid van co-morbiditeit (klep-lekkage, 
calcificatie van het klepbed, nierfalen, obesitas, COPD).
Hoofdstuk 4 toont de belangrijke rol van de diastolische disfunctie bij de toename 
van de pulmonaledrukken bij een oudere patienten populatie met ernstige aortaklep 
stenose en comorbiditeiten, met een belangrijke impact op de klinische traject en prog-
nostische evaluatie voor en na de TAVI-interventie.
Dilatatie van de linker boezem heeft voorspellende waarde voor verschillende hart-
ziektes, waaruit volgt dat goede beoordeling essentieel is. Technologische vooruitgang 
heeft ervoor gezorgd dat linker boezem functie kan worden gekwantificeerd met behulp 
van spikkel volgmenthode (speckle tracking) echografie.
In Hoofdstuk 5 hebben we het linker boezem functioneren van de spier en het volume 
onderzocht van een gezond cohort, en we hebben de correlatie met basiswaardes beke-
ken. In deze studie hebben we normaalwaarden kunnen vastleggen voor de drie phasen 
in het functioneren van het linker boezem, bepaald met spikkel volgmethode echografie 
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en volumetrische opnames. De gemiddelde linker-boezem rek (strain) was 39,7 ± 6,2%, 
de rek snelheid (strain rate) in vroege diastole was -2,78 ± 0,62 s-1 en de rek snelheid na 
boezem contractie was -2,56 ± 0,62 s-1 . De patiënten werden onderverdeeld in 5 leef-
tijdsgroepen (50%/50% man-vrouw verhouding). Rek en reksnelheid van de boezem in 
vroege diastole was lager in de oudste leeftijdscategorie, terwijl de boezemreksnelheid 
daarin hoger was. De reksnelheid was hoger bij mannen (-2,69 ± 0,68 s-1 tegen -2,42 ± 
0,52 s-1 ).
De methodes waarmee volumeveranderingen en deformatie van het linker boezem wor-
den gekarakteriseerd, zoals beschreven in voorgaande hoofdstuk, hangen sterk samen 
met technische factoren en zijn wellicht moeilijk te gebruiken in een klinische omgeving.
In hoofdstuk 6 bekeken we de verplaatsing van de mitraal annulus met behulp van de 
spikkel volgmethode als alternatieve methode voor het bekijken van de longitudinale 
linker-boezem functie.
Er was een grote correlatie tussen volumetrisch functie en de verplaatsing van de 
mitraal annulus, zowel voor de reservoir-functie (r=0,78; P < 0,0001) als de contractie-
functie (r = 0,76; P < 0,0001) De correlatie tussen de globale longitudinale rek (global 
longitudinal strain, GLS) en reservoir functie was r = 0,87, P > 0,0001 en r = 0,81, P < 0,0001 
met de contractiliteit. De mitraal annulus verplaatsing gaf een zeer goed onderschejd 
tussen normale en abnormale studiedeelnemers [oppervlak onder de curve (AUC) voor 
reservoir = 0,872 en voor contractiliteit  0,843; P < 0,0001], met slechtere prestaties dan 
3D echografie (AUC reservoir = 0,892 en contractiliteit = 0,915; P < 0,0001) of deformatie-
afbeelding (AUC = 0,921 en 0,903 respectivelijk; P < 0,0001), maar beter dan gepulseerde 
tissue Doppler imaging (TDI) (AUC  voor contractiliteit= 0,807; P < 0,0001). Verplaatsings-
metingen van de mitraal annulus met behulp van spikkel volgmethode is een betrouw-
bare en snelle methode om de linker boezem functie te analyseren. Vanwege de hoge 
correlatie met de meer algemene rek-methode, kan de verplaatsingsmethode gebruikt 
worden als surrogaat voor de deformatie-methode van de linker boezem.
In Hoofdstuk 7 hebben we de voorspellende waarde van echocardiografische ba-
siswaardes voor de schatting van systolische en diastolische functie vergeleken met 
herhaalde echografie in de prospectieve Bio-SHiFT studie cohort. De patiënten hadden 
stabiele chronisch hartfalen maar hadden over het algemeen weinig symptomen. Zowel 
initiële meetwaardes als repetitieve meetwaardes (Linker kamer ejectie fractie, diasto-
lische and systolische linker kamer diameter, systolische linker boezem diameter, E/A 
ratio en E/e’ ratio) waren gekoppeld aan de eindpunten van de studie. Tijdens de 2,3 
jaar-durende looptijd van de studie bleven alle waardes gemiddeld stabiel voorafgaand 
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aan een klinische gebeurtenis (ziekenhuisopname voor hartfalen, implantatie van linker 
kamer hulpapparaat, harttransplantatie, of overlijden als gevolg van hart- of vaatziekte). 
Het lijkt erop dat het regulier echocardiografische monitoren van systolische en dias-
tolische linker kamer functioneren in zo’n tijdsbestek geen voorspellende informatie 
toevoegt ten opzichte van de enkele startwaarde. Dit suggereert dat de conventionele 
echocardiografische parameters van hartfunctie onvoldoende gevoelig zijn voor vroege 
detectie van subtiele afwijkingen.
In Deel 2 stellen we een nieuwe methode voor die kijkt naar de eigenschappen van de 
hartspier met behulp van echografie met hoge beeldfrequentie en shear wave afbeel-
dingstechnieken.
De propagatiesnelheid van shear waves zijn gerelateerd aan weefsel stijfheid. In Hoofd-
stuk 8 laten we zien dat een reguliere klinisch echoscanner de snelheid van shear waves 
kan bepalen in de conventionele oorspronkelijke tissue Doppler imaging (TDI) mode in 
weefselfantomen en in vivo in parasternale probe-positie.
Het onderzoek was uitgevoerd op weefselfantomen, waarbij de shear waves werden ge-
induceerd en gevolgd met een experimenteel echosysteem als referentie. Het klinische 
systeem kon beeldfrequenties tussen de 400 en 700 beelden per seconde halen in TDI 
mode via nauwkeurige instelling van afbeeldingsparameters. De shear wave snelheden 
gemeten met het klinisch systeem zaten dicht bij de waardes gemeten met het experi-
mentele echosysteem, met een gemiddeld verschil van 0,18 ± 0,22 m/s, en zogenaamde 
limieten van overeenkomst tussen -0,27 en +0,63 m/s, wat als voldoende kan worden 
gezien voor onderzoeksdoeleinden.
De stijfheid van de hartspier, gemeten met niet-invasieve shear wave elastografie, kan 
mogelijk worden gebruikt voor kwantificatie van het functioneren van de hartspier. 
Klinische diagnose heeft echter een hoge precisie van een meting nodig. In Hoofdstuk 
9 hebben we de herhaalbaarheid bepaald van de uitkomst van shear wave propagatie-
snelheden die op natuurlijke wijze ontstaan na het sluiten van de aortaklep en de mi-
traalklep. Dit hebben we onderzocht met twee klinische systemen: de ene is de reguliere 
klinisch echoscanner zoals hiervoor beschreven, de andere is een klinisch systeem dat 
door de fabrikant is aangepast om hogere beeldfrequenties op te nemen en de data 
onbewerkt op te slaan voor latere verwerking. In een groep van gezonde vrijwilligers 
hadden de inter-scan en intra-scan waardes een vrijwel gelijk bereik. Propagatiesnelhe-
den waren herhaalbaar op verschillende dagen. We hebben verschillen gevonden in de 
waardes tussen de twee klinische systemen, die we verklaren uit verschillen in beeld-
frequentie en in verwerkingsmethode van de beelden. Uit analyse van de verschillen 
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tussen de gezonde vrijwilligers bleek dat deze voornamelijk veroorzaakt worden door 
meetonzekerheid. Deze meetonzekerheid kan verkleind worden tot klinisch acceptabele 
waardes door over meerdere hartslagen te middelen.
In Hoofdstuk 10 passen we de klinische hoge beeldfrequentie TDI toe op gezonde 
vrijwilligers en patiënten met hypertrofische cardiomyopathie (HCM) om de propagatie-
snelheid te meten na het sluiten van de aortaklep en de mitraalklep. In HCM was de ge-
middelde snelheid 5,1 ± 0,7 m/s voor de golf na sluiten van de aortaklep (3,61 ± 0,46 m/s 
in leeftijds-passende groep van gezonden, p < 0,0001) en 6,88 ± 1,12 m/s voor de shear 
wave na mitraalklepsluiting (4,65 ± 0,77 m/s in leeftijds-passende groep van gezonden, 
p < 0,0001). De significant verschillende snelheden tussen de twee groepen, vrijwel 
zonder overlappende waardes, suggereert dat ze gebruikt kunnen worden om verschil-
len te bepalen tussen normaal en pathologisch hartspierweefsel. Een drempelwaarde 
van 4 m/s voor de shear wave na sluiten van de aortaklep classificeerde pathologische 
hartspier met 95% gevoeligheid en 90% specificiteit.
Een lokale variatie in stijfheid zou moeten verschijnen als een lokale variatie in de pro-
pagatie snelheid van de natuurlijk-voorkomende shear waves. In Hoofdstuk 11 tonen 
we dit aan bij patiënten met lokaal littekenweefsel in de hartspier. Met deze techniek 
zou in de toekomst ook elasticiteitskaarten gemaakt kunnen worden met behulp van 
automatische volg-algorithmes.
In de apicale probe-positie wordt een golf-achtig patroon zichtbaar op het interventricu-
laire septum na de boezemcontractie in de hoge-beeldfrequentie TDI beelden. De propa-
gatiesnelheid van dit patroon na boezemcontractie was al eerder geïntroduceerd in de 
literatuur als maat voor de linker-kamer stijfheid in ontspannen toestand. In Hoofdstuk 
12 hebben we dit patroon onderzocht in dezelfde groep patiënten met hypertrofische 
cardiomyopathie en gezonde vrijwilligers als in hoofdstuk 8. Onze resultaten suggereren 
dat dit patroon niet de eigenschappen heeft van een longitudinale golf, in tegenstelling 
tot wat eerdere studies suggereerden. In ongeveer de helft van de patiënten laat de golf-
propagatie een acceleratie zien in het basaal-tot-midden gebied van de septale wand. 
Onze hypothese voor de reden van deze acceleratie is dat de maximale longitudinale 
rek van de linker kamer wordt bereikt in de HCM patiënten waardoor de momentane 
stijfheid zeer snel toeneemt. In tegenstelling tot eerdere hoopgevende resultaten lijkt de 
methode niet voldoende gevoelig voor stijfheidsmetingen tenzij deze acceleratie wordt 
meegenomen in de analyse.
Linker-kamer stromingspatronen zijn gemeten in eerdere studies om mogelijk vroege 
tekenen van dysfunctie van het hart te detecteren. Een relatief nieuwe manier van het 
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kwantificeren van de stromingspatronen, genaamd echo-deeltjes snelheidsafbeeldings-
techniek (echo-particle image velocimetry, echoPIV) volgt de beweging van echogra-
fische contrast middelen in het bloed. De lage framerates (50 -75 Hz) van de huidige 
generatie van klinische echoscanners zorgt echter voor aanzienlijke onderschatting van 
stroomsnelheden. Dit komt door de relatief grote verplaatsing van de microbellen in het 
contrastmiddel tussen de opeenvolgende beelden. De recente mogelijkheden van hoge 
beeldfrequentie echografie, nu aangepast voor detectie van deze contrastmiddelen, 
geeft een beeldfrequentie die tot 100 keer hoger is dan op de conventionele scanners. 
In Hoofdstuk 13 geven we hiermee een eerste voorbeeld van echoPIV waarbij we de 
snelheid schatten van de hoge-snelheids trans-mitrale pluim in 2D, wat niet mogelijk 
was met voorgaande conventionele beeldfrequenties.
De discussie vat de resultaten samen van ons onderzoek en analyseert de implicaties, 
sterktes en limitaties van deze nieuwe methode. Het bevat ook een vooruitblik op het 
mogelijk pad in de richting van klinische toepassing. We weten nog niet of stijfheid an 
sich een goede maat is voor het functioneren van het hart in zijn geheel. Verder, om 
hoge diagnostische opbrengst en klinische relevantie te hebben in de vroege detectie 
van hartfalen, moeten de shear wave snelheden een continu verloop hebben in de ont-
wikkeling van normaal naar pathologisch. Deze twee punten moet nog getest worden in 
theoretische modellen, in grotere controlegroepen, en in pathologische harten.
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